PFDWEEK2017 OCTOBER 3-7 | RHODE ISLAND CONVENTION CENTER | PROVIDENCE, RI

CONFERENCE PROGRAM #PFDWeek NON109895-2017-AUGS PFD Meet-Experts Program Ad.qxp 9/7/17 12:20 PM Page 1

PFD WEEK 2017

Proud to be a Platinum Sponsor Fellow's Day Lunch Program Sponsor Allied Health Professionals Lunch Program Sponsor

Please visit us at the Allergan Booth MEET THE EXPERTS

Weds 10/4 5:30 PM - 6:30 PM Sangeeta Mahajan, MD

Weds 10/4 6:30 PM - 7:30 PM Michael Kennelly, MD

Thurs 10/5 10:30 AM - 11:00 AM Karyn Eilber, MD

Thurs 10/5 5:30 PM - 6:30 PM Michael Kennelly, MD

Fri 10/6 10:00 AM - 10:30 AM Sangeeta Mahajan, MD

Allergan sincerely appreciates the AUGS and community for your continued focus and support in bringing excellence to patient care

© 2017 Allergan. All rights reserved. All trademarks are the property of their respective owners. NON109895 08/17 NON109895-2017-AUGS PFD Meet-Experts Program Ad.qxp 9/7/17 12:20 PM Page 1

PFD WEEK PROGRAM COMMITTEE PFD WEEK 2017 Dear fellow AUGS Friends and Colleagues, Cheryl Iglesia, MD Eric Sokol, MD th Committee Chair Workshop Chair Welcome to the AUGS 38 Annual Scientific Meeting in beautiful Providence, Rhode Island, where the city motto is, Felicia Lane, MD Heather van Raalte, MD “What Cheer!” Committee Vice-Chair Workshop Vice Chair The 2017 AUGS Pelvic Floor Disorders (PFD) Week is the go-to meeting for healthcare professionals interested in or Members: actively practicing Female Pelvic Medicine and Reconstructive PFD WEEK 2017 Jan Baker, MS, APRN Peter Jeppson, MD . We are excited to kick off the meeting festivities. Elizabeth Geller, MD Una Lee , MD The 2017 Program Committee and I have created a robust Proud to be a John Gleason, MD John Occhino, MD, MS scientific program showcasing national and international research of the highest caliber on relevant topics that can Platinum Sponsor Oz Harmanli, MD Christopher Tarnay, MD be immediately implemented into your practices. This year’s event features a wide array of learning opportunities, Fellow's Day Lunch Program Sponsor Abstract Review Committee: including 18 workshops chaired by experts in the field, 25 A. Lenore Ackerman, MD Peter Jeppson, MD roundtable discussions, and more than 200 oral, oral poster, poster, and video presentations. Allied Health Professionals Lunch Program Sponsor Marianna Alperin, MD, MS Nicole Korbly, MD New conference features include a clinical seminar and Mallika Anand, MD, MS Bela Kudish, MD, MS surgical tutorial as well as a master surgeon session. Other Jan Baker, MS, APRN Felicia Lane, MD meeting highlights are the not-to-be-missed interactive Daniel Biller, MD, MMHC Una Lee, MD and lively debates, and three very relevant expert panels on product liability, payment reform, and prevention of urinary Lauren Anne Cadish, MD Lioudmila Lipetskaia, MD incontinence incorporating the most up-to-date evidence on Chi Chiung Grace Chen, MD Please visit us at the Allergan Booth Jaime Long, MD behavioral and basic science. Sara Cichowski, MD MEET THE EXPERTS Jeannine Miranne, MD, MS PFD Week is a great opportunity to connect with friends and Seth Ashley Cohen, MD Leah Moynihan, RNC, MSN colleagues—old and new! We encourage you to utilize our networking events and dedicated Exhibit Hall times to connect Catrina Crisp, MD, MS, Tyler Muffly, MD Weds 10/4 5:30 PM - 6:30 PM Sangeeta Mahajan, MD FACOG with exhibitors and share lessons learned and best practices. Diane Newman, DNP, FAAN, Christina Dancz, MD For all you divas and divos out there—please join us for the Weds 10/4 6:30 PM - 7:30 PM Michael Kennelly, MD BCB-PMO Friday AUGSome Beach Carnival at the WaterFire Arts Center! Vani Dandolu, MD, MPH, MBA Gina Northington, MD, PhD The AUGSome Beach Carnival is family-friendly and offers a Thurs 10/5 10:30 AM - 11:00 AM Karyn Eilber, MD Keith Downing, MD perfect opportunity to relax and showcase your singing and John Occhino, MD, MS Gena Dunivan, MD dancing talents. We are all so excited to see your creativity Thurs 10/5 5:30 PM - 6:30 PM Michael Kennelly, MD Begum Ozel, MD during this year’s karaoke challenge! Tola Fashokun, MD Amy Park, MD We hope you enjoy your time in Providence and return home Fri 10/6 10:00 AM - 10:30 AM Sangeeta Mahajan, MD Elizabeth Geller, MD Danielle Patterson, MD, MSc with an expanded network, a renewed spirit, and more Dobie Giles, MD, MS knowledge to share. Lee Richter, MD Jonathan Gleason, MD In Peace and Good Cheer, Ying Sheng, MSN, RN Cara Grimes, MD, MAS Eric Sokol, MD Allergan sincerely appreciates the Oz Harmanli, MD Christopher Tarnay, MD AUGS and Urogynecology community Heidi Harvie, MD, MSCE, MBA Cecile Unger, MD for your continued focus and support Juana Hutchinson-Colas, Cheryl Iglesia, MD MD, MBA Heather van Raalte, MD in bringing excellence to patient care AUGS PFD Week Program Committee Chair Cheryl Iglesia, MD Emily Whitcomb, MD, MAS @cheryliglesia Karl Jallad, MD Ladin Yurteri-Kaplan, MD #PFDWeek

© 2017 Allergan. All rights reserved. All trademarks are the property of their respective owners. NON109895 08/17 PFD WEEK 2017 OCT 3 – 7 3 TABLE OF CONTENTS

Meeting Information...... 5 Industry Supported Education...... 27

Continuing Education...... 7 Scientific Program Tuesday...... 28 Networking Events...... 8 Wednesday...... 28 Non-Educational Industry Supporters...... 11 Thursday...... 28 Schedule at-a-Glance...... 12 Friday...... 36 Saturday...... 46 Concurrent Schedule at-a-Glance...... 14 Exhibit Hall Floor Plan...... 48 Pre-Conference Workshop Schedule...... 20 Exhibitor Listing...... 49 Fellows’ Day...... 22

Meet the Experts Educational Roundtables...... 23 Exhibitor Directory ...... 51

General Scientific Sessions...... 24 AUGS Award Recipients...... 56

Special Sessions...... 25 PFD Research Award Recipients...... 57

Keynote Presentations...... 26 AUGS Leadership...... 60

ENHANCE YOUR MEETING EXPERIENCE WITH THE PFD WEEK MOBILE APP Connect with fellow attendees and access program details all through your mobile device. Search “AUGS PFD Week” in the Apple App Store or Google Play Store to download the app. • Quickly reference meeting logistics including times and locations • Search the meeting schedule and build your personal agenda • Find your favorite speakers and view all the sessions he/she is presenting • Access the 2017 exhibitor list and navigate the Exhibit Hall

4 PFD WEEK 2017 OCT 3 – 7 MEETING INFORMATION

ATTENDEE SERVICES DESK HOURS EXHIBIT HALL HOURS Tuesday, October 3 Wednesday, October 4 | 5:30 p.m. – 7:30 p.m. 7:30 a.m. – 5:00 p.m. 5:30 p.m. – 7:30 p.m. Wednesday, October 4 Welcome Reception in the Exhibit Hall 7:15 a.m. – 5:30 p.m. Thursday, October 5 | 10:30 a.m. – 6:30 p.m. Thursday, October 5 10:30 a.m. – 11:00 a.m. 6:15 a.m. – 6:00 p.m. Break in Exhibit Hall Friday, October 6 11:45 a.m. – 1:30 p.m. 6:15 a.m. – 5:30 p.m. Lunch in Exhibit Hall Saturday, October 7 5:30 p.m. – 6:30 p.m. 6:15 a.m. – 1:30 p.m. Exhibit Hall Happy Hour SPEAKER READY ROOM Friday, October 6 | 9:45 a.m. – 2:45 p.m. Room 558 A 9:45 a.m. – 10:15 a.m. AUGS provides a room for all speakers to review and submit their Break in Exhibit Hall presentations before their session. To better serve you, this process 1:00 p.m. – 2:45 p.m. must be completed at least three hours prior to your session. Lunch in Exhibit Hall Tuesday, October 3 6:30 a.m. – 6:30 p.m. Wednesday, October 4 6:30 a.m. – 6:30 p.m. FIND GARRETT POPCORN IN THE EXHIBIT HALL Thursday, October 5 6:30 a.m. – 4:30 p.m. Celebrate the return of PFD Week to Friday, October 6 Chicago early with Garrett Popcorn! 6:30 a.m. – 6:00 p.m. What makes this treat even sweeter? Find the Saturday, October 7 7:30 a.m. – 10:00 a.m. hidden popcorn in the Exhibit Hall and your reward could be free registration to PFD Week 2018 in Chicago!

PFD WEEK 2017 OCT 3 – 7 5 Stop by AUGS Booth #317 to Discover all that We Offer

Join AUGS, Renew Your Membership, or Just Stop In

Grab a special treat at the Welcome Reception on Wednesday, October 4 at 5:30 p.m. – 7:30 p.m.! AUGS Booth • NEW! Test the POP-Q Interactive • LEARN how you can participate in the Assessment Tool, which is now also AUGS Urogynecology Quality Registry available as an app (AQUIRE) – Your tool for PQRS and MIPS reporting • NEWLY EXPANDED TOPICS! Take home copies of our Patient Fact Sheets • DISCOVER how to become a member and other patient resources or learn more about your AUGS membership benefits

Dedicated to Research, Education, and Advocacy

Designs are confidential and the exclusive property of T3 Expo, LLC. Designs are provided solely for the purpose of evaluating T3 Expo’s proposal. Designs may not be used for any other purpose or reproduced or publicly disclosed without T3 Expo’s written consent. 050317v05 CONTINUING EDUCATION

WHO SHOULD ATTEND EDUCATION CREDITS PFD Week is for physicians, nurses, physical therapists, Creighton University designates this live activity for a maximum students, researchers, educators, and other healthcare of 32.0 AMA PRA Category 1 Credit(s)™. Physicians should professionals interested in Female Pelvic Medicine and claim only the credit commensurate with the extent of their Reconstructive Surgery. New treatment techniques and participation in the activity. (10/3=7.0 credits; 10/4=7.0 credits; developments in both surgical and non-surgical settings will 10/5=6.25 credits; 10/6=7.0 credits; 10/7=4.75 credits) AAPA be shared through a variety of educational formats designed accepts AMA category 1 credit for the PRA from organizations to encourage interactive discussion. Scientific material will accredited by ACCME. be presented through lectures, posters, videos, recorded Nurses CE , and tips and tricks presentations. Creighton University Health Sciences Continuing Education EDUCATIONAL GOALS AND OBJECTIVES designates this activity for up to 32.0 contact hour(s) for nurses. Nurses should claim only the credit commensurate with the • Describe and discuss the pathophysiology of pelvic extent of their participation in the activity (10/3=7.0 credits; floor disorders, including pelvic organ , urinary 10/4=7.0 credits; 10/5=6.25 credits; 10/6=7.0 credits; incontinence, fecal incontinence, and 10/7=4.75 credits) • Identify risk factors and the epidemiology of pelvic Accreditation Statement floor disorders This activity has been planned • Delineate the impact of pelvic floor disorders on the quality and implemented by Creighton of life for women who suffer from these conditions University Health Sciences Continuing Education (HSCE) and • Review and discuss the tools to assess and quantify pelvic the American Urogynecologic floor disorders Society (AUGS) for the advancement • Explain non-surgical and surgical treatments used to manage of patient care. Creighton University Health Sciences Continuing pelvic floor disorders Education is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy • Identify methods for preventing lower urinary tract symptoms Education (ACPE), and the Accreditation Council for Continuing • Review methods for treating mesh related complications Medical Education (ACCME) to provide continuing education for the healthcare team. • Identify methods to avoid nerve injury during pelvic surgery • Describe indications for uterine preservations during prolapse surgery

PFD WEEK 2017 OCT 3 – 7 7 NETWORKING EVENTS

SPECIAL INTEREST GROUPS (SIGS) Mesh/Graft Use in Pelvic Reconstructive Surgery BUSINESS MEETINGS Chair: Vince Lucente, MD, FACOG AUGS Special Interest Groups (SIGs) provide a sense of Vice Chair: Andrew P. Cassidenti, MD community and focused education around specific areas of Meeting Information: Wednesday, October 4, 4:30 p.m. – 6:00 p.m. interest in the field of FPMRS. All attendees are welcome to join Rotunda (Convention Center) the SIG meetings to learn more about each SIG’s activities and Private Practice become involved with AUGS. The SIGs below will be meeting Chair: Jorge F. Peacher, MD during PFD Week. Vice Chair: Magdalene Karon, MD Advanced Practice, Physical Therapy, and Meeting Information: Friday, October 6, 6:45 a.m. – 7:45 a.m. Allied Health (APPTAH) Room 555 Chair: Ingrid Harm-Ernandes, PT, WCS, BCBPMD Vice Chair: Jan Baker, MS, APRN PFD WEEK WELCOME RECEPTION Change doesn’t take commitment, Meeting Information: Wednesday, October 4, 4:30 p.m. – 6:00 p.m. Wednesday, October 4 leadership, or collaboration... Ballroom A 5:30 p.m. – 7:30 p.m. | Exhibiton Hall AB Basic Science Kick-off PFD Week at the Welcome Reception! This is your first opportunity to catch up with colleagues while you meet with Chair: Matthew Fraser, PhD industry exhibitors and enjoy light refreshments. Vice Chair: Marianna Alperin, MD, MS It takes all three. Meeting Information: Friday, October 6, 6:45 a.m. – 7:45 a.m. EXHIBIT HALL HAPPY HOUR Room 553 Thursday, October 5 As leaders in Urology, we relentlessly pursue new science to make Electronic Medical Record (EMR) 5:30 p.m. – 6:30 p.m. | Exhibiton Hall AB a difference in patients’ lives. We make it our priority to stay on Chair: Adam S. Holzberg, DO, FACOG Join AUGS in the Exhibit Hall for a happy hour and celebration Vice Chair: Audrey E. Curtis, MD of PFD Week. Visit the 2017 exhibitors and stop by the AUGS the cutting edge of urologic research to address unmet clinical Meeting Information: Thursday, October 5, 6:45 a.m. – 7:45 a.m. booth, while you mingle with peers and make new connections. and patient needs. And our commitment extends beyond product Room 551 FELLOWSHIP PROGRAM MEET-AND-GREET development. We seek to support the Urology community and Fellows FOR RESIDENTS to improve the lives of patients with urologic disease. Chair: Lauren Siff, MD Thursday, October 5 Vice Chair: Emily Wu, MD 5:30 p.m. – 6:30 p.m. | Exhibiton Hall AB (rear of hall) Meeting Information: Fellows’ Day, Wednesday, October 4, 7:45 a.m. – 5:00 p.m. During the Exhibit Hall happy hour, residents will have an Ballroom B opportunity to learn more about FPMRS fellowship programs from across the country. Changing tomorrow together, today. Fellowship Program Directors Chair: Felicia Lane, MS, MD AUGSOME BEACH CARNIVAL Vice Chair: Elizabeth Geller, MD Friday, October 6 Meeting Information: Fellowship Program Directors’ Workshop, 7:00 p.m. – 11:00 p.m. | WaterFire Arts Center Wednesday, October 4, 8:00 a.m. – 4:00 p.m. Join AUGS for a beach party, complete with carnival-inspired Room 555 games, food, drinks, and much more. As always, the AUGSome Global Health event is home to the Karaoke Challenge — sign up now in the AUGS booth! All ticket sales benefit the PFD Research Foundation. Chair: Joan L. Blomquist, MD Vice Chair: Rahel Nardos, MD Meeting Information: Wednesday, October 4, 4:30 p.m. – 6:00 p.m. Providence Ballroom I & IV (Omni)

©2015 Astellas Pharma US, Inc. All rights reserved. Printed in USA 080-0578-PM November 2015

8 PFD WEEK 2017 OCT 3 – 7

2017_ACOG_ASTELLAS_CORPORATEAD.indd 1 3/24/17 10:51 AM Change doesn’t take commitment, leadership, or collaboration... It takes all three.

As leaders in Urology, we relentlessly pursue new science to make a difference in patients’ lives. We make it our priority to stay on the cutting edge of urologic research to address unmet clinical and patient needs. And our commitment extends beyond product development. We seek to support the Urology community and to improve the lives of patients with urologic disease.

Changing tomorrow together, today.

©2015 Astellas Pharma US, Inc. All rights reserved. Printed in USA 080-0578-PM November 2015

2017_ACOG_ASTELLAS_CORPORATEAD.indd 1 3/24/17 10:51 AM The AUGS POP-Q Tool is Now Available for Desktop and Mobile

You can now use the POP-Q Interactive Assessment Tool to show pelvic floor exam results to your patients on your desktop computer or mobile device.

• Enter POP-Q Scores • Educate Patients Before and After Surgery • Visually Demonstrate Captured Patient • Option to Print Patient- Measurements Specific Results

Now Available at www.augs.org/patient-services/pop-q-tool NON-EDUCATIONAL INDUSTRY SUPPORTERS

THANK YOU TO THE 2017 PFD WEEK SPONSORS!

PLATINUM LEVEL SPONSORS Allergan Coloplast Boston Scientific Medtronic, Inc.

GOLD LEVEL SPONSOR Astellas

BRONZE LEVEL SPONSORS

Caldera Medical Neomedic International Thermi Intuitive Surgical Sciton Viveve

COPPER LEVEL SPONSORS

ACell Innovation Compounding, Inc. V-Revive Ethicon Pelvalon

PFD WEEK 2017 OCT 3 – 7 11 SCHEDULE AT-A-GLANCE

TUESDAY, OCTOBER 3 7:30 a.m. – 5:00 p.m. Registration Open | Exhibit Level Atrium 8:30 a.m. – 12:00 p.m. Pre-Conference Workshops | See pages 20–21 1:30 p.m. – 5:00 p.m. Pre-Conference Workshops | See pages 20–21 WEDNESDAY, OCTOBER 4 7:15 a.m. – 5:30 p.m. Registration Open | Exhibit Level Atrium 7:45 a.m. – 5:00 p.m. Fellows’ Day | Ballroom B | See page 22 8:00 a.m. – 3:00 p.m. Program Directors’ Workshop | Room 555 8:30 a.m. – 12:00 p.m. Pre-Conference Workshops | See pages 20–21 11:45 p.m. – 1:15 p.m. The Future of Treating Moderate to Severe Dyspareunia: A New, Locally Administered Treatment for Moderate to Severe Dyspareunia Due to Menopause supported by AMAG | Rotunda | See page 27 1:00 p.m. – 5:00 p.m. Pre-Conference Workshops | See pages 20–21 3:00 p.m. – 3:45 p.m. Bonus Session: Post or Perish | Room 553 | See page 21 4:00 p.m. – 4:45 p.m. Bonus Session: Future of Medicine and Technology: The Art of the Possible | Room 553 | See page 21 4:30 p.m. – 6:00 p.m. SIG Meetings: Advanced Practice, Physical Therapy, and Allied Health (APPTAH); Global Health; Mesh/Graft Use in Pelvic Reconstructive Surgery | See page 8 5:30 p.m. – 7:30 p.m. Welcome Reception in the Exhibit Hall | Exhibition Hall AB THURSDAY, OCTOBER 5 6:15 a.m. – 6:00 p.m. Registration Open | Exhibit Level Atrium 6:30 a.m. – 7:30 a.m. The Use of Multimodal Analgesia to Reduce Opioid Use in Urogynecological Procedures supported by Pacira | Room 552 | See page 27 6:45 a.m. – 7:45 a.m. Meet the Experts Educational Roundtables | Rotunda | See page 23 6:45 a.m. – 7:45 a.m. SIG Meeting: Electronic Medical Records (EMR) | See page 8 8:00 a.m. – 8:15 a.m. Welcome and Introduction | Exhibition Hall C 8:15 a.m. – 9:15 a.m. General Scientific Session I | Exhibition Hall C 9:15 a.m. – 10:30 a.m. State of the Society Presidential Address | Exhibition Hall C 10:30 a.m. – 11:00 a.m. Break in the Exhibit Hall | Exhibition Hall AB 11:00 a.m. – 11:45 a.m. Scientific Concurrent Sessions 1–3 | Ballroom A–E | See page 14 11:00 a.m. – 12:00 p.m. Clinical Seminar: Abnormal Uterine Bleeding: Wading through the Evidence on Evaluation and Treatment Effectiveness | Room 551 | See page 25 11:45 a.m. – 1:30 p.m. Lunch in the Exhibit Hall | Exhibition Hall AB 12:00 p.m. – 1:30 p.m. Improving Your Efficiency: New Digital Resources to Address Physician Needssupported by Boston Scientific | Room 555 | See page 27

1:30 p.m. – 2:00 p.m. Sling Selections and What to do When They Fail! | Exhibition Hall C | See page 24 2:00 p.m. – 2:30 p.m. Raymond A. Lee Lecture: Life-long Learning, Loving What You Do, and Paying It Forward | Exhibition Hall C | See page 26 Presented by Marie Fidela Rustia Paraiso, MD 2:30 p.m. – 2:40 p.m. FPMRS Journal Update | Exhibition Hall C 2:45 p.m. – 4:00 p.m. General Scientific Session II | Exhibition Hall C 4:00 p.m. – 4:15 p.m. Break | Exhibit Level Atrium

12 PFD WEEK 2017 OCT 3 – 7 4:15 p.m. – 5:15 p.m. Scientific Concurrent Sessions 4–6 |Ballroom A–E | See pages 14-15 4:15 p.m. – 5:15 p.m. Surgical Tutorial: Laparoscopic and Robotic Sacrocolpopexy Pearls | Room 551 | See page 25 5:30 p.m. – 6:30 p.m. Exhibit Hall Happy Hour | Exhibition Hall AB 5:30 p.m. – 6:30 p.m. Fellowship Program Meet-and-Greet for Residents | Exhibition Hall AB (rear of hall) FRIDAY, OCTOBER 6 6:15 a.m. – 5:30 p.m. Registration Open | Exhibit Level Atrium 6:45 a.m. – 7:45 a.m. Meet the Experts Educational Roundtables | Rotunda | See page 23 6:45 a.m. – 7:45 a.m. SIG Meetings: Basic Science, Private Practice | See page 8 8:00 a.m. – 8:05 a.m. Welcome and Introduction | Exhibition Hall C 8:05 a.m. – 8:15 a.m. PFD Research Foundation Update | Exhibition Hall C 8:15 a.m. – 8:45 a.m. Mesh Removal Debate | Exhibition Hall C | See page 24 8:45 a.m. – 9:45 a.m. General Scientific Session III | Exhibition Hall C 9:45 a.m. – 10:15 a.m. Break in the Exhibit Hall | Exhibition Hall AB 10:15 a.m. – 10:50 a.m. J. Marion Sims Lecture: Vesico-Vaginal : Historical Understanding, Medical Ethics, and Modern Sensibilities | Exhibition Hall C Presented by L. Lewis Wall, MD, DPhil 10:50 a.m. – 11:35 a.m. Prevention of : A Behavioral and Basic Science Perspective | Exhibition Hall C | See page 24 11:35 a.m. – 11:55 a.m. Treatment of Non-Neurogenic Urinary Retention: When and When Not to Intervene – Recommendations from the AUA | Exhibition Hall C Presented by Gary Lemack, SUFU President 11:55 a.m. – 1:00 p.m. General Scientific Session IV | Exhibition Hall C 1:00 p.m. – 2:30 p.m. Laser Applications in Vaginal Health Specifically Related to GSM, SUI, and Atrophysupported by Alma Lasers | Room 555 | See page 27 1:00 p.m. – 2:30 p.m. Single-Incision Slings: Data, Barriers, and the Patient Experience supported by Coloplast | Room 552 | See page 27 1:00 p.m. – 2:45 p.m. Lunch in the Exhibit Hall | Exhibition Hall AB 2:45 p.m. – 4:00 p.m. Scientific Concurrent Sessions 7–9 | Ballroom A–E | See page 16 3:15 p.m. – 5:00 p.m. Video Café | Room 553 4:00 p.m. – 4:15 p.m. Break | Exhibit Level Atrium 4:15 p.m. – 5:30 p.m. Scientific Concurrent Sessions 10–12 | Ballroom A–E | See page 17 7:00 p.m. – 11:00 p.m. AUGSome Beach Carnival and Karaoke Challenge | WaterFire Arts Center SATURDAY, OCTOBER 7 8:00 a.m. – 1:30 p.m. Registration Open | Exhibit Level Atrium 8:30 a.m. – 8:35 a.m. Announcements and Preview of 2018 | Exhibition Hall C 8:35 a.m. – 9:30 a.m. General Scientific Session V | Exhibition Hall C 9:30 a.m. – 10:30 a.m. Insights on How to Navigate Product Controversy | Exhibition Hall C | See page 24 10:30 a.m. – 10:45 a.m. Break 10:45 a.m. – 11:30 a.m. Master Surgeon Presentations | Exhibition Hall C | See page 25 11:30 a.m. – 12:30 p.m. General Scientific Session VI | Exhibition Hall C 12:30 p.m. – 1:30 p.m. What Are Urogynecologists Going to Get Paid and How? | Exhibition Hall C | See page 25 1:30 p.m. Adjourn

KEY: = Virtual Conference = This session requires a ticket

PFD WEEK 2017 OCT 3 – 7 13 CONCURRENT SCHEDULE AT-A-GLANCE

THURSDAY, OCTOBER 5 | 11:00 a.m. – 11:45 a.m. TIME SCIENTIFIC CONCURRENT SCIENTIFIC CONCURRENT TIME SCIENTIFIC CONCURRENT SESSION 3 — SESSION 1 — SURGERY SESSION SESSION 2 — QUALITY OF LIFE/ BASIC SCIENCE SESSION BALLROOM A HEALTH SERVICES RESEARCH SESSION BALLROOM D/E BALLROOM B/C 11:00 a.m. – Oral Poster 1 — RESPONSIVENESS AND Oral Poster 7 — RECOVERING SEXUAL 11:00 a.m. – Oral Poster 13 — BIG POTASSIUM (BK) CHANNEL 11:04 a.m. MINIMALLY IMPORTANT DIFFERENCE SATISFACTION AFTER PROLAPSE SURGERY 11:04 a.m. REGULATES IN VIVO UROTHELIAL CYTOKINE RELEASE OF SF-6D AND EQ-5D UTILITY SCORES INDUCED BY LIPOPOLYSACCHRIDE: NEW INSIGHT FOR THE TREATMENT OF PELVIC ORGAN INTO UROTHELIAL INNATE IMMUNE RESPONSE IN PROLAPSE PATHOGENESIS OF 11:04 a.m. – Oral Poster 2 — THE PATIENT Oral Poster 8 — THE PURSUIT OF MOBILE 11:04 a.m. – Oral Poster 14 — IN VIVO EVALUATION OF THE 11:08 a.m. PERSPECTIVE ON PELVIC FLOOR APPLICATIONS FOR PATIENTS WITH PELVIC 11:08 a.m. HOST RESPONSE TO AN ELASTOMERIC MESH: AN DISORDERS SURGICAL ADVERSE EVENTS FLOOR DISORDERS ALTERNATIVE TO POLYPROPYLENE MESH 11:08 a.m. – Oral Poster 3 — PREDICTIVE FACTORS Oral Poster 9 — INCONTINENCE & 11:08 a.m. – Oral Poster 15 — THE IMPACT OF COMMON 11:12 a.m. OF POSTOPERATIVE PAIN FOLLOWING INTIMATE PARTNERS CLINICAL TRIAL: 11:12 a.m. VAGINAL LUBRICANTS ON E. COLI VAGINAL RECONSTRUCTIVE SURGERY THE SEXUAL BENEFIT OF SUCCESSFUL TREATMENT (IIMPACT) 11:12 a.m. – Oral Poster 4 — PREDICTORS OF Oral Poster 10 — TOPICAL LIDOCAINE 11:12 a.m. – Oral Poster 16 — RETHINKING THE URINARY 11:16 a.m. SUCCESS AT 5 YEARS POST-IMPLANT FOR URODYNAMIC TESTING: A DOUBLE 11:16 a.m. CATHETER: LESS TRAUMA THRU BETTER OF THE INTERSTIM SYSTEM FOR BLINDED RANDOMIZED CONTROL TRIAL DESIGN—A SHEEP MODEL OVERACTIVE BLADDER 11:16 a.m. – Questions for Oral Posters 1–4 Questions for Oral Posters 7–10 11:16 a.m. – Questions for Oral Posters 13–16 11:20 a.m. 11:20 a.m. 11:20 a.m. – Oral Poster 5 — A RANDOMIZED Oral Poster 11 — LONG TERM SEXUAL 11:20 a.m. – Oral Poster 17 — DETERMINATION OF LOXL1 AND 11:24 a.m. CONTROLLED TRIAL OF POST-OPERATIVE FUNCTION AFTER OBSTETRIC ANAL 11:24 a.m. FIBULIN-5 LEVELS IN THE VAGINAL SECRETIONS

11:00 a.m. – 11:45 a.m. 11:00 a.m. PELVIC FLOOR PHYSICAL THERAPY AFTER SPHINCTER INJURIES OF WOMEN WITH AND WITHOUT PELVIC ORGAN VAGINAL RECONSTRUCTIVE SURGERY PROLAPSE 11:24 a.m. – Oral Poster 6 — ENHANCED RECOVERY Oral Poster 12 — ACCIDENTAL BOWEL 11:24 a.m. – Oral Poster 18 — THE URINARY MICROBIOME IN 11:28 a.m. AFTER UROGYNECOLOGIC SURGERY: LEAKAGE EVALUATION (ABLE): A NEW 11:28 a.m. WOMEN WITH MIXED URINARY INCONTINENCE A SURVEY OF PATIENT EXPERIENCE PATIENT-CENTERED VALIDATED MEASURE OF ACCIDENTAL BOWEL LEAKAGE SYMPTOMS 11:28 a.m. – Video 2 — PERSISTENT VAGINAL Video 3 — SACROCOLPOPEXY 11:28 a.m. – Oral Poster 19 — NATURAL HISTORY OF AN ACUTE 11:34 a.m. LEAKAGE IN THE SETTING OF AN APICAL MODIFICATION IN THE SETTING OF A 11:32 a.m. URINARY TRACT INFECTION IN A YOUNG WOMAN VAGINAL SINUS TRACT PELVIC KIDNEY 11:34 a.m. – Questions for Oral Posters 5–6 Questions for Oral Posters 11–12 11:32 a.m. – Oral Poster 20 — EXPLORATION OF A 11:40 a.m. 11:36 a.m. REGENERATIVE EXTRACELLULAR MATRIX BIOSCAFFOLD IN SACROCOLPOPEXY: IMPACT ON VAGINAL SMOOTH MUSCLE 11:36 a.m. – Oral Poster 21 — IMPACT OF A REGENERATIVE ECM 11:40 a.m. BIOSCAFFOLD ON VAGINAL SMOOTH MUSCLE 11:40 a.m. – Questions for Oral Posters 17–21 11:45 a.m.

THURSDAY, OCTOBER 5 | 4:15 p.m. – 5:15 p.m. TIME SCIENTIFIC CONCURRENT TIME SCIENTIFIC CONCURRENT TIME SCIENTIFIC CONCURRENT SESSION 4 — HOT TOPICS IN SESSION 5 — EPIDEMIOLOGY SESSION 6 — BASIC SCIENCE II SURGERY AND QUALITY OF LIFE AND OTHER PELVIC FLOOR SESSION SESSION DISORDERS SESSION BALLROOM D/E BALLROOM A BALLROOM B/C 4:15 p.m. – Oral Poster 22 — MATERNAL LOWER 4:15 p.m. – Oral Poster 31 — GENOME-WIDE 4:15 p.m. – Oral Poster 41 — CHARACTERIZATION 4:19 p.m. URINARY TRACT INJURY AT THE TIME OF 4:19 p.m. ASSOCIATION STUDY FOR URINARY 4:19 p.m. OF THE T CELL POPULATION IN VAGINAL PERIPARTUM AND FECAL INCONTINENCE IN WOMEN MESH REMOVED FROM WOMEN WITH 4:15 p.m. – 5:15 p.m. – 5:15 p.m. 4:15 p.m. COMPLICATIONS

14 PFD WEEK 2017 OCT 3 – 7 Scientific Program

THURSDAY, OCTOBER 5 | 4:15 p.m. – 5:15 p.m. (continued) 4:19 p.m. – Oral Poster 23 — CORRELATION OF 4:19 p.m. – Oral Poster 32 — OPERATING ROOM 4:19 p.m. – Oral Poster 42 — OVEREXPRESSION OF 4:23 p.m. VIRTUAL REALITY SIMULATION AND DRY 4:23 p.m. EFFICIENCY: EXAMINING THE ROLE OF 4:23 p.m. ORNITHINE DECARBOXYLASE (ODC) IN LAB ROBOTIC TECHNICAL SKILLS PERSONNEL HANDOFFS BLADDER UROTHELIUM RECAPITULATES OVERACTIVE BLADDER (OAB) PHENOTYPE 4:23 p.m. – Oral Poster 24 — DID THE 2015 4:23 p.m. – Oral Poster 33 — FACE: FEMALE 4:23 p.m. – Oral Poster 43 — DETECTING 4:27 p.m. NATIONAL HEALTH INSURER POLICY 4:27 p.m. PELVIC MEDICINE & RECONSTRUCTIVE 4:27 p.m. UROPATHOGENS IN A UROGYNECOLOGIC REQUIRING PRIOR AUTHORIZATION FOR SURGERY AWARENESS CAMPAIGN: POPULATION: A COMPARISON OF UTI NON-VAGINAL HYSTERECTOMY ROUTES INCREASING EXPOSURE DIAGNOSTIC THRESHOLDS INCREASE UTILIZATION OF VAGINAL HYSTERECTOMY? 4:27 p.m. – Oral Poster 25 — DOES MESH WEIGHT 4:27 p.m. – Oral Poster 34 — VARIATION IN 4:27 p.m. – Oral Poster 44 — THE VAGINAL 4:31 p.m. AFFECT TIME TO FAILURE AFTER 4:31 p.m. PATIENT REFERRAL NETWORKS 4:31 p.m. AND URINARY MICROBIOME IN ROBOTIC-ASSISTED LAPAROSCOPIC TO FEMALE PELVIC MEDICINE AND PREMENOPAUSAL WOMEN WITH SACROCOLPOPEXY? RECONSTRUCTIVE SURGEONS ACROSS INTERSTITIAL CYSTITIS/PAINFUL THE BLADDER SYNDROME AS COMPARED TO NORMAL CONTROLS: A COHORT STUDY 4:31 p.m. – Questions for Oral Posters 22–25 4:31 p.m. – Questions for Oral Posters 31–34 4:31 p.m. – Questions for Oral Posters 41–44 4:35 p.m. 4:35 p.m. 4:35 p.m. 4:35 p.m. – Oral Poster 26 — TOBACCO USE, 4:35 p.m. – Oral Poster 35 — REFRACTORY 4:35 p.m. – Oral Poster 45 — LACTOBACILLUS 4:39 p.m. PSYCHIATRIC, IMMUNOSUPPRESSIVE, 4:39 p.m. PUDENDAL PAIN AND PELVIC 4:39 p.m. SPECIES INHIBIT GROWTH OF E. COLI AND CHRONIC PAIN CONDITIONS FLOOR DYSFUNCTION CAUSED BY ARE PREVALENT IN WOMEN WITH INTRAPELVIC NERVE ENTRAPMENT: A SYMPTOMATIC MESH COMPLICATIONS REVIEW OF 50 CONSECUTIVE CASES UNDERGOING MESH REMOVAL SURGERY 4:39 p.m. – Oral Poster 27 — PERIOPERATIVE 4:39 p.m. – Oral Poster 36 — PELVIC FLOOR AND 4:39 p.m. – Oral Poster 46 — CAN 4:43 p.m. OUTCOMES IN PATIENTS WITH 4:45 p.m. OBTURATOR INTERNUS MYOFASCIAL 4:43 p.m. PHARMACOGENETICS BE USED HEREDITARY DISORDERS OF PAIN IS COMMON IN PATIENTS WITH TO PREDICT THE RESPONSE TO CONNECTIVE TISSUE: A RETROSPECTIVE PELVIC FLOOR SYMPTOMS FESOTERODINE FUMARATE? COHORT STUDY Oral Poster 37 — PELVIC FLOOR AND OBTURATOR INTERNUS MYOFASCIAL PAIN IS CORRELATED WITH LOWER URINARY TRACT SYMPTOM SEVERITY

4:15 p.m. – 5:15 p.m. – 5:15 p.m. 4:15 p.m. 4:43 p.m. – Oral Poster 28 — PREDICTORS FOR 4:45 p.m. – Oral Poster 38 — COST- 4:43 p.m. – Oral Poster 47 — EFFECT OF 4:47 p.m. LONG-TERM POSTOPERATIVE FOLLOW- 4:49 p.m. EFFECTIVENESS OF ROUTINE 4:47 p.m. ESTROGEN THERAPY ON THE UP IN A COHORT OF PELVIC ORGAN POSTOPERATIVE RETROGRADE POSTMENOPAUSAL INFLAMMATORY PROLAPSE PATIENTS VOIDING TRIALS FOLLOWING BLADDER STATE GYNECOLOGICAL PROCEDURES 4:47 p.m. – Questions for Oral Posters 26–28 4:49 p.m. – Questions for Oral Posters 35–38 4:47 p.m. – Questions for Oral Posters 45–47 4:51 p.m. 4:53 p.m. 4:51 p.m. 4:51 p.m. – Oral Poster 29 — IDENTIFYING 4:53 p.m. – Oral Poster 39 — RANDOMIZED 4:51 p.m. – Oral Poster 48 — THE ROLE OF 4:55 p.m. PREDICTORS OF POSTDISCHARGE 4:57 p.m. CONTROLLED TRIAL TO ASSESS 4:55 p.m. BACTERIAL VIRUSES IN THE FEMALE SURGICAL RECOVERY FOLLOWING THE IMPACT OF INTRAURETHRAL URINARY MICROBIOME LAPAROSCOPIC SACROCOLPOPEXY: A LIDOCAINE ON URODYNAMIC VOIDING PROSPECTIVE LONGITUDINAL STUDY PARAMETERS 4:55 p.m. – Oral Poster 30 — EVALUATING 4:57 p.m. – Oral Poster 40 — PREOPERATIVE 4:55 p.m. – Oral Poster 49 — THE FEMALE 4:59 p.m. THE IMPACT OF DAYS BETWEEN 5:01 p.m. LABORATORY TESTING PRIOR 4:59 p.m. GENITOURINARY MICROBIOTA: SHORT- PROCEDURES ON CLINICAL OUTCOMES: TO UROGYNECOLOGIC SURGERY: TERM STABILITY, RESILIENCE AND DO SURGEONS GET RUSTY? A NECESSARY EVIL OR JUST PERI-URETHRAL RELATIONSHIPS UNNECESSARY? 4:59 p.m. – Video 5 — AUTOLOGOUS 5:01 p.m. – Video 7 — RECTOVAGINAL FISTULA 4:59 p.m. – Video 8 — MANAGEMENT OF 5:04 p.m. FASCIA LATA SPIRAL SLING ANAL 5:07 p.m. REPAIR USING A GRACILIS MUSCLE 5:07 p.m. PRESACRAL BLEEDING SPHINCTEROPLASTY: SALVAGE REPAIR FLAP AND FULL THICKNESS SKIN FOR FECAL INCONTINENCE GRAFT Video 6 — HARVEST OF AUTOLOGOUS FASCIA LATA FROM THE THIGH SURGICAL TECHNIQUE VIDEO 5:04 p.m. – Questions for Oral Posters 29–30 5:07 p.m. – Questions for Oral Posters 39–40 5:07 p.m. – Questions for Oral Posters 48–49 5:08 p.m. 5:11 p.m. 5:12 p.m.

PFD WEEK 2017 OCT 3 – 7 15 CONCURRENT SCHEDULE AT-A-GLANCE (CONTINUED)

FRIDAY, OCTOBER 6 | 2:45 p.m. – 4:00 p.m. TIME SCIENTIFIC CONCURRENT TIME SCIENTIFIC CONCURRENT TIME SCIENTIFIC CONCURRENT SESSION 7 — SURGERY/ANATOMY SESSION 8 — OFFICE-BASED SESSION 9 — POPULATION SESSION THERAPY AND PATIENT STUDIES SESSION BALLROOM A COUNSELING SESSION BALLROOM D/E BALLROOM B/C 2:45 p.m. – Oral Poster 50 — POSTERIOR 2:45 p.m. – Oral Poster 63 — HOLDING IT 2:45 p.m. – Oral Poster 76 — ASSOCIATION 2:49 p.m. VAGINAL WALL PROLAPSE ON MRI 2:49 p.m. TOGETHER: GROUP BEHAVIORAL 2:49 p.m. BETWEEN CO-MORBIDITIES AND FEMALE AND ASSOCIATION WITH DEFECATORY INTERVENTION IMPROVES URINARY AND SEXUAL DYSFUNCTION: FINDINGS FROM SYMPTOMS BOWEL SYMPTOMS IN OLDER WOMEN THE THIRD NATIONAL SURVEY OF SEXUAL ATTITUDES AND LIFESTYLES (NATSAL-3) 2:49 p.m. – Oral Poster 51 — EFFECT OF MORBID 2:49 p.m. – Oral Poster 64 — UREAPLASMA 2:49 p.m. – Oral Poster 77 — MODERN PRACTICE 2:53 p.m. OBESITY ON MID-URETHRAL SLING 2:53 p.m. UREALYTICUM AND PAINFUL LOWER 2:53 p.m. PATTERNS IN WOMEN TREATED FOR EFFECACY FOR THE MANAGEMENT OF URINARY TRACT SYMPTOMS NON-NEUROGENIC OVERACTIVE STRESS URINARY INCONTINENCE BLADDER: HOW QUICKLY DO PATIENTS PROGRESS TO THIRD-LINE THERAPY? 2:53 p.m. – Oral Poster 52 — PREOPERATIVE 2:53 p.m. – Oral Poster 65 — EARLY AND CONSIS- 2:53 p.m. – Oral Poster 78 — WEIGHT AND WEIGHT 2:57 p.m. PELVIC FLOOR MUSCLE WEAKNESS AS 2:57 p.m. TENT IMPROVEMENTS IN URINARY SYMP- 2:57 p.m. CHANGE IMPACT STRESS AND URGE A RISK FACTOR OF SURGICAL FAILURE TOMS AND QUALITY OF LIFE OUTCOMES URINARY INCONTINENCE SYMPTOMS IN OF ANTERIOR VAGINAL WALL PROLAPSE IN FEMALE OVERACTIVE BLADDER POSTMENOPAUSAL WOMEN REPAIR PATIENTS WITH URINARY INCONTINENCE TREATED WITH ONABOTULINUMTOXINA IN A MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 4 TRIAL 2:57 p.m. – Oral Poster 53 — POSTERIOR 2:57 p.m. – Oral Poster 66 — PRIMIPAROUS 2:57 p.m. – Oral Poster 79 — PROPHYLACTIC 3:01 p.m. COMPARTMENT SURGERY PROVIDES 3:01 p.m. WOMEN'S EXPERIENCE AND 3:01 p.m. ANTIBIOTICS AT THE TIME OF NO DIFFERENTIAL BENEFIT FOR UNDERSTANDING SURROUNDING OBSTETRIC ANAL SPHINCTER INJURY DEFECATORY SYMPTOMS BEFORE OBSTETRIC PERINEAL TRAUMA: REPAIR: ARE WE MEETING THE MARK? OR AFTER CONCOMITANT MESH A QUALITATIVE STUDY AUGMENTED APICAL SUSPENSION 3:01 p.m. – Oral Poster 54 — MECHANISM OF 3:01 p.m. – Oral Poster 67 — ARE WOMEN 3:01 p.m. – Oral Poster 80 — STRESS URINARY 3:05 p.m. ACTION OF URETHRAL BULKING VERSUS 3:05 p.m. PREPARED FOR BIRTH? A STUDY OF 3:05 p.m. INCONTINENCE SURGERY IN MIDURETHRAL SLING MEASURED BY HOW COUNSELING, PREPARATION WASHINGTON STATE BEFORE AND 2:45 p.m. – 4:00 p.m. 2:45 p.m. HIGH RESOLUTION MANOMETRY AND INFORMED CONSENT AFFECT AFTER INTRODUCTION OF THE MESH SATISFACTION AND REGRET AFTER MIDURETHRAL SLING DELIVERY 3:05 p.m. – Questions for Oral Posters 50–54 3:05 p.m. – Questions for Oral Posters 63–67 3:05 p.m. – Questions for Oral Posters 76–80 3:09 p.m. 3:09 p.m. 3:09 p.m. 3:09 p.m. – Oral Poster 55 — TARGET-BASED 3:09 p.m. – Oral Poster 68 — PATIENT 3:09 p.m. – Oral Poster 81 — INCIDENCE AND 3:13 p.m. 3D STRESS MRI MEASUREMENT 3:13 p.m. COUNSELING ON STRESS URINARY 3:13 p.m. RISK FACTORS FOR THE DEVELOPMENT TECHNIQUE FOR APICAL, PARAVAGINAL INCONTINENCE AND/OR PELVIC ORGAN OF LOWER URINARY TRACT AND HIATAL CHANGES AFTER SURGERY PROLAPSE CONDITIONS AFTER HYSTERECTOMY DIAGNOSED FOR ANTERIOR/APICAL PROLAPSE IN THE IMMEDIATE POST-OPERATIVE PERIOD: AN ANALYSIS OF THE NATIONAL SURGERY QUALITY IMPROVEMENT PROGRAM (NSQIP) DATABASE 3:13 p.m. – Oral Poster 56 — THE FAILURE 3:13 p.m. – Oral Poster 69 — TOILETING HABITS 3:13 p.m. – Oral Poster 82 — ONLINE PHYSICIAN 3:17 p.m. RATE OF A SECONDARY PROCEDURE 3:17 p.m. OF NURSES 3:17 p.m. RATINGS IN FEMALE PELVIC MEDICINE FOR RECURRENT STRESS URINARY & RECONSTRUCTIVE SURGERY: WHAT INCONTINENCE FOLLOWING A FAILED DO PATIENTS REALLY WANT? MIDURETHRAL SLING IS NOT AFFECTED BY ALTERATION OF THE PRIMARY SLING 3:17 p.m. – Oral Poster 57 — COST-EFFECTIVENESS 3:17 p.m. – Oral Poster 70 — A COST- 3:17 p.m. – Oral Poster 83 — URINARY INCONTI- 3:21 p.m. ANALYSIS OF A PRE-OPERATIVE PELVIC 3:21 p.m. EFFECTIVENESS ANALYSIS OF BOTOX 3:21 p.m. NENCE REMISSION BY SUBTYPE AND MRI TO IDENTIFY PATIENTS AT HIGH RISK BOTULINUM-A TOXIN AS FIRST-LINE RELATION TO INDICATORS OF SEVERITY OF SURGICAL FAILURE TREATMENT FOR OVERACTIVE Oral Poster 84 — PELVIC ORGAN BLADDER PROLAPSE AND URINARY INCONTINENCE AFTER BARIATRIC SURGERY

16 PFD WEEK 2017 OCT 3 – 7 Scientific Program

FRIDAY, OCTOBER 6 | 2:45 p.m. – 4:00 p.m. (continued) 3:21 p.m. – Oral Poster 58 — IMPACT OF MORBID 3:21 p.m. – Oral Poster 71 — THERAPEUTIC 3:25 p.m. – Oral Poster 85 — PATIENT 3:25 p.m. OBESITY ON PERIOPERATIVE OUTCOMES IN 3:25 p.m. OUTCOMES FOR FEMALES AND MALES 3:29 p.m. UNDERSTANDING: HEALTH LITERACY WOMEN UNDERGOING RECONSTRUCTIVE IN THE INSITE STUDY FOR OVERACTIVE IN WOMEN WITH PELVIC FLOOR SURGERY BLADDER DISORDERS 3:29 p.m. – Questions for Oral Posters 55–58 3:25 p.m. – Questions for Oral Posters 68–71 3:29 p.m. – Questions for Oral Posters 81–85 3:33 p.m. 3:29 p.m. 3:33p.m. 3:33 p.m. – Oral Poster 60 — DOES SURGICAL 3:29 p.m. – Oral Poster 72 — A PILOT STUDY 3:33 p.m. – Oral Poster 86 — WHAT THE 3:37 p.m. CORRECTION OF A WIDE PRE-OPERATIVE 3:33 p.m. EVALUATING A NON-INVASIVE 3:37 p.m. INTERNET SAYS ABOUT VAGINAL MESH: GENITAL HIATUS IMPACT ANATOMIC METHOD TO CHARACTERIZE BLADDER SENTIMENT ANALYSIS OF WEBSITES FAILURE AFTER ROBOTIC-ASSISTED GEOMETRY FOR OVERACTIVE BLADDER RELATED TO GRAFT USE IN PLEVIC LAPAROSCOPIC SACROCOLPOPEXY? RECONSTRUCTIVE SURGERY 3:37 p.m. – Oral Poster 61 — REDUCTION OF 3:33 p.m. – Oral Poster 73 — MYOFASCIAL PAIN 3:37 p.m. – Oral Poster 87 — COST IMPACT OF 3:41 p.m. GENITAL HIATUS SIZE DECREASES 3:37 p.m. IN PATIENTS WITH SYMPTOMS OF 3:41 p.m. ELECTIVE CESAREAN DELIVERY ON ANATOMIC FAILURE AFTER NATIVE URINARY TRACT INFECTION FUTURE PELVIC FLOOR DISORDERS TISSUE VAGINAL VAULT SUSPENSION 3:41 p.m. – Oral Poster 62 — LEVATOR ANI 3:37 p.m. – Oral Poster 74 — FECAL 3:41 p.m. – Oral Poster 88 — BLADDER AND 2:45 p.m. – 4:00 p.m. 2:45 p.m. 3:45 p.m. SUBTENDED VOLUME IN PATIENTS 3:41 p.m. INCONTINENCE SYMPTOMS AND 3:45 p.m. BOWEL DYSFUNCTION IN PATIENTS WITH MESH AUGMENTATION AND IMPACT IN OLDER VERSUS YOUNGER WITH SPINAL STENOSIS SURGICAL FAILURE WOMEN SEEKING CARE 3:45 p.m. – Video 12 — RETROPUBIC ROBOTIC 3:41 p.m. – Oral Poster 75 — VARIATION IN 3:45 p.m. – Video 13 — MINIMALLY INVASIVE 3:55 p.m. EXCISION OF MESH FOR THE 3:45 p.m. COUNSELING PRIOR 3:49 p.m. CYSTOSCOPIC SUTURE EXCISION TREATMENT OF MIDURETHRAL SLINGS TO SURGERY FOR PELVIC ORGAN AND TRANSVAGINAL PROLAPSE MESH PROLAPSE EROSION INTO THE BLADDER 3:55 p.m. – Questions for Oral Posters 60–62 3:45 p.m. – Questions for Oral Posters 72–75 3:49 p.m. – Questions for Oral Posters 86–88 4:00 p.m. 3:50 p.m. 3:53 p.m.

FRIDAY, OCTOBER 6 | 4:15 p.m. – 5:30 p.m. TIME SCIENTIFIC CONCURRENT TIME SCIENTIFIC CONCURRENT TIME SCIENTIFIC CONCURRENT SESSION 10 — SURGERY SESSION 11 — HOT TOPICS IN SESSION 12 — NOVEL SESSION UROGYNECOLOGY II SESSION TECHNOLOGIES AND BALLROOM A BALLROOM B/C NEUROMODULATION SESSION BALLROOM D/E 4:15 p.m. – Oral Poster 89 — ENHANCED 4:15 p.m. – Oral Poster 102 — RATE AND 4:15 p.m. – Oral Poster 115 — PATIENT- 4:19 p.m. RECOVERY PROGRAM FOR OUTPATIENT 4:19 p.m. PREDICTORS OF URINARY 4:19 p.m. IMPORTANT CRITICAL CONTENT AND UROGYNECOLOGIC SURGERY INCONTINENCE AT 12 MONTHS THE ROLE OF PEER SUPPORT FOR POSTPARTUM WOMEN UNDERGOING SURGERY FOR PELVIC FLOOR DISORDERS 4:19 p.m. – Oral Poster 90 — DOES VARIATION IN 4:19 p.m. – Oral Poster 103 — EARLY POST- 4:19 p.m. – Oral Poster 116 — LOWER URINARY 4:23 p.m. BONY LANDMARKS PREDICT SUCCESS 4:23 p.m. INJECTION URINARY TRACT INFECTION 4:23 p.m. TRACT SYMPTOMS IN A CHRONIC PAIN WITH SACRAL NEUROMODULATION: (UTI) PREDICTS RECURRENT UTI AFTER POPULATION ONE SIZE FITS ALL? ONABOTULINUM TOXIN A 4:23 p.m. – Oral Poster 91 — IMPACT OF 4:23 p.m. – Oral Poster 104 — EDUCATIONAL 4:23 p.m. – Oral Poster 117 — CAN WOMEN 4:27 p.m. PREEMPTIVE ANALGESIA ON 4:27 p.m. AND ELECTRONIC REFERRAL 4:27 p.m. WITH LEVATOR ANI TEAR ON MR POSTOPERATIVE PAIN AFTER INTERVENTIONS IN IMPROVING IMAGES EFFECTIVELY INCREASE

4:15 p.m. – 5:30 p.m. 4:15 p.m. CYSTOSCOPY WITH HYDRODISTENTION INCONTINENCE SCREENING AMONG URETHRAL CLOSURE PRESSURE FOR PAINFUL BLADDER SYNDROME/ PRIMARY CARE PHYSICIANS DURING A VOLITIONAL PELVIC FLOOR INTERSTITIAL CYSTISIS: A PILOT STUDY MUSCLE CONTRACTION? A FOCUS ON POSTPARTUM WOMEN AT HIGH RISK FOR LEVATOR ANI TEAR FROM RECENT VAGINAL 4:27 p.m. – Oral Poster 92 — DO SPINALS 4:27 p.m. – Oral Poster 105 — FRACTIONAL 4:27 p.m. – Oral Poster 118 — TRANSFORMING 4:31 p.m. INCREASE RATES OF URINARY 4:31 p.m. CO2 LASER OF THE FOR 4:31 p.m. COMMUNITY-BASED CONTINENCE RETENTION: A RANDOMIZED GENITOURINARY SYNDROME OF PROMOTION: THE BOWEL MOVEMENT CONTROLLED TRIAL MENOPAUSE: IS THE OUT-OF-POCKET COST WORTH THE OUTCOME OF TREATMENT

PFD WEEK 2017 OCT 3 – 7 17 CONCURRENT SCHEDULE AT-A-GLANCE (CONTINUED)

FRIDAY, OCTOBER 6 | 4:15 p.m. – 5:30 p.m. (continued) 4:31 p.m. – Oral Poster 93 — DOES PREOPERATIVE 4:31 p.m. – Oral Poster 106 — RATES OF 4:31 p.m. – Oral Poster 119 — ELECTRICAL 4:35 p.m. PROLAPSE STAGE PREDICT RISK OF 4:35 p.m. OBSTETRIC ANAL SPHINCTER INJURIES 4:35 p.m. STIMULATION OF AFFERENT NERVES PERIOPERATIVE COMPLICATIONS BEFORE AND AFTER TRAINING IN THE FOOT WITH TRANSCUTANEOUS DURING VAGINAL RECONSTRUCTIVE INVOLVING PERINEAL PROTECTION ADHESIVE PAD ELECTRODES IN WOMEN SURGERY? WITH OAB: COMPARISON OF DIFFERENT STIMULATION DURATIONS 4:35 p.m. – Questions for Oral Posters 89–93 4:35 p.m. – Questions for Oral Posters 102–106 4:35 p.m. – Questions for Oral Posters 115–119 4:39 p.m. 4:39 p.m. 4:39 p.m. 4:39 p.m. – Oral Poster 94 — DOES GABAPENTIN 4:39 p.m. – Oral Poster 107 — COMPARISON OF 4:39 p.m. – Oral Poster 124 — PROSPECTIVE 4:43 p.m. REDUCE OPOID USE POSTOPERATIVELY? 4:43 p.m. ANORECTAL MANOMETRY TESTING 4:43 p.m. NON-COMPARATIVE STUDY TO (“GROUP STUDY”): A RANDOMIZED IN LEFT LATERAL AND DORSAL ASSESS THE EFFECTIVENESS OF A CONTROL TRIAL IN WOMEN UNDERGOING LITHOTOMY POSITIONS PIXEL CO2 LASER SYSTEM IN THE TREATMENT OF VULVOVAGINAL RECONSTRUCTIVE PELVIC SURGERY ATROPHY: INTERIM ANALYSIS 4:43 p.m. – Oral Poster 95 — PRIMARY PELVIC 4:43 p.m. – Oral Poster 108 — CONNECTING 4:43 p.m. – Oral Poster 121 — DENERVATION OF 4:47 p.m. ORGAN PROLAPSE SURGERY USING 4:47 p.m. THE DOTS: RELATIONSHIPS BETWEEN 4:47 p.m. THE TRIGONE FOR TREATMENT OF DELAYED ABSORBABLE SUTURE: REVIEW OF SYSTEMS RESPONSES AND URGENCY URINARY INCONTINENCE ONE-YEAR OUTCOMES COMPARING CHRONIC UROGYNECOLOGIC PAIN ASSOCIATED WITH OVERACTIVE ANTERIOR WALL SUCCESS IN VAGINAL BLADDER UTEROSACRAL LIGAMENT SUSPENSION VERSUS SACRAL COLPOPEXY 4:47 p.m. – Oral Poster 96 — INDWELLING VS 4:47 p.m. – Oral Poster 109 — EASY TO FIND 4:47 p.m. – Oral Poster 122 — ACCURACY 4:51 p.m. IMMEDIATE REMOVAL OF FOLEY 4:51 p.m. BUT DIFFICULT TO UNDERSTAND? 4:51 p.m. OF REPORTING METHODS FOR CATHETER AFTER ROBOTIC ASSISTED ANALYZING THE READABILITY OF PERIOPERATIVE COMPLICATIONS AFTER LAPORASCOPIC SACROCOLPOPEXY: A ONLINE UROGYNECOLOGIC PATIENT SUB-URETHRAL SLINGS RANDOMIZED PROSPECTIVE STUDY INFORMATION 4:51 p.m. – Oral Poster 97 — OUTCOMES OF 4:51 p.m. – Oral Poster 110 — OPIOID 4:51 p.m. – Oral Poster 123 — ANALYSIS OF 4:55 p.m. RECURRENT RECTOVAGINAL FISTULA 4:55 p.m. REQUIREMENTS AFTER VAGINAL 4:55 p.m. DIFFERENT REFERENCE LINE BY USING REPAIR HYSTERECTOMY WITH MINIMALLY DYNAMIC MAGNETIC RESONANCE INVASIVE SACROCOLPOPEXY IMAGING IN POSTERIOR VAGINAL WALL PROLAPSE AND A NOVEL PARAMETER: EXPOSED VAGINAL LENGTH

4:55 p.m. – Oral Poster 98 — IS MESH 4:55 p.m. – Oral Poster 111 — URINARY 4:55 p.m. – Oral Poster 120 — BACLOFEN: A 4:59 p.m. EXPOSURE AFTER LAPAROSCOPIC 4:59 p.m. SYMPTOMS AND THEIR EFFECT ON 4:59 p.m.

4:15 p.m. – 5:30 p.m. 4:15 p.m. FORGOTTEN DRUG FOR VOIDING SACROCOLPOPEXY A MYTH IN THE ERA QUALITY OF LIFE IN WOMEN LIVING DYSFUNCTION OF THE LIGHT WEIGHT POLYPROPYLENE WITH HIV: A CROSS-SECTIONAL STUDY MESH?

4:59 p.m. – Questions for Oral Posters 94–98 4:59 p.m. – Questions for Oral Posters 107–111 4:59 p.m. – Questions for Oral Posters 120–124 5:03 p.m. 5:03 p.m. 5:03 p.m. 5:03 p.m. – Oral Poster 99 — PREDICTORS OF 5:03 p.m. – Oral Poster 112 — NORMAL 5:03 p.m. – Oral Poster 125 — DEVELOPMENT 5:07 p.m. OPIOID ADMINISTRATION IN THE ACUTE 5:07 p.m. POP-Q VALUES IN THE AVERAGE 5:07 p.m. OF A NEUROSTIMULATOR IMPLANT POST OPERATIVE PERIOD GYN POPULATION: REVISITING THE TECHNIQUE FOR TIBIAL NERVE POSST STUDY STIMULATION 5:07 p.m. – Oral Poster 100 — A NOVEL, 5:07 p.m. – Oral Poster 113 — RISK OF ACUTE 5:07 p.m. – Oral Poster 126 — VAGINAL SACRAL 5:11 p.m. STRUCTURED FELLOW TRAINING 5:11 p.m. CARDIAC MORBIDITY FOLLOWING 5:11 p.m. COLPOPEXY: A NATURAL ORIFICE PATHWAY FOR ROBOTIC-ASSISTED SURGERY FOR PELVIC ORGAN PROLAPSE APPROACH TO A GOLD STANDARD SACROCOLPOPEXY PROCEDURE 5:11 p.m. – Oral Poster 101 — PERSISTENT 5:11 p.m. – Oral Poster 114 — DOES A RECENT 5:11 p.m. – Oral Poster 127 — EVALUATION 5:15 p.m. STRESS URINARY INCONTINENCE AFTER 5:15 p.m. URINARY TRACT INFECTION (UTI) 5:15 p.m. OF SER120 FOR THE TREATMENT SYNTHETIC MIDURETHRAL SLING INCREASE THE RISK OF POST-INJECTION OF PATIENTS WITH NOCTURIA DUE PROCEDURE: A SURGICAL SOLUTION UTI AFTER ONABOTULINUM TOXIN A? TO NOCTURNAL POLYURIA WITH CONCOMITANT OVERACTIVE BLADDER 5:15 p.m. – Video 14 — 5:15 p.m. – Video 15 — LOGOTHETOPULOS: 5:15 p.m. – Video 16 — EXCISION OF VAGINAL 5:23 p.m. TECHNIQUE FOR REFRACTORY 5:22 p.m. CONTROL OF INTRAOPERATIVE 5:25 p.m. MESH EXPOSURE IN THE BLADDER: HEMORRHAGE WITH PELVIC A ROBOTIC APPROACH PRESSURE PACK

5:23 p.m. – Questions for Oral Posters 99–101 5:22 p.m. – Questions for Oral Posters 112–114 5:25 p.m. – Questions for Oral Posters 125–127 5:27 p.m. 5:26 p.m. 5:29 p.m.

18 PFD WEEK 2017 OCT 3 – 7 SAVE THE DATE PFDWEEK2018 CHICAGO

OCTOBER 9-13, 2018 HYATT REGENCY CHICAGO CHICAGO, IL PRE-CONFERENCE WORKSHOP SCHEDULE Pre-Conference Workshops require separate registration and are an additional fee.

TUESDAY, OCTOBER 3 INTEGRATING TECHNOLOGY INTO YOUR TEACHING 8:30 a.m. – 12:00 p.m. ARMAMENTARIUM Room 552 EVALUATION AND TREATMENT OF VESICOVAGINAL AND Workshop Director: Robert F. Flora, MD, MBA, MPH, McLaren RECTOVAGINAL FISTULAS IN LOWER RESOURCE SETTINGS Health Care Presented by the Global Health SIG Room 550 SURGICAL FAILURES: MANAGING THE ANATOMY, THE Workshop Director: Saifuddin T. Mama MD, MPH, FACOG, PATIENT, AND THE DOCTOR: GETTING IT RIGHT THE FACS, FPMRS, Cooper Medical School of Rowan University SECOND TIME Room 555 CONTINENCE BEGINS WITH PREVENTION: A NEW Workshop Director: Christopher M. Tarnay, MD, FACOG, David Geffen PARADIGM USING A TRANSDISCIPLINARY SCIENCE School of Medicine at UCLA APPROACH Room 555 WEDNESDAY, OCTOBER 4 Workshop Director: Alayne D. Markland, DO, MSc, The University of Alabama at Birmingham 8:30 a.m. – 12:00 p.m. CHALLENGES IN FPMRS SURGICAL CODING FOR 2017 ENERGY BASED THERAPIES IN GYNECOLOGY AND AND BEYOND VAGINAL HEALTH: LASER, LIGHT, AND RADIO-FREQUENCY Presented by the AUGS Coding Committee THERAPIES Ballroom D Ballroom D Kevin Stepp, MD, Workshop Director: Marc Toglia, MD, Sidney Kimmel School of Medicine Workshop Director: Carolinas Healthcare System QUALITY IMPROVEMENT BOOTCAMP NEUROPATHOLOGY OF CHRONIC PELVIC PAIN DISORDERS Room 552 Workshop Director: Robert F. Flora, MD, MBA, MPH, McLaren Room 551 Health Care Workshop Director: Bruce S. Kahn, MD, FACOG, Uniformed Services University School of Medicine 1:30 p.m. – 5:00 p.m. A TRANSDISCIPLINARY APPROACH TO MATERNAL BUILDING ACADEMIC SUCCESS IN UROGYNECOLOGY: BIRTH TRAUMA: A DAY IN THE LIFE OF A PERINEAL HEALTH SERVICES RESEARCH AND THE POWER OF CLINIC BIG DATA Room 553 This workshop is free for Fellows Workshop Director: Christina Lewicky-Gaupp, MD, Northwestern Room 551 University Feinberg School of Medicine Workshop Director: Donna Mazloomdoost, MD, Pelvic Floor Disorders ROBOTIC AND STRAIGHT LAPAROSCOPIC Network (PFDN) Gynecologic Health and Disease Branch; Eunice SACROCOLPOPEXY 2.0: HOW TO AVOID AND GET OUT Kennedy Shriver, National Institutes of Health OF TROUBLE COMPREHENSIVE APPROACH TO FISTULA CARE Room 552 Presented by the Global Health SIG Workshop Directors: Patrick Culligan, MD, FACOG, FPMRS, Weill Room 550 Cornell Department of Urology; Peter Rosenblatt, MD, FACOG, FPMRS, Workshop Director: Rahel Nardos, MD, MCR, Oregon Health & Mount Auburn Hospital Science University UNDERSTANDING MINDFULNESS: FOSTERING RESILIENCE CODING CHALLENGES AND OPPORTUNITIES FOR AND QUALITY OF LIFE IN OURSELVES AND OUR PATIENTS OFFICE BASED ACTIVITIES AND PROCEDURES FOR Room 550 THE FPMRS SPECIALIST Workshop Director: David A. Richardson, MD, Henry Ford Health System Presented by the AUGS Coding Committee Ballroom D Workshop Director: Marc Toglia, MD, Sidney Kimmel School of Medicine

20 PFD WEEK 2017 OCT 3 – 7 Scientific Program

12:30 p.m. – 5:00 p.m. 3:00 p.m. – 5:00 p.m. MULTIDISCIPLINARY EVALUATION AND TREATMENT OF PERSPECTIVES ON THE QUALITY PAYMENT PROGRAM VULVAR DISORDERS AND PERFORMANCE IMPROVEMENT IN UROGYN Presented by the Advanced Practice, Physical Therapy, and Allied Health SIG Presented by the AUGS Quality Committee Supported by Allergan Room 551 Balloom A Workshop Director: Sarah Boyles, MD, MPH, The Oregon Clinic Workshop Director: Julie Starr, APRN, PhD, Missouri Center for Female Continence and Advanced Pelvic Surgery University of Missouri 1:00 p.m. – 4:30 p.m. BONUS SESSIONS Bonus Sessions are complimentary. EFFECTIVE ACCOUNTABILITY CONVERSATIONS Room 550 Post or Perish | Room 553 Workshop Director: Mikio A. Nihira, MD, MPH, University of California Wednesday, October 4 | 3:00 p.m. – 3:45 p.m. Riverside, Riverside Community Hospital Speaker: Brian Jacob, MD, Icahn School of Medicine at Mount Sinai Laparoscopic Surgical Center of New York SURGERY AND CARE: THE ROLE OF THE UROGYNECOLOGIST Future of Medicine and Technology: Room 552 The Art of the Possible | Room 553 Workshop Director: Cecile A. Unger, MD, MPH, Center for Wednesday, October 4 | 4:00 p.m. – 4:45 p.m. Urogynecology & Pelvic Reconstructive Surgery, Center for LGBT Care Speaker: Michael Ruiz, MedStar Health , Gynecology & Women’s Health Institute, Cleveland Clinic

Enroll Now!

AUGS AQUIRE Quality Improvement Registry

AQUIRE is a Qualified Clinical Data Registry (QCDR). AQUIRE meets the reporting requirements for the CMS Merit-Based Incentive Payment System (MIPS).

Developed by urogynecologists for urogynecologists to measure and report healthcare quality patient outcomes:

• FREE Participation for AUGS Members • Fulfill MIPS Reporting Requirements • Easy Web Data Entry • Meet MOC Part IV Requirements • Collect and Report on 20 FPMRS Quality Measures • Receive The Urogyn Quality Champion Designation

www.augs.org/clinical-practice/AQUIRE

PFD WEEK 2017 OCT 3 – 7 21 FELLOWS’ DAY

WEDNESDAY, OCTOBER 4 Ballroom B Join fellows and faculty from the AUGS community for a full-day program geared toward fellows’ interests. There will be a panel discussion focused on how to find a job after fellowship, including experts from an academia, HMO setting, private practice model, and urology practice model, as well as an expert in contract negotiations. We look forward to having you join us for this informative and interactive program. Residents are also welcomed to attend Fellows’ Day.

7:45 a.m. – 8:00 a.m. Breakfast and Welcome

8:00 a.m. – 9:00 a.m. Expert Panel Discussion of Job Mentoring • Academic Practice – Lieschen Quiroz, MD • HMO Practice – Emily Whitcomb, MD • Private Practice – Mike Moen, MD • Urology Practice – Quinn Lippmann, MD • Contract Lawyer

9:00 a.m. – 9:15 a.m. Q&A for Panel

9:15 a.m. – 9:30 a.m. Break

9:30 a.m. – 10:45 a.m. Fellows Abstract Presentations Moderators: Taylor Brueseke, MD; Robert F. Flora, MD, MBA, MPH; Marc Toglia, MD

10:45 a.m. – 11:15 a.m. Stump the Professor Catherine Matthews, MD; Anthony Visco, MD

11:15 a.m. – 11:30 a.m. Break

11:30 a.m. – 12:30 p.m. Roundtable Discussions (select one) • How to Teach and Lead in the Operating Room – Mikio Nihira, MD | Ballroom B • Coding/Billing – Marc Toglia, MD | Ballroom E • Successful Manuscript Submission – Jennifer Wu, MD | Room 556 A • Global Health Opportunities in FPMRS – Joan Blomquist, MD; Grace Chen, MD | Room 556 B • QI Project Ideas – Robert F. Flora, MD, MBA, MPH | Ballroom C

12:30 p.m. – 12:45 p.m. Break

12:45 p.m. – 1:45 p.m. Connecting with OAB Patients-Guide for Productive Communication and Gaining Third-Line Treatment Acceptance | Ballroom B Supported by Allergan

1:45 p.m. – 2:00 p.m. AUGS Spotlight Meet the President – Halina M. Zyczynski, MD

2:30 p.m. – 5:00 p.m. AUGS-SGS Fellows’ Pelvic Research Network (FPRN®) Meeting

22 PFD WEEK 2017 OCT 3 – 7 MEET THE EXPERTS EDUCATIONAL ROUNDTABLES Scientific Program

Roundtables have limited availability; pre-registration is required for an additional fee. All roundtables are taking place in the Rotunda (Convention Center). THURSDAY, OCTOBER 5 FRIDAY, OCTOBER 6 6:45 a.m. – 7:45 a.m. 6:45 a.m. – 7:45 a.m. Using Acupuncture for Pelvic Floor Issues: Fact Complications After Apical Vaginal Prolapse Surgeries | or Fiction? | Table 100 Table 200 Ilana Addis, MD Samuel S. Badalian, MD, PhD Surgical Anatomy of Vaginal Hysterectomy: Make Your Stem Cell and Tissue Engineering Applications in Own Model | Table 101 FPMRS | Table 201 Mallika Anand, MD, MS, FACOG Jeffrey L. Cornella, MD Sustainable Global Health Programs | Table 102 Building a Successful Interstim Program | Table 202 Joan Blomquist, MD; Rahel Nardos, MD James A. Daucher, MD, MS Best Practice in Your Busy Practices | Table 103 To Poop or Not to Poop | Table 203 Cassandra Carberry, MD, MS Angel Marie Johnson, MD Teaching Surgical Skills to Millennials and Digitals | Embryology, Diagnosis, and Treatment of Table 104 Congenital Anomalies | Table 204 Robert F. Flora, MD, MBA, MPH Saifuddin T. Mama MD, MPH, FACOG, FACS, FPMRS The Gynecologist’s Role in Identifying and Responding The Nighttime Battle Between the Bedroom to Human Trafficking | Table 105 and Bathroom | Table 205 Julia Geynisman-Tan, MD Deborah L. Myers, MD The Role of 2D Dynamic and 3D Multicompartment Actively Managing Academic Mentorship Sonographic Imaging | Table 106 Relationships | Table 206 Aparna Hegde, MD Vivian Sung, MD, MPH How to be an Effective Witness in a Deposition | Use of Near Infrared Imaging in Complex Table 107 Robotic Surgery | Table 207 Michael Karram, MD Lioudmila Lipetskaia, MD Sling Revision: When, Why, and How | Table 108 Essential Gynecology for the Female Pelvic Mary Grey Maher, MD, FPMRS Medicine Specialist | Table 208 Christopher Tarnay, MD Research in Action: Beyond Retrospective Chart Reviews | Table 109 Botulinum Toxin: Practical Applications in Jameca R. Price, MD, MPH, MCR Urogynecology | Table 209 Michael J. Kennelly, MD, FACS, FPMRS Implementing Enhanced Recovery Programs in Your Clinical Practice | Table 110 How to be a Successfully Employed Elisa Rodriguez Trowbridge, MD, FACOG FPMRS Subspecialist | Table 210 Folusho Stephen Tugbiyele, MD Neurourology for the Urogynecologist | Table 111 Michael J. Kennelly, MD, FACS, FPMRS Tips and Tricks on the Difficult Vaginal Hysterectomy | Table 211 Sex and Chronic Pelvic Pain | Table 112 Michael Karram, MD Kristene E. Whitmore, MD

PFD WEEK 2017 OCT 3 – 7 23 GENERAL SCIENTIFIC SESSIONS

Sling Selections and What to do When They Fail! Prevention of Urinary Incontinence: A Behavioral Thursday, October 5 and Basic Science Perspective 1:30 p.m. – 2:00 p.m. Friday, October 6 10:50 a.m. – 11:35 a.m. Exhibition Hall C Moderator: Lynsey Hayward, MD Exhibition Hall C Speakers: Matthew Barber, MD, MHS; Holly Richter, MD, PhD Moderator: Una Lee, MD This discussion will provide an evidence-based approach to Panelists: Catherine Bradley, MD, MSCE; Marianna Alperin, MD, the surgical management of stress urinary incontinence (SUI). MS; Gina Northington, MD, MPH Full length midurethral slings are placed via a retropubic or Join us for a scientific discussion on what we know, what transobturator approach and data exists which may guide an we don’t know, and where we are going in the prevention individualized approach. Midurethral slings are the current gold- of urinary incontinence. We will review the literature on the standard treatment for primary surgical management and have pathophysiology of both urgency incontinence and stress been used for over 20 years. It is also reasonable to consider urinary incontinence. It is only through a deeper understanding that there may be some women who develop recurrent SUI. of the potential mechanisms, that we can identify pathways to prevent and treat incontinence now and in the future. This Mesh Removal Debate session will spark your clinical understanding and ultimately lead to improved patient care and counseling. Friday, October 6 8:15 a.m. – 8:45 a.m. Insights on How to Navigate Product Controversy Exhibition Hall C Saturday, October 7 Moderator: Christopher Tarnay, MD 9:30 a.m. – 10:30 a.m. Speakers: Roger Dmochowski, MD; Miles Murphy, MD, MSPH Exhibition Hall C The debate regarding optimal management of a patient Moderator: Cheryl Iglesia, MD who has mesh placed and subsequent functional and/or Speakers: Julie Cantor MD, JD; Patrick Culligan, MD; Alan consequences and complications is ongoing. The complexity of Garely, MD functional outcomes related to pelvic floor interventions clearly Product controversies are one of the largest mass torts in makes management of mesh complications a multi-factorial history, and it has caught the attention of our specialty. This undertaking inclusive of optimization of medical, surgical, and session will provide an overview and update on the mesh social circumstances to benefit the patient. Topics will include product litigation. We will also review the litigation’s timeline, the participants' views on what symptoms are attributed explain multidistrict litigation (MDL), and review key legal directly to mesh, how much needs to be removed, and the issues in the product liability field. The session will also include impact of mesh removal on future pelvic floor function. a discussion with two physicians who have served as experts in this litigation. They will share their perspectives and answer audience questions. The session will also cover the potential impact this MDL may have on our specialty.

24 PFD WEEK 2017 OCT 3 – 7 Scientific Program

Master Surgeon Presentations What Are Urogynecologists Going to Get Paid Saturday, October 7 and How? 10:45 a.m. – 11:30 a.m. Saturday, October 7 12:30 p.m. – 1:30 p.m. Exhibition Hall C Get a first-hand look at real-world surgeries on Saturday morning. Exhibition Hall C This session will showcase Laparoscopic Nerve Sparing Surgery Panelists: Jonathan Gleason, MD; Mitchell Schuster, MD; and Laparoscopic Hysteropexy and provide an overview of how Samantha Pulliam, MD to control massive blood loss while in the operating room. This timely session will raise awareness about our professions LAPAROSCOPIC NERVE SPARING SURGERY revenue problem, value transformation, and its implications. Moderator: Marlene Corton, MD Reimbursements are down with no indication of a bounce back. Surgeon: Nucelio Lemos, MD, PhD This session will inform you about how value transformation will impact FPMRS, your practice, and how we treat patients with LAPAROSCOPIC HYSTEROPEXY SURGERY pelvic floor disorders. Moderator: Felicia Lane, MD Surgeon: Beri Ridgeway, MD

SPECIAL SESSIONS These sessions require Pre-registration for an additional fee. Clinical Seminar: Abnormal Uterine Bleeding: • Critically evaluate medical and surgical therapies for AUB not Wading Through the Evidence on Evaluation and caused by structural abnormalities or systemic diseases Treatment Effectiveness • Develop strategies for choosing the best treatment for Thursday, October 5 patients in his/her practice 11:00 a.m. – 12:00 p.m. Surgical Tutorial: Laparoscopic and Robotic Room 551 Sacrocolpopexy Pearls Speaker: Kristen A. Matteson, MD, MPH Thursday, October 5 Abnormal uterine bleeding (AUB) affects up to 30 percent of 4:15 p.m. – 5:15 p.m. women during their reproductive lives and has a major impact Room 551 on the quality of life of suffering women. While hysterectomy is the definitive treatment for AUB, a multitude of alternative Speaker: Elizabeth Geller, MD; Andrew Sokol, MD less invasive medical and surgical treatments are available, This surgical tutorial will outline strategies to maximize efficiency making selecting the best treatment for the individual patient during both laparoscopic and robotic sacral colpopexy. Tips challenging. This clinical seminar will cover the burden of AUB on and tricks will be reviewed for patient positioning and docking, women and the healthcare system; the use of FIGO classification optimizing exposure, dissection, and graft fixation. system for symptoms and etiologies associated with AUB in Learning Objectives: order to standardize publications and documentation; and the • Describe optimal patient positioning and docking evidence of effectiveness of treatments for AUB (combined • Discuss time-saving strategies for exposing the vesicovaginal, oral contraceptives, progestin, NSAIDs, antifibrinolytics, the rectovaginal, and pre-sacral spaces levonorgestrel intrauterine system, and ). • Employ different techniques for mesh fixation to the vagina Learning Objectives: during laparoscopic and robotic sacral colpopexy • Describe the definitions of abnormal uterine bleeding (AUB) • Describe techniques for the efficient use of these minimally and the terminologies supported by FIGO and ACOG invasive techniques for sacralcolpopexy

PFD WEEK 2017 OCT 3 – 7 25 KEYNOTE PRESENTATIONS

RAYMOND A. LEE LECTURE J. MARION SIMS LECTURE Thursday, October 5 Friday, October 6 2:00 p.m. – 2:30 p.m. 10:15 a.m. – 10:50 a.m. Exhibition Hall C Exhibition Hall C The Raymond A. Lee Endowment is a named lectureship created The J. Marion Sims Lecture is presented annually at PFD Week by AUGS to honor one person annually who contributed to the to continue to educate today’s gynecological surgeon about the development and surgical advancement of urogynecology and importance of supporting and encouraging innovation within to further advance the knowledge and teaching of gynecologic women’s health. surgery through ongoing AUGS educational programs. Generous support for the J. Marion Sims Lecture is provided Life-long Learning, Loving What You Do, and Paying by ABOG. it Forward Vesico-Vaginal Fistula: Historical Understanding, Medical Presented by Marie Fidela Rustia Paraiso, MD Ethics, and Modern Sensibilities This lectureship will detail Dr. Paraiso’s 20-year Presented by L. Lewis Wall, MD, DPhil journey from striving for work-life balance to The 2017 J. Marion Sims Lecture will be delivered by achieving personal and professional satisfaction. She Dr. L. Lewis Wall, Selina Okin Kim Conner Professor will discuss the importance of teamwork, mentorship, in Arts and Sciences at Washington University in self-assessment and reflection, and lifelong learning. St. Louis. The lecture will address the contributions to th Dr. Marie Fidela Paraiso is Professor of Surgery at Cleveland Clinic fistula surgery made by Dr. Sims in the 19 Century Lerner College of Medicine, Section Head of Urogynecology at and the controversies that have arisen concerning his operations in the Cleveland Clinic in Cleveland, OH. She is a graduate of the the last several decades. University of Notre Dame and Indiana University School of Medicine. L. Lewis Wall received his medical degree from the University of She completed her OBGYN residency at Good Samaritan Hospital Kansas School of Medicine and completed his residency training in Cincinnati and her fellowship in Advanced Pelvic Surgery and in obstetrics and gynecology at Duke University Medical Center. Minimally Invasive Gynecology at the Cleveland Clinic. She is Board Dr. Wall did sub-specialty fellowship training in female urology and Certified in OBGYN and Female Pelvic Medicine and Reconstructive urodynamics at the University of London (St. George’s Hospital) and Surgery. She was Section Head for Urogynecology and Reconstructive St. Mary’s Hospital for Women and Children in Manchester, England. Pelvic Surgery at the University of Missouri, Kansas City prior to returning to Cleveland Clinic in 1998, where she currently works. She He is board-certified in both general obstetrics and gynecology and has completed three executive courses in leadership: Leadership in in the sub-specialty of female pelvic medicine and reconstructive Healthcare, Leadership in Surgery, and Fast Track Leadership. surgery. In addition to his clinical qualifications, he has a master’s degree in bioethics from the Center for Human Bioethics at Monash Nationally, Dr. Paraiso served twice on the Board of Directors for University in Australia. the American Urogynecologic Society (AUGS) 2000-2003 and 2007 2010, and on the Board Trustees for the American Association Dr. Wall has a longstanding interest in the health problems of women of Gynecologic Laparoscopists from 2012-2014. She is currently in Africa. He founded the Worldwide Fistula Fund in 1995, a not-for- Secretary Treasurer of AAGL and will serve as President in 2019. profit public charity dedicated to providing care for women who have Dr. Paraiso has lectured throughout North America, Europe, the developed obstetric fistulas from prolonged obstructed labor. Middle East, Asia, Central and South America, and Australia. She has published over 135 manuscripts, 20 book chapters, and a 2014 textbook for Office Gynecology.

26 PFD WEEK 2017 OCT 3 – 7 INDUSTRY SUPPORTED EDUCATION

Wednesday, October 4 12:00 p.m. – 1:30 p.m. 11:45 a.m. – 1:15 p.m. IMPROVING YOUR EFFICIENCY: NEW DIGITAL THE FUTURE OF TREATING MODERATE TO SEVERE RESOURCES TO ADDRESS PHYSICIAN NEEDS DYSPAREUNIA: A NEW, LOCALLY ADMINISTERED Room 555 TREATMENT FOR MODERATE TO SEVERE DYSPAREUNIA Supported by Boston Scientific DUE TO MENOPAUSE. Faculty: Peter Rosenblatt MD, FACOG, FPMRS, Mount Auburn Rotunda Hospital Supported by AMAG

12:00 p.m. – 1:30 p.m. Friday, October 6 CONNECTING WITH OAB PATIENTS-GUIDE FOR 1:00 p.m. – 2:30 p.m. PRODUCTIVE COMMUNICATION AND GAINING THIRD-LINE TREATMENT ACCEPTANCE LASER APPLICATIONS IN VAGINAL HEALTH SPECIFICALLY Ballroom A RELATED TO GSM, SUI, AND ATROPHY Supported by Allergan Room 555 Faculty: Karyn Eilber, MD, Cedars-Sinai Medical Center, Supported by Alma Lasers Beverly Hills, CA Faculty: G. Willy Davila, MD, Chairman, Department of *Available to registrants of Multidisciplinary Evaluation and Gynecology, Head of the Section of Urogynecology and Treatment of Vulvar Disorders workshop only Reconstructive Pelvic Surgery, Cleveland Clinic Florida; Yona Tadir, MD, Professor, Obstetrics and Gynecology, Beckman 12:45 p.m. – 1:45 p.m. Laser Institute and Medical Clinic, University of California Irvine; CONNECTING WITH OAB PATIENTS-GUIDE FOR Yair Leopold, VP of Alma Lasers Surgical PRODUCTIVE COMMUNICATION AND GAINING THIRD-LINE 1:00 p.m. – 2:30 p.m. TREATMENT ACCEPTANCE Ballroom B SINGLE-INCISION SLINGS: DATA, BARRIERS, AND THE PATIENT EXPERIENCE Supported by Allergan Faculty: Michael Kennelly, MD, Charlotte Continence Center, Room 552 Charlotte, NC Supported by Coloplast Faculty: Mickey Karram, M.D. (Cincinnati, Ohio), Prof. Jan-Paul *Available to registrants of Fellows Day only Roovers, MD (Amsterdam, The Netherlands) Thursday, October 5 6:30 a.m. – 7:30 a.m. THE USE OF MULTIMODAL ANALGESIA TO REDUCE OPIOID USE IN UROGYNECOLOGICAL PROCEDURES Room 552 Supported by Pacira Faculty: Javier D. Lasala, MD; Catrina Crisp, MD

PFD WEEK 2017 OCT 3 – 7 27 SCIENTIFIC PROGRAM

TUESDAY, OCTOBER 3 4:30 p.m. – 6:00 p.m. 8:15 a.m. – 8:27 a.m. ADVANCED PRACTICE, PHYSICAL Paper 1 – CHANGES OVER TIME IN 8:30 a.m. – 12:00 p.m. ANTERIOR AND POSTERIOR VAGINAL THERAPY, AND ALLIED HEALTH (APPTAH) SUPPORT AFTER CESAREAN VERSUS PRE-CONFERENCE WORKSHOPS SIG BUSINESS MEETING — ROOM 553 See page 20 for details VAGINAL BIRTH GLOBAL HEALTH SIG BUSINESS V. L. Handa1, J. L. Blomquist2, A. Munoz3. 1:30 p.m. – 5:00 p.m. MEETING — SOUTH COUNTY (OMNI HOTEL) 1Johns Hopkins, Baltimore, MD; 2Greater MESH/GRAFT USE IN PELVIC Baltimore Medical Center, Baltimore, MD; PRE-CONFERENCE WORKSHOPS 3Johns Hopkins Bloomberg School of RECONSTRUCTIVE SURGERY SIG See page 20 for details Public Health, Baltimore, MD BUSINESS MEETING — ROTUNDA (CONVENTION CENTER) 8:27 a.m. – 8:37 a.m. WEDNESDAY, OCTOBER 4 Paper 2 – CONTROLLING ANAL 5:30 p.m. – 7:30 p.m. 7:45 a.m. – 5:00 p.m. INCONTINENCE IN WOMEN BY PFD WEEK WELCOME RECEPTION IN THE PERFORMING ANAL EXERCISES FELLOWS’ DAY — BALLROOM B WITH MANOMETRIC-ASSISTED EXHIBIT HALL — EXHIBITION HALL AB See page 22 for details BIOFEEDBACK OR LOPERAMIDE: THE CAPABLE TRIAL 8:00 a.m. – 4:00 p.m. THURSDAY, OCTOBER 5 J. E. Jelovsek1, A. D. Markland2, 3 1 FELLOWSHIP PROGRAM DIRECTORS’ W. E. Whitehead , M. D. Barber , D. K. 6:30 a.m. – 7:30 a.m. 4 5 6 WORKSHOP — ROOM 555 Newman , R. G. Rogers , K. Y. Dyer , A. G. INDUSTRY-SUPPORTED EDUCATION — Visco7, V. W. Sung8, H. M. Zyczynski10, 9 11 9 8:30 a.m. – 12:00 p.m. THE USE OF MULTIMODAL ANALGESIA B. Carper , S. F. Meikle , M. Gantz . 1Obstetrics, Gynecology & Women’s Health PRE-CONFERENCE WORKSHOPS TO REDUCE OPIOID USE IN UROGYNECOLOGICAL PROCEDURES — Institute, Cleveland Clinic, Cleveland, OH; See page 20 for details 2Medicine, University of Alabama at ROOM 552 Birmingham, Birmingham, AL; 3OBGYN 11:45 a.m. – 1:15 p.m. Supported by Pacira and Medicine, University of North Carolina, INDUSTRY-SUPPORTED EDUCATION — Chapel Hill, NC; 4Urology, University of 6:45 a.m. – 7:45 a.m. 5 THE FUTURE OF TREATING MODERATE TO Pennsylvania, Philadelphia, PA; OBGYN, SEVERE DYSPAREUNIA: A NEW, LOCALLY MEET THE EXPERTS EDUCATIONAL University of New Mexico, Albuquerque, NM; 6Permanente, Kaiser, San Diego, CA; ADMINISTERED TREATMENT FOR ROUNDTABLES — ROTUNDA 7OBGYN, Duke University, Durham, NC; MODERATE TO SEVERE DYSPAREUNIA See page 23 for details 8OBGYN, Brown University, Providence, DUE TO MENOPAUSE — ROTUNDA 9 6:45 a.m. – 7:45 a.m. RI; RTI International, Research Triangle Supported by AMAG Park, NC; 10Department of Obstetrics, ELECTRONIC MEDICAL RECORDS (EMR) Gynecology and Reproductive Sciences, 1:00 p.m. – 5:00 p.m. SIG BUSINESS MEETING — ROOM 551 University of Pittsburgh Medical Center, PRE-CONFERENCE WORKSHOPS See page 8 for details Pittsburgh, PA; 11Department of Internal See page 21 for details Medicine, University of at , 8:00 a.m. – 8:15 a.m. Houston, TX 3:00 p.m. – 3:45 p.m. WELCOME AND INTRODUCTION — 8:37 a.m. – 8:47 a.m. BALLROOM AB POST OR PERISH — ROOM 553 Paper 3 – DIFFERENTIAL IMPACT OF FECAL INCONTINENCE SUBTYPES ON Brian Jacob, MD, Icahn School of Medicine at 8:15 a.m. – 9:15 a.m. Mount Sinai Laparoscopic Surgical Center of TREATMENT EFFICACY IN WOMEN New York GENERAL SCIENTIFIC SESSION I — USING THE VAGINAL BOWEL CONTROL BALLROOM C SYSTEM 4:00 p.m. – 4:45 p.m. Moderator: David Rahn, MD I. Meyer1, C. A. Matthews2, T. W. Muir6, 5 7 FUTURE OF MEDICINE AND TECHNOLOGY: Discussant: Christina Lewicky-Gaupp, MD M. M. Takase-Sanchez , D. S. Hale , D. M. Van Drie3, M. G. Varma4, H. E. THE ART OF THE POSSIBLE — ROOM 553 Richter1. 1Obstetrics and Gynecology, Michael Ruiz, MedStar Health University of Alabama at Birmingham,

28 PFD WEEK 2017 OCT 3 – 7 KEY: = Virtual Conference = This session requires a ticket Scientific Program

Birmingham, AL; 2Wake Forest Baptist 11:00 a.m. – 11:04 a.m. 11:08 a.m. – 11:12 a.m. Health, Winston Salem, NC; 3Female Oral Poster 1 – RESPONSIVENESS AND Oral Poster 3 – PREDICTIVE FACTORS Pelvic Medicine & Urogynecology MINIMALLY IMPORTANT DIFFERENCE OF POSTOPERATIVE PAIN FOLLOWING Institute of Michigan, Grand Rapids, MI; OF SF-6D AND EQ-5D UTILITY SCORES VAGINAL RECONSTRUCTIVE SURGERY 4University of California, San Francisco, FOR THE TREATMENT OF PELVIC A. Shatkin-Margolis, C. C. Crisp, R. N. San Francisco, CA; 5Centers for Family ORGAN PROLAPSE Pauls. TriHealth Good Samaritan Hospital, Health Santa Rosa & San Buenaventura H. S. Harvie1, A. A. Honeycutt7, S. J. Cincinnati, OH Urology, Ventura, CA; 6Houston Methodist Neuwahl7, M. D. Barber4, H. E. Richter9, Urogynecology Associates, Houston, TX; A. G. Visco3, V. W. Sung2, J. P. Shepherd5, 11:12 a.m. – 11:16 a.m. 7Indiana University Health, Indianapolis, IN R. G. Rogers8, S. Jakus-Waldman10, Oral Poster 4 – PREDICTORS OF D. Mazloomdoost6. 1Obstetrics and SUCCESS AT 5 YEARS POST-IMPLANT 8:47 a.m. – 8:57 a.m. Gynecology, University of Pennsylvania, OF THE INTERSTIM SYSTEM FOR Paper 4 – THE EFFECT OF Philadelphia, PA; 2Obstetrics and OVERACTIVE BLADDER PERIOPERATIVE PEER SUPPORT 1 2 3 Gynecology, Brown, Providence, RI; K. L. Noblett , J. Mangel , J. Bennett , ON SURGICAL PREPAREDNESS 4 5 6 3Obstetrics and Gynecology, Duke, C. Comiter , S. Zylstra , E. T. Bird , IN WOMEN UNDERGOING PELVIC 7 8 Durham, NC; 4Obstetrics and Gynecology, T. L. Griebling , S. E. Sutherland , K. J. RECONSTRUCTIVE SURGERY 9 9 10 1 Cleveland, Cleveland, OH; 5Obstetrics Berg , F. Kan , S. Siegel . University of 1 2 2 A. M. Madsen , R. G. Rogers , and Gynecology, University of Pittsburgh, California, Riverside, CA; MetroHealth 3 4 3 G. C. Dunivan , A. M. Parrillo , C. A. Pittsburgh, PA; 6NICHD, NIH, Bethesda, Medical Center, Cleveland, OH; Female 5 1 1 Raker , V. W. Sung . Urogynecology/ MD; 7Clinical Research Network Pelvic Medicine, Grand Rapids, MI; 4 5 Obstetrics and Gynecology, Women Coordination, RTI, Research Triangle Stanford University, Stanford, CA; Milford and Infants Hospital/Warren Alpert Park, NC; 8Department of Women’s Regional Medical Center, Whitinsville, 6 Medical School of Brown University, Health, University of Texas, Austin, TX; MA; Scott & White Hospital, Temple, TX; 2 7 Providence, RI; Department of 9Obstetrics and Gynecology, University of University of Kansas, Kansas City, KS; 8 Women’s Health, Dell Medical School, Alabama at Birmingham, AL; 10Obstetrics University of Washington, Seattle, WA; 3 9 Austin, TX; Urogynecology, University and Gynecology, Kaiser Downey, Clinical, Medtronic, Minneapolis, MN; 10 of New Mexico, Albuquerque, NM; Downey, CA Metro Urology, Woodbury, MN 4Warren Alpert Medical School of Brown University, Providence, RI; 5Division of 11:04 a.m. – 11:08 a.m. 11:16 a.m. – 11:20 a.m. Research, Women & Infants’ Hospital, Oral Poster 2 – THE PATIENT QUESTIONS FOR ORAL POSTERS 1–4 Providence, RI PERSPECTIVE ON PELVIC FLOOR 11:20 a.m. – 11:24 a.m. DISORDERS SURGICAL ADVERSE 8:57 a.m. – 9:10 a.m. Oral Poster 5 – A RANDOMIZED EVENTS CONTROLLED TRIAL OF POST- Video 1 – MODIFIED PENILE 1 2 G. C. Dunivan , A. L. Sussman , J. E. OPERATIVE PELVIC FLOOR PHYSICAL INVERSION FOR THE 3 4 5 Jelovsek , V. W. Sung , U. U. Andy , THERAPY AFTER VAGINAL TRANSGENDER WOMAN 6 7 A. Ballard , S. Jakus-Waldman , RECONSTRUCTIVE SURGERY T. N. Thomas, K. Jallad, C. Unger. 8 9 C. L. A.m. undsen , C. Chermansky , M. Dawson1, H. T. Yuen4, P. G. O’Hare2, Cleveland Clinic, Cleveland, OH 10 11 1 C. Bann , R. G. Rogers . Obstetrics J. Mann3, K. Widdoes5, H. Goldstein6. and Gynecology, University of New 1Obstetrics and Gynecology, Drexel 9:15 a.m. – 10:30 a.m. 2 Mexico, Albuquerque, NM; Family University College of Medicine, STATE OF THE SOCIETY and Community Medicine, University Philadelphia, PA; 2Division of Female PRESIDENTIAL ADDRESS – of New Mexico, Albuquerque, NM; Pelvic Medicine and Reconstructive 3 4 EXHIBITION HALL C Cleveland Clinic, Cleveland, OH; Women Surgery, MedStar Franklin Square 5 and Infants, Providence, RI; University Medical Center, Baltimore, MD; 10:30 a.m. –11:00 a.m. of Pennsylvania, Philadelphia, PA; 3Obstetrics and Gynecology Research, 6 University of Alabama and Birmingham, Christiana Care Health System, BREAK IN THE EXHIBIT HALL – EXHIBITION 7 Birmingham, AL; Kaiser Permanente, Newark, DE; 4Obstetrics and Gynecology, HALL AB 8 Downey, CA; Duke University Medical Christiana Care Health System, 9 Center, Durham, NC; University of Newark, DE; 5Physical Therapy, Women’s 11:00 a.m. – 11:45 a.m. 10 Pittsburgh, Pittsburgh, PA; RTI, Health, Christiana Care Health System, 11 SCIENTIFIC CONCURRENT SESSION 1: Research Triangle Park, NC; University Newark, DE; 6Obstetrics and Gynecology, SURGERY SESSION – BALLROOM A of Texas at Austin, Austin, TX Division of Urogynecology, Christiana Moderators: Amy Park, MD; Eric Sokol, MD Care Health System, Newark, DE

PFD WEEK 2017 OCT 3 – 7 29 SCIENTIFIC PROGRAM (CONTINUED)

THURSDAY, OCTOBER 5 (Continued) Lewicky-Gaupp, K. Kenton, M. G. Mueller. 11:16 a.m. – 11:20 a.m. Obstetrics and Gynecology, Northwestern QUESTIONS FOR ORAL POSTERS 7–10 11:24 a.m. – 11:28 a.m. University, Chicago, IL Oral Poster 6 – ENHANCED RECOVERY 11:20 a.m. – 11:24 a.m. 11:04 a.m. – 11:08 a.m. AFTER UROGYNECOLOGIC SURGERY: Oral Poster 11 – LONG TERM SEXUAL A SURVEY OF PATIENT EXPERIENCE Oral Poster 8 – THE PURSUIT OF FUNCTION AFTER OBSTETRIC ANAL M. F. Schmidt1, S. Evans1, S. Podwika2, MOBILE APPLICATIONS FOR PATIENTS SPHINCTER INJURIES 2 1 A. T. Knisely2, B. Sarosiek1, K. L. WITH PELVIC FLOOR DISORDERS M. O’Shea , C. Lewicky-Gaupp , D. R. 1 1 2 3 1 Hullfish3, E. Trowbridge3. 1OB/GYN, N. T. Sudol , E. Adams-Piper , R. Perry , Gossett . Obstetrics & Gynecology, 3 1 University of Virginia, Charlottesville, VA; K. T. Chen , F. Lane1. FPMRS, UC Division of Female Pelvic Medicine and 2 2University of Virginia School of Medicine, Irvine, Orange, CA; OBGYN, UC Irvine, Reconstructive Surgery, Northwestern 3 Charlottesville, VA; 3OB/GYN and Urology, Orange, CA; OBGYN, Icahn School of University Feinberg School of Medicine, 2 University of Virginia, Charlottesville, VA Medicine at Mount Sinai, New York, NY Chicago, IL; Obstetrics & Gynecology, Northwestern University Feinberg 11:08 a.m. – 11:12 a.m. 11:28 a.m. – 11:34 a.m. School of Medicine, Chicago, IL; Video 2 – PERSISTENT VAGINAL Oral Poster 9 – INCONTINENCE & 3Obstetrics and Gynecology, Division of LEAKAGE IN THE SETTING OF AN INTIMATE PARTNERS CLINICAL TRIAL: Obstetrics, Gynecology, and Gynecologic APICAL VAGINAL SINUS TRACT THE SEXUAL BENEFIT OF SUCCESSFUL Subspecialties, University of California, D. Bastawros, M. Kennelly, K. Stepp. TREATMENT (IIMPACT) San Francisco, San Francisco, CA 4 2 3 Carolinas Health Care System, Charlotte, NC J. Cunkelman , T. Dune , C. J. Joyce , M. Tulke1, N. El-Kouri1, L. Brubaker1, 11:24 a.m. – 11:28 a.m. 11:34 a.m. – 11:40 a.m. C. Brincat1, E. R. Mueller1. 1Obstetrics/ Oral Poster 12 – ACCIDENTAL BOWEL QUESTIONS FOR ORAL POSTERS 5–6 Gynecology & Urology, Loyola University LEAKAGE EVALUATION (ABLE): A NEW Stritch School of Medicine, Maywood, IL; PATIENT-CENTERED VALIDATED 11:00 a.m. – 11:45 a.m. 2Urology, Weill Cornell Medicine, MEASURE OF ACCIDENTAL BOWEL New York, NY; 3Department of Public LEAKAGE SYMPTOMS SCIENTIFIC CONCURRENT SESSION 2: Health Sciences, Loyola University R. G. Rogers1, C. Bann2, V. W. Sung3, E. S. QUALITY OF LIFE/HEALTH SERVICES Chicago, Maywood, IL; 4US Federal Drug Lukacz4, L. A. Arya6, M. D. Barber7, A. D. RESEARCH SESSION – BALLROOM B/C Administration, Silver Springs, MD Markland8, P. Fairchild5, N. Y. Siddiqui9. Moderators: Jeannine Miranne, MD; Mikio 1Department of Women’s Health, 11:12 a.m. – 11:16 a.m. Nihira, MD University of Texas Austin Dell Medical Oral Poster 10 – TOPICAL LIDOCAINE 2 11:00 a.m. – 11:04 a.m. School, Austin, TX; RTI International, FOR URODYNAMIC TESTING: A DOUBLE 3 Oral Poster 7 – RECOVERING SEXUAL Research Triangle Park, NC; Department BLINDED RANDOMIZED CONTROL TRIAL of Obstetrics and Gynecology, Brown/ SATISFACTION AFTER PROLAPSE K. Zinkgraf, S. Aschkenazi, R. Anderson, SURGERY Women and Infants Hospital of Rhode K. R. Stevenson. Urogynecology, Island, Providence, RI; 4Obstetrics J. Geynisman-Tan, A. Leader-Cramer, ProHealth Care, Inc, Waukesha, WI and Gynecology, UC San Diego, La K. Bochenska, B. Davé, S. A. Collins, C. Jolla, CA; 5Obstetrics and Gynecology, University of Pittsburgh, Pittsburgh, PA; 6Department of Obstetrics and Gynecology, University of Pennsylvania, Philadelphia, PA; 7Obstetrics and Gynecology, Cleveland Clinic, Cleveland, OH; 8University of Alabama at Birmingham, Birmingham, AL; 9Obstetrics and Gynecology, Duke University, Durham, NC

30 PFD WEEK 2017 OCT 3 – 7 KEY: = Virtual Conference = This session requires a ticket Scientific Program

11:28 a.m. – 11:35 a.m. 11:12 a.m. – 11:16 a.m. 11Gynecologic Health and Disease Video 3 – SACROCOLPOPEXY Oral Poster 16 – RETHINKING THE Branch, Eunice Kennedy Shriver National MODIFICATION IN THE SETTING OF A URINARY CATHETER: LESS TRAUMA Institute of Child Health and Human PELVIC KIDNEY THRU BETTER DESIGN: A SHEEP MODEL Development (NICHD) National Institutes E. R. Davidson, J. Ashburn, M. Paraiso. X. SUN2, A. T. Grazul-Bilska2, K. Vonnahme2, of Health (NIH), Bethesda, MD; 12Social, Cleveland Clinic, Cleveland, OH B. T. Webb2, N. Kohli1. 1Ob/Gyn, Brigham Statistical & Environmental Sciences, RTI and Women’s Hospital, Wellesley, MA; International, Research Triangle Park, NC 11:35 a.m. – 11:40 a.m. 2Animal Sciences, North Dakota State 11:28 a.m. – 11:32 a.m. QUESTIONS FOR ORAL POSTERS 11–12 University, Fargo, ND Oral Poster 19 – NATURAL HISTORY OF 11:00 a.m. – 11:45 a.m. 11:16 a.m. – 11:20 a.m. AN ACUTE URINARY TRACT INFECTION IN A YOUNG WOMAN SCIENTIFIC CONCURRENT SESSION 3: QUESTIONS FOR ORAL POSTERS 13–16 D. Johansen, T. K. Price, R. Limeira, A. BASIC SCIENCE SESSION – BALLROOM D/E 11:20 a.m. – 11:24 a.m. J. Wolfe. Microbiology & Immunology, Toby Chai, MD; JP Moderators: Oral Poster 17 – DETERMINATION OF Loyola University Chicago, Stritch School Roovers, MD LOXL1 AND FIBULIN-5 LEVELS IN THE of Medicine, Maywood, IL VAGINAL SECRETIONS OF WOMEN WITH 11:00 a.m. – 11:04 a.m. AND WITHOUT PELVIC ORGAN PROLAPSE 11:32 a.m. – 11:36 a.m. Oral Poster 13 – BIG POTASSIUM B. A. Garcia, T. J. Lechuga, A. Nasiri, D. Oral Poster 20 – EXPLORATION OF (BK) CHANNEL REGULATES IN VIVO Chen, F. Lane. Female Pelvic Medicine A REGENERATIVE EXTRACELLULAR UROTHELIAL CYTOKINE RELEASE and Reconstructive Surgery, University of MATRIX BIOSCAFFOLD IN INDUCED BY LIPOPOLYSACCHRIDE: California Irvine, Orange, CA SACROCOLPOPEXY: IMPACT ON NEW INSIGHT INTO UROTHELIAL INNATE VAGINAL SMOOTH MUSCLE IMMUNE RESPONSE IN PATHOGENESIS 11:24 a.m. – 11:28 a.m. R. Liang3, R. M. Shaffer2, C. M. OF URINARY TRACT INFECTION Oral Poster 18 – THE URINARY CARTER-BROOKS1, S. Palcsey3, S. D. J. Y. Yeh, L. Alvarez-Lugo, M. Lu, MICROBIOME IN WOMEN WITH MIXED Abramowitch4, P. A. Moalli3. 1Department T. C. Chai. Yale School of Medicine, URINARY INCONTINENCE of OB & GYN, School of Medicine, New Haven, CT Y. M. Komesu1, H. E. Richter2, B. University of Pittsburgh, Pittsburgh, PA; Carper3, D. L. Dinwiddie7, V. W. Sung4, 2 11:04 a.m. – 11:08 a.m. Department of Obstetrics, Gynecology, E. S. Lukacz5, H. M. Zyczynski9, B. Oral Poster 14 – IN VIVO EVALUATION and Reproductive Sciences, University of Ridgeway6, N. Y. Siddiqui8, L. A. Arya10, OF THE HOST RESPONSE TO AN Vermont College of Medicine, Burlington, R. G. Rogers1, D. Mazloomdoost11, M. 3 ELASTOMERIC MESH: AN ALTERNATIVE VT; MWRI, Department of Obstetrics, Gantz12. 1Obstetrics & Gynecology, TO POLYPROPYLENE MESH Gynecology, and Reproductive Sciences, University of New Mexico Health University of Pittsburgh, School of K. Knight1, S. D. Abramowitch1, P. A. Sciences Center, Albuquerque, NM; Medicine, Pittsburgh, PA; 4Department of Moalli2. 1Bioengineering, University of 2Obstetrics & Gynecology, University of Bioengineering, University of Pittsburgh, Pittsburgh, Pittsburgh, PA; 2Department Alabama at Birmingham, Birmingham, School of Engineering, Pittsburgh, PA of Obstetrics and Gynecology and AL; 3Social, Statistical & Environmental Reproductive Sciences at Magee Sciences, RTI, Research Triangle Park, 11:36 a.m. – 11:40 a.m. Womens Hospital, Magee-Womens NC; 4Obstetrics & Gynecology, Alpert Oral Poster 21 – IMPACT OF A Research Institute, Pittsburgh, PA Medical School of Brown University, REGENERATIVE ECM BIOSCAFFOLD ON 11:08 a.m. – 11:12 a.m. Providence, RI; 5Obstetrics & Gynecology, VAGINAL SMOOTH MUSCLE R. Liang1, S. Palcsey1, S. D. Oral Poster 15 – THE IMPACT OF UC San Diego Health System, San Diego, 6 Abramowitch2, P. A. Moalli1. 1 COMMON VAGINAL LUBRICANTS CA; Obstetrics & Gynecology, Cleveland MWRI, 7 ON E. COLI Clinic, Cleveland, OH; Pediatrics and Department of Obstetrics, Gynecology & Reproductive Science, School of K. J. Hung, A. Bergerat-Thompson, Microbiology, University of New Mexico Health Sciences Center, Albuquerque, Medicine, University of Pittsburgh, M. M. Weinstein, C. Mitchell. OB/GYN, 8 Pittsburgh, PA; 2Department of Massachusetts General Hospital, NM; Obstetrics & Gynecology, Duke University, Durham, NC; 9Obstetrics & Bioengineering, School of Engineering, Boston, MA Gynecology, University of Pittsburgh University of Pittsburgh, Pittsburgh, PA School of Medicine, Pittsburgh, PA; 11:40 a.m. – 11:45 a.m. 10Obstetrics & Gynecology, University of Pennsylvania, Philadelphia, PA; QUESTIONS FOR ORAL POSTERS 17–21

PFD WEEK 2017 OCT 3 – 7 31 SCIENTIFIC PROGRAM (CONTINUED)

THURSDAY, OCTOBER 5 (Continued) 2:40 p.m. – 2:47 p.m. 5Genitourinary Surgical Associates, Denver, CO; 6Regional Urological AUGS–SGS FPRN® UPDATE – EXHIBITION 11:00 a.m. – 12:00 p.m. Associates, Shreveport, LA; 7Chesapeake HALL C Urology Associates, Glen Burnie, MD; CLINICAL SEMINAR 8WomenCare, Arlington Heights, IL; 2:47 p.m. – 4:0 p.m. ABNORMAL UTERINE BLEEDING: WADING 3 9Urology of Virginia, Virginia Beach, VA; THROUGH THE EVIDENCE ON EVALUATION GENERAL SCIENTIFIC SESSION II – 10Medical College of South Carolina, AND TREATMENT EFFECTIVENESS – EXHIBITION HALL C Charleston, SC; 11Virginia Women’s ROOM 551 Moderators: John Occhino, MD; Rebecca Center, Richmond, VA; 12Women and Kristen A. Matteson, MD Rogers, MD Infants Hospital, Providence, RI

11:45 a.m. – 1:30 p.m. 2:47 p.m. – 2:57 p.m. 3:07 p.m. – 3:17 p.m. Paper 5 – TWO-YEAR OUTCOMES Paper 7 – RISK AFTER LUNCH IN THE EXHIBIT HALL OF SACRAL NEUROMODULATION MIDURETHRAL SLING SURGERY VS. ONABOTULINUMTOXINA FOR USING POLYPROPYLENE MESH: A 12:00 p.m. – 1:30 p.m. REFRACTORY URGENCY URINARY NATIONWIDE POPULATION-BASED INDUSTRY-SUPPORTED EDUCATION — INCONTINENCE COHORT STUDY IMPROVING YOUR EFFICIENCY: NEW C. L. Amundsen1, T. S. Wilson3, D. D. D. Altman1, R. G. Rogers2, L. Yin3, 4 5 DIGITAL RESOURCES TO ADDRESS Wallace2, S. P. Vasavada4, J. N. Nguyen5, K. Tamussino , C. B. Iglesia . 6 7 1 PHYSICIAN NEEDS – ROOM 555 D. L. Myers , Y. M. Komesu , A. A. Department of Clinical Sciences, Honeycutt2, H. S. Harvie8, W. T. Gregory9, Karolinska Institutet, Stockholm, Supported by Boston Scientific C. Chermansky10. 1Duke University, Sweden; 2Department of Women’s 2 Health, University of Texas Austin Dell 12:00 p.m. – 1:30 p.m. Durham, NC; RTI International, Research Triangle Park, NC; 3University of Alabama Medical School, Austin, TX; 3Department INDUSTRY-SUPPORTED EDUCATION — at Birmingham, Birmingham, AL; of Epidemiology and Biostatistics, ROOM 552 4Cleveland Clinic, Cleveland, OH; 5Kaiser Karolinska Institutet, Stockholm, 4 Supported by Medtronic Permanente – Bellflower, Downey, Sweden; Department of Obstetrics and CA; 6Brown University, Providence, Gynecology, Medical University of Graz, 1:30 p.m. – 2:00 p.m. RI; 7University of New Mexico Health Graz, Austria; 5Department of Obstetrics Sciences Center, Albuquerque, NM; and Gynecology, MedStar Washington DEBATE 1 8University of Pennsylvania, Hospital Center / Georgetown University SLING SELECTIONS AND WHAT TO DO Philadelphia, PA; 9Oregon Health and School of Medicine, Washington, WHEN THEY FAIL! – EXHIBITION HALL C Science University, Portland, OR; 3:17 p.m. – 3:27 p.m. Moderator: Lynsey Hayward, MD 10University of Pittsburgh, Pittsburgh, PA Paper 8 – GROSS AND HISTOLOGIC Speakers: Holly Richter, MD, PhD; Matthew Barber, MD, MHS 2:57 p.m. – 3:07 p.m. RELATIONSHIPS OF THE RETROPUBIC Paper 6 – A RANDOMIZED, TO LATERAL PELVIC 2:00 p.m. – 2:30 p.m. MULTICENTER STUDY OF AN SIDEWALL AND ANTERIOR VAGINAL INTRAVESICAL BALLOON WALL IN FEMALE CADAVERS: RAYMOND A. LEE LECTURE TO TREAT FEMALE STRESS CLINICAL APPLICATIONS TO LIFE-LONG LEARNING, LOVING WHAT URINARY INCONTINENCE (SUI): RETROPUBIC SURGERY YOU DO, AND PAYING IT FORWARD – 12 MONTH RESULTS J. J. Hamner1, K. S. Carrick2, 1 1 EXHIBITION HALL C S. A. Malik1, H. A. Winkler2, K. M. Corton . Female Pelvic Medicine Marie Fidela Rustia Paraiso, MD Jacoby3, S. J. Kalota4, J. Snyder5, K. and Reconstructive Surgery, University J. Cline6, K. Robertson7, R. Kahan8, L. of Texas Southwestern, Dallas, TX; 2:30 p.m. – 2:40 p.m. Green11, K. McCammon9, E. Rovner10, 2Pathology, University of Texas C. R. Rardin12. 1Valley Urogynecology Southwestern, Dallas, TX FPMRS JOURNAL UPDATE – EXHIBITION Associates, University of Arizona- HALL C 3:27 p.m. – 3:33 p.m. Phoenix College of Medicine, Phoenix, Linda Brubaker, MD, MHS, FACOG Tip and Trick 1 – REMOVAL OF VAGINAL AZ; 2Norwell Health, Great Neck, NY; CALCULUS WITH SURGICAL DRILL 3Integrity Medical Research, Westlake Terrace, WA; 4Urological Associates N. Young-Lin, D. Lum, L. Rogo- of Southern Arizona, Tucson, AZ; Gupta. Department of Obstetrics and

32 PFD WEEK 2017 OCT 3 – 7 KEY: = Virtual Conference = This session requires a ticket Scientific Program

Gynecology/Division of Urogynecology and 4:15 p.m. – 4:19 p.m. 4:35 p.m. – 4:39 p.m. Pelvic Reconstructive Surgery, Stanford Oral Poster 22 – MATERNAL LOWER Oral Poster 26 – TOBACCO USE, University, Stanford, CA URINARY TRACT INJURY AT THE TIME PSYCHIATRIC, IMMUNOSUPPRESSIVE, OF PERIPARTUM HYSTERECTOMY AND CHRONIC PAIN CONDITIONS 3:33 p.m. – 3:43 p.m. K. Bochenska1, A. Peters2, N. K. ARE PREVALENT IN WOMEN WITH Paper 9 – EFFECT OF VAGINAL MESH ON Ayala3, A. Strohl4, S. A. Collins1, H. M. SYMPTOMATIC MESH COMPLICATIONS VEGFA EXPRESSION Zyczynski5, K. Kenton1. 1Female Pelvic UNDERGOING MESH REMOVAL J. Kowalski, M. Goodheart, C. S. Bradley. Medicine and Reconstructive Surgery, SURGERY Obstetrics and Gynecology, University of Northwestern University, Chicago, IL; S. A. Adelstein, E. Blau, A. Lucioni, Iowa Hospitals and Clinics, Iowa City, IA 2Obstetrics and Gynecology, University K. Kobashi, U. J. Lee. Virginia Mason, 3 3:43 p.m. – 3:55 p.m. of Pittsburgh, Pittsburgh, PA; Obstetrics Seattle, WA (Papers 10 and 11 are combined) Paper 10 and Gynecology, Northwestern University, Chicago, IL; 4Gynecologic 4:39 p.m. – 4:43 p.m. – COST ANALYSIS OF REUSABLE Oncology, Northwestern University, Oral Poster 27 – PERIOPERATIVE UNDERWEAR VERSUS DISPOSABLE Chicago, IL; 5Female Pelvic Medicine and OUTCOMES IN PATIENTS WITH PADS FOR MILD TO MODERATE Reconstructive Surgery, University of HEREDITARY DISORDERS URINARY INCONTINENCE Pittsburgh, Pittsburgh, PA OF CONNECTIVE TISSUE: A B. Clark, L. Burkett, P. Alam, L. A. Richter. RETROSPECTIVE COHORT STUDY MedStar Washington Hospital Center/ 4:19 p.m. – 4:23 p.m. P. Alam1, E. R. Davidson2, J. N. Byrnes3, Georgetown University, Washington Oral Poster 23 – CORRELATION OF K. Bochenska4, M. E. Florian-Rodriguez5, VIRTUAL REALITY SIMULATION AND C. M. CARTER-BROOKS6, E. N. Myer7, Paper 11 – RANDOMIZED CROSS-OVER DRY LAB ROBOTIC TECHNICAL SKILLS M. Good8, R. E. Gutman1. 1MedStar COMPARISON OF ICON REUSABLE 1 1 Washington Hospital Center/Georgetown UNDERWEAR TO DISPOSABLE PADS L. K. Newcomb , M. S. Bradley , 1 1 2 1 University, Washington; 2Cleveland Clinic, FOR THE MANAGEMENT OF MILD TO T. Truong , M. Tang , B. Comstock , Y. Li , 1 1 Cleveland, OH; 3Mayo Clinic, Rochester, MODERATE URINARY INCONTINENCE N. Y. Siddiqui . OBGYN, Duke University 2 MN; 4Northwestern University, Chicago, P. Alam1, L. Burkett1, B. Clark1, N. C. Hospital, Durham, NC; C-SATS, IL; 5University of Texas Southwestern White2, L. A. Richter1. 1MedStar Washington San Francisco, CA Medical Center, Dallas, TX; 6University Hospital Center/ Georgetown University, 4:23 p.m. – 4:27 p.m. of Pittsburgh Medical Center/Magee Washington; 2Vanderbilt University, Oral Poster 24 – DID THE 2015 Women’s Hospital, Pittsburgh, PA; Nashville, TN NATIONAL HEALTH INSURER POLICY 7Johns Hopkins Hospital, Baltimore, 3:55 p.m. – 4:03 p.m. REQUIRING PRIOR AUTHORIZATION MD; 8University of Florida Health, Video 4 – DECONSTRUCTION OF FOR NON-VAGINAL HYSTERECTOMY Jacksonville, FL AND VAGINAL ROUTES INCREASE UTILIZATION OF 4:43 p.m. – 4:47 p.m. RESUSPENSION VAGINAL HYSTERECTOMY? Oral Poster 28 – PREDICTORS E. M. English, J. O. DeLancey. OB/GYN, C. W. Swenson, N. S. Kamdar, E. M. FOR LONG-TERM POSTOPERATIVE University of Michigan Health System, Ann English, D. M. Morgan. Obstetrics and FOLLOW-UP IN A COHORT OF PELVIC Arbor, MI Gynecology, University of Michigan, Ann Arbor, MI ORGAN PROLAPSE PATIENTS 4:03 p.m. – 4:15 p.m. C. Jung1, S. A. Menefee2, J. N. Nguyen3, 4:27 p.m. – 4:31 p.m. K. Y. Dyer2. 1Reproductive Medicine, BREAK – EXHIBIT LEVEL ATRIUM Oral Poster 25 – DOES MESH WEIGHT University of California, San Diego, AFFECT TIME TO FAILURE AFTER San Diego, CA; 2Female Pelvic Medicine 4:15 p.m. – 5:15 p.m. ROBOTIC-ASSISTED LAPAROSCOPIC and Reconstructive Surgery, Kaiser SCIENTIFIC CONCURRENT SESSION 4: SACROCOLPOPEXY? Permanente, San Diego, CA; 3Obstetrics HOT TOPICS IN SURGERY AND QUALITY A. L. Askew, A. G. Visco, A. C. Weidner, & Gynecology, Kaiser Permanente, OF LIFE SESSION – BALLROOM A N. Y. Siddiqui, M. S. Bradley. Obstetrics Downey, CA Moderators: Dobie Giles, MD; Heather & Gynecology, Duke University Hospital, van Raalte, MD Durham, NC 4:47 p.m. - 4:51 p.m. 4:31 p.m. – 4:35 p.m. QUESTIONS FOR ORAL POSTERS 26-28 QUESTIONS FOR ORAL POSTERS 22–25

PFD WEEK 2017 OCT 3 – 7 33 SCIENTIFIC PROGRAM (CONTINUED)

THURSDAY, OCTOBER 5 (Continued) Video 6 – HARVEST OF AUTOLOGOUS Cincinnati, OH; 5Northwestern University FASCIA LATA FROM THE THIGH Feinberg School of Medicine, Chicago, IL 4:51 p.m. – 4:55 p.m. SURGICAL TECHNIQUE VIDEO 4:27 p.m. – 4:31 p.m. Oral Poster 29 – IDENTIFYING M. T. Nguyen1, J. Oliver2, T. Y. Sadun2, 2 1 Oral Poster 34 – VARIATION IN PREDICTORS OF POSTDISCHARGE S. Raz . Obstetrics and Gynecology, PATIENT REFERRAL NETWORKS SURGICAL RECOVERY FOLLOWING Female Pelvic Medicine and LAPAROSCOPIC SACROCOLPOPEXY: Reconstructive Surgery, UCLA TO FEMALE PELVIC MEDICINE AND A PROSPECTIVE LONGITUDINAL STUDY David Geffen School of Medicine, RECONSTRUCTIVE SURGEONS ACROSS THE UNITED STATES M. Heit1, J. S. Carpenter2, R. Stewart3, J. Los Angeles, CA; 2Urology, Pelvic 1 2 1 3 4 J. Hajagos . J. Hamner , K. L. Rand . 1Female Pelvic Medicine and Reconstructive Surgery, T. M. Muffly , Female Pelvic Medicine and Reconstructive Surgery, UCLA, Los Angeles, CA Medicine and Reconstructive Surgery, 2 Indiana University School of Medicine, Denver Health, Denver, CO; Department Indianapolis, IN; 2Indiana University 5:04 p.m. – 5:08 p.m. of Biomedical Informatics, Stony Brook School of Nursing, Indianapolis, IN; QUESTIONS FOR ORAL POSTERS 29–30 University, Stony Brook, NY 3Obstetrics and Gynecology, Indiana 4:15 p.m. – 5:15 p.m. 4:31 p.m. – 4:35 p.m. University School of Medicine, QUESTIONS FOR ORAL POSTERS 31–34 Indianapolis, IN; 4Department of SCIENTIFIC CONCURRENT Psychology, Indiana University-Purdue SESSION 5: EPIDEMIOLOGY AND 4:35 p.m. – 4:39 p.m. University at Indianapolis (IUPUI), OTHER PELVIC FLOOR DISORDERS Oral Poster 35 – REFRACTORY Indianapolis, IN SESSION – BALLROOM B/C PUDENDAL PAIN AND PELVIC FLOOR DYSFUNCTION CAUSED BY 4:55 p.m. – 4:59 p.m. Moderators: Bela Kudish, MD; Anthony INTRAPELVIC NERVE ENTRAPMENT: A Oral Poster 30 – EVALUATING Visco, MD REVIEW OF 50 CONSECUTIVE CASES THE IMPACT OF DAYS BETWEEN 4:15 p.m. – 4:19 p.m. N. Lemos2, J. Papillon-Smith2, PROCEDURES ON CLINICAL Oral Poster 31 – GENOME-WIDE R. Moretti-Marques1, G. Fernandes1, OUTCOMES: DO SURGEONS GET ASSOCIATION STUDY FOR URINARY M. Girao1, M. J. Solnik2. 1Obstetrics RUSTY? AND FECAL INCONTINENCE IN WOMEN and Gynecology, Federal University of L. E. Giugale1, E. S. Lavelle1, C. M. Carter- K. L. Penney, F. Grodstein, M. K. Sao Paulo, Sao Paulo, Brazil; 2Obstetrics Brooks1, J. P. Shepherd2. 1Obstetrics, Townsend, V. Minassian. Brigham and and Gynecology, University of Toronto, Gynecology and Reproductive Sciences, Womens, Boston, MA Toronto, ON, Canada Magee-Womens Hospital of UPMC, Pittsburgh, PA; 2St. Francis Hospital and 4:19 p.m. – 4:23 p.m. 4:39 p.m. – 4:45 p.m. Medical Center, Hartford, CT Oral Poster 32 – OPERATING ROOM (Oral poster 36 and oral poster 37 are combined) 4:59 p.m. – 5:04 p.m. EFFICIENCY: EXAMINING THE ROLE OF Oral Poster 36 – PELVIC FLOOR AND (Video 5 and Video 6 are combined) PERSONNEL HANDOFFS O. Brown, K. OBTURATOR INTERNUS MYOFASCIAL Video 5 – AUTOLOGOUS FASCIA J. Geynisman-Tan, Bochenska, A. Leader-Cramer, B. Davé, PAIN IS COMMON IN PATIENTS WITH LATA SPIRAL SLING ANAL S. A. Collins, M. G. Mueller, C. Lewicky- PELVIC FLOOR SYMPTOMS SPHINCTEROPLASTY: Gaupp, K. Kenton. Urogynecology, M. Meister3, S. Sutcliffe1, A. Badu2, SALVAGE REPAIR FOR FECAL Northwestern University, Chicago, IL C. Ghetti3, J. L. Lowder3. 1Surgery, INCONTINENCE Washington University, Saint Louis, 1 2 M. T. Nguyen , T. Y. Sadun , 4:23 p.m. – 4:27 p.m. MO; 2School of Medicine, Washington 2 2 1 J. Oliver , S. Raz . Obstetrics and Oral Poster 33 – FACE: FEMALE University, Saint Louis, MO; 3Obstetrics Gynecology, Female Pelvic Medicine PELVIC MEDICINE & RECONSTRUCTIVE & Gynecology, Washington University, and Reconstructive Surgery, UCLA SURGERY AWARENESS CAMPAIGN: Saint Louis, MO David Geffen School of Medicine, INCREASING EXPOSURE Los Angeles, CA; 2Urology, Pelvic S. Barr1, C. C. Crisp4, A. B. White3, S. A. Oral Poster 37 – PELVIC FLOOR AND Medicine and Reconstructive Surgery, Malik2, K. Kenton5. 1OB/GYN, University OBTURATOR INTERNUS MYOFASCIAL UCLA, Los Angeles, CA of Arkansas for Medical Science, Little PAIN IS CORRELATED WITH LOWER Rock, AR; 2Banner University Medical URINARY TRACT SYMPTOM SEVERITY Center – Phoenix, Phoenix, AZ; 3Dell M. Meister1, S. Sutcliffe2, A. Badu3, C. Medical School at the University of Ghetti4, J. L. Lowder4. 1Ob/Gyn, Barnes Texas at Austin, Austin, TX; 4TriHealth, Jewish Hospital/Washington University in

34 PFD WEEK 2017 OCT 3 – 7 KEY: = Virtual Conference = This session requires a ticket Scientific Program

St. Louis, Saint Louis, MO; 2Department 5:01 p.m. – 5:07 p.m. 4:23 p.m. – 4:27 p.m. of Surgery, Washington University, Video 7 – RECTOVAGINAL FISTULA Oral Poster 43 – DETECTING Saint Louis, MO; 3School of Medicine, REPAIR USING A GRACILIS MUSCLE UROPATHOGENS IN A UROGYNECOLOGIC Washington University, Saint Louis, MO; FLAP AND FULL THICKNESS SKIN GRAFT POPULATION: A COMPARISON OF UTI 4Obstetrics & Gynecology, Washington R. Newman1, B. A. Garcia1, DIAGNOSTIC THRESHOLDS University, Saint Louis, MO J. Carmichael2, M. Kobayashi3, F. Lane1. T. K. Price1, E. E. Hilt1, T. Dune2, 1Female Pelvic Medicine & Reconstructive C. Brincat3, L. Brubaker4, E. R. Mueller3, 4:45 p.m. – 4:49 p.m. Surgery, University of California Irvine, P. C. Schreckenberger5, A. J. Wolfe1. Oral Poster 38 – COST-EFFECTIVENESS Orange, CA; 2Colorectal Surgery, 1Microbiology & Immunology, Loyola OF ROUTINE POSTOPERATIVE University of California Irvine, Orange, University Chicago, Stritch School of RETROGRADE VOIDING TRIALS CA; 3Plastic and Reconstructive Surgery, Medicine, Maywood, IL; 2Center for FOLLOWING GYNECOLOGICAL University of California Irvine, Orange, CA Female Pelvic Health, Cornell University, PROCEDURES Weill Cornell Medical College, New 1 2 1 R. Wang , D. Soeteman , M. R. Hacker , 5:07 p.m. – 5:11 p.m. York, NY; 3Obstetrics & Gynecology 1 R. Lefevre1. Obstetrics and Gynecology, QUESTIONS FOR ORAL POSTERS 39–40 and Urology, Loyola University Medical Beth Israel Deaconess Medical Center, Center, Maywood, IL; 4Reproductive Harvard Medical School, Boston, MA; 4:15 p.m. – 5:15 p.m. Medicine, University of California 2Center for Health Decision Science, SCIENTIFIC CONCURRENT San Diego, Division of Female Pelvic Harvard T.H. Chan School of Public SESSION 6: BASIC SCIENCE II SESSION Medicine and Reconstructive Surgery, La Health, Boston, MA 5 – BALLROOM D/E Moderators: Marsha Jolla, CA; Pathology, Loyola University 4:49 p.m. – 4:53 p.m. Guess, MD; Nicole Korbly, MD Chicago, Stritch School of Medicine, QUESTIONS FOR ORAL POSTERS 35–38 Maywood, IL 4:53 p.m. – 4:57 p.m. 4:15 p.m. – 4:19 p.m. 4:27 p.m. – 4:31 p.m. Oral Poster 39 – RANDOMIZED Oral Poster 41 – CHARACTERIZATION Oral Poster 44 – THE VAGINAL CONTROLLED TRIAL TO ASSESS OF THE T CELL POPULATION IN AND URINARY MICROBIOME THE IMPACT OF INTRAURETHRAL VAGINAL MESH REMOVED FROM IN PREMENOPAUSAL WOMEN LIDOCAINE ON URODYNAMIC VOIDING WOMEN WITH COMPLICATIONS WITH INTERSTITIAL CYSTITIS/ PAINFUL BLADDER SYNDROME AS PARAMETERS L. Tennyson1, S. Palcsey2, S. D. COMPARED TO NORMAL CONTROLS: C. K. Kisby1, E. J. Gonzalez2, C. L. Abramowitch3, P. A. Moalli2. 1Urology, A COHORT STUDY. Amundsen3, A. G. Visco3, W. M. Grill2. UPMC, Pittsburgh, PA; 2Magee Womens K. V. Meriwether1, V. R. Jala2, 1Obstetrics and Gynecology, Duke Research Institute, Pittsburgh, PA; D. Hobson1, C. L. Kinman1, R. Stewart1, Hospital, Durham, NC; 2Biomedical 3Department of Bioengineering, S. L. Francis1, Z. Lei1. 1 Engineering, Duke University, Durham, University of Pittsburgh, Pittsburgh, PA Obstetrics & 3 Gynecology, University of Louisville, NC; Female Pelvic Medicine and 2 Reconstructive Surgery, Duke Hospital, 4:19 p.m. – 4:23 p.m. Louisville, KY; Microbiology and Immunology, University of Louisville, Durham, NC Oral Poster 42 – OVEREXPRESSION OF ORNITHINE DECARBOXYLASE Louisville, KY 4:57 p.m. – 5:01 p.m. (ODC) IN BLADDER UROTHELIUM 4:31 p.m. – 4:35 p.m. Oral Poster 40 – PREOPERATIVE RECAPITULATES OVERACTIVE QUESTIONS FOR ORAL POSTERS 41–44 LABORATORY TESTING PRIOR BLADDER (OAB) PHENOTYPE TO UROGYNECOLOGIC SURGERY: J. Y. Yeh1, L. Alvarez-Lugo1, M. G. 4:35 p.m. – 4:39 p.m. 1 1 2 A NECESSARY EVIL OR JUST Acevedo Alvarez , M. Lu , W. Hill , Oral Poster 45 – LACTOBACILLUS 1 1 UNNECESSARY? T. C. Chai . Yale School of Medicine, SPECIES INHIBIT GROWTH OF E. COLI 2 K. Husk, M. Willis-Gray, A. A. Dieter, New Haven, CT; Beth Israel Deaconess K. J. Hung, A. Bergerat-Thompson, J. Wu. Urogynecology, University of North Medical Center, Boston, MA M. M. Weinstein, C. Mitchell. OB/GYN, Carolina Hospitals, Chapel Hill, NC Massachusetts General Hospital, Boston, MA

PFD WEEK 2017 OCT 3 – 7 35 SCIENTIFIC PROGRAM (CONTINUED)

THURSDAY, OCTOBER 5 (Continued) Chicago, Chicago, IL; 2Bioinformatics, 5:30 p.m. – 6:30 p.m. Loyola University Chicago, Chicago, IL; EXHIBIT HALL HAPPY HOUR – EXHIBITION 4:39 p.m. – 4:43 p.m. 3Biology, Loyola University Chicago, HALL AB Oral Poster 46 – CAN Chicago, IL; 4Microbiology and Immunology, Loyola University Chicago, PHARMACOGENETICS BE USED 5:30 p.m. – 6:30 p.m. TO PREDICT THE RESPONSE TO Maywood, IL FESOTERODINE FUMARATE? FELLOWSHIP PROGRAM MEET-AND- 4:55 p.m. – 4:59 p.m. J. Wu1, T. Wiltshire3, N. Y. Siddiqui2, GREET FOR RESIDENTS IN THE EXHIBIT Oral Poster 49 – THE FEMALE O. Suzuki3, K. Jamieson3, D. Voora4, HALL – EXHIBITION HALL AB (REAR HALL) GENITOURINARY MICROBIOTA: SHORT- K. Schmader5. 1University of North TERM STABILITY, RESILIENCE AND Carolina at Chapel Hill, Chapel Hill, PERI-URETHRAL RELATIONSHIPS NC; 2Obstetrics & Gynecology, Duke FRIDAY, OCTOBER 6 3 T. K. Price, D. Johansen, A. J. Wolfe. University, Durham, NC; Center for 6:45 a.m. – 7:45 a.m. Pharmacogenetics & Individualized Microbiology & Immunology, Loyola Therapy, 1University of North Carolina at University Chicago, Stritch School of MEET THE EXPERTS EDUCATIONAL Chapel Hill, Chapel Hill, NC; 4Cardiology, Medicine, Maywood, IL ROUNDTABLES – ROTUNDA 5 Duke University, Durham, NC; Geriatrics, 4:59 p.m. – 5:07 p.m. (CONVENTION CENTER) Duke University, Durham, NC Video 8 – MANAGEMENT OF See page 23 for details PRESACRAL BLEEDING 4:43 p.m. – 4:47 p.m. 6:45 a.m. – 7:45 a.m. Oral Poster 47 – EFFECT OF ESTROGEN E. D. Hokenstad, J. Occhino. Division THERAPY ON THE POSTMENOPAUSAL of Urogynecology, Mayo Clinic, BASIC SCIENCE SIG BUSINESS INFLAMMATORY BLADDER STATE Rochester, MN MEETING – ROOM 553 M. Meister, C. Wang, J. L. Lowder, I. U. 5:07 p.m. – 5:12 p.m. PRIVATE PRACTICE SIG BUSINESS Mysorekar. Obstetrics & Gynecology, QUESTIONS FOR ORAL POSTERS 45–49 MEETING – ROOM 555 Washington University, Saint Louis, MO 8:00 a.m. – 8:05 a.m. 4:51 p.m. – 4:55 p.m. 4:15 p.m. – 5:15 p.m. Oral Poster 48 – THE ROLE OF SURGICAL TUTORIAL WELCOME AND INTRODUCTION – BACTERIAL VIRUSES IN THE FEMALE LAPAROSCOPIC AND ROBOTIC EXHIBITION HALL C URINARY MICROBIOME SACROCOLPOPEXY PEARLS – 1 2 3 8:05 a.m. – 8:15 a.m. C. Putonti , A. Garretto , J. W. Shapiro , ROOM 551 4 A. J. Wolfe . 1Bioinformatics, Biology & Elizabeth Geller, MD; Andrew Sokol, MD PFD RESEARCH FOUNDATION Computer Science, Loyola University UPDATE – EXHIBITION HALL C

8:15 a.m. – 8:45 a.m. MESH REMOVAL DEBATE – EXHIBITION HALL C Moderator: Christopher Tarnay, MD Speakers: Miles Murphy, MD; Roger Dmochowski, MD

8:45 a.m. – 9:46 a.m. GENERAL SCIENTIFIC SESSION III – EXHIBITION HALL C Moderators: Robert Gutman, MD; Deborah Myers, MD

36 PFD WEEK 2017 OCT 3 – 7 KEY: = Virtual Conference = This session requires a ticket Scientific Program

8:45 a.m. – 8:57 a.m. University School of Medicine, Stanford, 11:35 a.m. – 11:55 a.m. Paper 12 – OVEREXPRESSION CA; 3Stanford Prevention Research TREATMENT OF NON-NEUROGENIC OF ESTROGEN RECEPTOR BETA IN Center, Stanford University School of URINARY RETENTION: WHEN AND WHEN BLADDER UROTHELIUM PROTECTS Medicine, Stanford, CA NOT TO INTERVENE – RECOMMENDATIONS AGAINST UROPATHOGENIC E. COLI Paper 16 – CAN A HIGH-GRAIN, HIGH INFECTION FROM THE AUA – EXHIBITION HALL C FAT DIET PREVENT DE NOVO STRESS J. Y. Yeh, L. Alvarez-Lugo, M. G. Acevedo Gary Lemack, SUFU President AND URGE URINARY INCONTINENCE IN Alvarez, C. Jain, M. Lu, T. C. Chai. Yale POSTMENOPAUSAL WOMEN? School of Medicine, New Haven, CT 11:55 a.m. – 1:00 p.m. L. Rogo-Gupta1, J. Yang2, H. Hedlin2, 3 1 1 GENERAL SCIENTIFIC SESSION IV – 8:57 a.m. – 9:07 a.m. M. L. Stefanick , N. Young-Lin , B. Chen . EXHIBITION HALL C Video 9 – EXTRAVESICAL ROBOTIC 1Department of Obstetrics and Moderators: Douglass Hale, MD; URETERAL REIMPLANTATION FOR Gynecology/Division of Urogynecology Kim , MD URETEROVAGINAL FISTULA and Pelvic Reconstructive Surgery, Kenton B. J. Linder, I. Frank, J. Occhino. Mayo Stanford University, Menlo Park, CA; 11:55 a.m. – 12:05 p.m. Clinic, Rochester, MN 2Department of Medicine/Quantitative Paper 17 – THE CARAT TRIAL: A Sciences Unit, Stanford University RANDOMIZED TRIAL COMPARING 9:07 a.m. – 9:17 a.m. School of Medicine, Stanford, CA; THE EFFECTIVENESS OF CATHETER Paper 13 – DOES TRANSITION OF 3 Stanford Prevention Research Center, REMOVAL ON THE DAY OF SURGERY URINARY INCONTINENCE FROM ONE Stanford University School of Medicine, VERSUS POST-OPERATIVE DAY 1 SUBTYPE TO ANOTHER REPRESENT Stanford, CA AFTER MAJOR PROLAPSE SURGERY PROGRESSION OF DISEASE? C. M. CARTER-BROOKS1, P. A. Moalli1, V. Minassian1, X. Yan2, A. L. Pilzek3, 9:39 a.m. – 9:46 a.m. H. M. Zyczynski1, J. P. Shepherd2. W. F. Stewart2. 1Brigham and Women’s, Video 10 – ASSESSING FRAILTY IN 1Urogynecology and Reconstructive Boston, MA; 2Sutter Health System, WOMEN UNDERGOING ELECTIVE Surgery, Magee Womens Hospital of Walnut Creek, CA; 3Geisinger, Danville, PA PELVIC RECONSTRUCTIVE SURGERY A. Zeno, C. Truong, T. Yazdany. FPMRS, UPMC, Pittsburgh, PA; 2Urogynecology, St. 9:17 a.m. – 9:27 a.m. Harbor UCLA Medical Center, Torrance, CA Frances Medical Center, Hartford, CT Paper 14 – PELVIC FLOOR MUSCLE 12:05 p.m. – 12:15 p.m. TRAINING VERSUS WATCHFUL WAITING 9:45 a.m. – 10:15 a.m. Paper 18 – THE EFFECT OF ORAL ON PELVIC FLOOR DISORDERS IN BREAK IN EXHIBIT HALL – EXHIBITION PHENAZOPYRIDINE ON POSTOPERATIVE POSTPARTUM WOMEN: A SYSTEMATIC HALL AB VOIDING AFTER MID-URETHRAL SLINGS REVIEW AND META-ANALYSIS O. F. Duenas, T. Sierra, D. L. Taylor, Y. Wu1, N. McInnes2, Y. Leong1. 10:15 a.m. – 10:50 a.m. K. Leung, C. D. Hall, M. Flynn. 1 Obstetrics and Gynecology, Western Urogynecology, University of University, London, ON, Canada; 2Clinical J. MARION SIMS LECTURE Massachusetts, Worcester, MA Epidemiology and Biostatistics, McMaster VESICO-VAGINAL FISTULA: University, Hamilton, ON, Canada HISTORICAL UNDERSTANDING, 12:15 p.m. – 12:25 p.m. MEDICAL ETHICS, AND MODERN Paper 19 – ROLE OF PROTEASE 9:27 a.m. – 9:39 a.m. SENSIBILITIES – EXHIBITION HALL C INHIBITORS IN HEALING OF THE (Paper 15 and Paper 16 are combined) VAGINAL WALL Paper 15 – LOW-FAT DIET ELIMINATES L. Lewis Wall, MD, PhD 1 2 STRESS INCONTINENCE BUT M. E. Florian-Rodriguez , K. Chin , 10:50 a.m. – 11:35 a.m. H. Shi3, J. f. Acevedo3, R. A. Word3. WORSENS URGE INCONTINENCE IN 1 POSTMENOPAUSAL WOMEN PREVENTION OF URINARY Female Pelvic Medicine and Reconstructive Surgery, UT Southwestern, L. Rogo-Gupta1, J. Yang2, H. Hedlin2, INCONTINENCE: A BEHAVIORAL AND Dallas, TX; 2Obstetrics and Gynecology, M. L. Stefanick3, N. Young-Lin1, B. Chen1. BASIC SCIENCE PERSPECTIVE– Kaiser Permanente, Santa Clara, 1 Department of Obstetrics and EXHIBITION HALL C CA; 3Obstetrics and Gynecology, UT Gynecology/Division of Urogynecology Moderator: Una Lee, MD Southwestern Medical Center, Dallas, TX and Pelvic Reconstructive Surgery, Speakers: Catherine Bradley, MD, Gina Stanford University School of Medicine, Northington, MD; Marianna Alperin, MD Stanford, CA; 2Department of Medicine/ Quantitative Sciences Unit, Stanford

PFD WEEK 2017 OCT 3 – 7 37 SCIENTIFIC PROGRAM (CONTINUED)

FRIDAY, OCTOBER 6 (Continued) 2:45 p.m. – 4:00 p.m. 3:01 p.m. – 3:05 p.m. SCIENTIFIC CONCURRENT SESSION 7: Oral Poster 54 – MECHANISM OF 12:25 p.m. – 12:35 p.m. ACTION OF URETHRAL BULKING SURGERY/ANATOMY – BALLROOM A Paper 20 – CHANGES IN VAGINAL VERSUS MIDURETHRAL SLING Moderators: Vivian Aguilar, MD; Shawn MICROENVIRONMENT AS RELATED TO MEASURED BY HIGH RESOLUTION Menefee, MD FREQUENCY OF PESSARY REMOVAL IN MANOMETRY WOMEN USING PESSARY FOR PELVIC 2:45 p.m. – 2:49 p.m. E. J. Wasenda1, A. C. Kirby2, E. S. 1 FLOOR DISORDERS Oral Poster 50 – POSTERIOR VAGINAL Lukacz , C. W. Nager1. 1Department N. Fregosi, D. Hobson, C. L. Kinman, WALL PROLAPSE ON MRI AND of , Division R. Stewart, K. V. Meriwether. Obstetrics ASSOCIATION WITH DEFECATORY of Female Pelvic Medicine and and Gynecology, University of Louisville, SYMPTOMS Reconstructive Surgery, UC San Diego 2 Louisville, KY M. T. Nguyen1, J. Y. Mei2, C. Tarnay1. Health System, La Jolla, CA; Department 1 of Obstetrics & Gynecology, Division of 12:35 p.m. – 12:45 p.m. Obstetrics and Gynecology, Female Pelvic Medicine and Reconstructive Urogynecology, University of Washington, Paper 21 – PREDICTIVE VALUE OF Seattle, WA MICROSCOPIC HEMATURIA FOR Surgery, UCLA David Geffen School of 2 UROLOGIC MALIGNANCIES IN WOMEN Medicine, Los Angeles, CA; OBGYN, 3:05 p.m. – 3:09 p.m. AND MEN UCLA, Los Angeles, CA QUESTIONS FOR ORAL POSTERS 50–54 J. Heft, E. Braxton, N. D. Mercaldo, R. M. 2:49 p.m. – 2:53 p.m. 3:09 p.m. – 3:13 p.m. Ward. Vanderbilt University, Nashville, TN Oral Poster 51 – EFFECT OF MORBID Oral Poster 55 – TARGET-BASED 12:45 p.m. – 12:55 p.m. OBESITY ON MID-URETHRAL SLING 3D STRESS MRI MEASUREMENT EFFECACY FOR THE MANAGEMENT OF Video 11 – THE 4-WALL SACROSPINOUS TECHNIQUE FOR APICAL, STRESS URINARY INCONTINENCE LIGAMENT SUSPENSION: SECRETS TO PARAVAGINAL AND HIATAL CHANGES SUCCESS FOR COMPLEX CASES S. ElShatanoufy, Y. Wang, A. Matthews, AFTER SURGERY FOR ANTERIOR/ M.L. Jamil, M. Yousif, S. Gutta, H. Gill, A. N. E. Karp, Z. Xue, A. G. Sammarco, E. APICAL PROLAPSE Luck. M. English, D. E. Fenner, D. M. Morgan, Obstetrics and Gynecology, Henry L. Chen1, B. Xie2, J. O. DeLancey2. Ford Health System, Detroit, MI J. O. DeLancey. Female Pelvic Medicine 1Biomedical Engineering, University of and Reproductive Surgery, University of 2:53 p.m. – 2:57 p.m. Michigan, Ann Arbor, MI; 2Obstetrics Michigan, Ann Arbor, MI Oral Poster 52 – PREOPERATIVE and Gynecology, University of Michigan, PELVIC FLOOR MUSCLE WEAKNESS Ann Arbor, MI 1:00 p.m. – 2:30 p.m. AS A RISK FACTOR OF SURGICAL 3:13 p.m. – 3:17 p.m. INDUSTRY SUPPORTED EDUCATION — FAILURE OF ANTERIOR VAGINAL Oral Poster 56 – THE FAILURE RATE LASER APPLICATIONS IN VAGINAL WALL PROLAPSE REPAIR OF A SECONDARY PROCEDURE HEALTH SPECIFICALLY RELATED TO GSM, J. Schachar, H. Devakumar, L. Martin, FOR RECURRENT STRESS URINARY SUI, AND ATROPHY — ROOM 555 E. A. Hurtado, G. Davila. Female Pelvic INCONTINENCE FOLLOWING A Medicine and Reconstructive Surgery, Supported by Alma Lasers FAILED MIDURETHRAL SLING IS NOT Cleveland Clinic Florida, Hollywood, FL AFFECTED BY ALTERATION OF THE 1:00 p.m. – 2:30 p.m. 2:57 p.m. – 3:01 p.m. PRIMARY SLING K. Buono1, A. Alabaster2, P. Mallipeddi3. INDUSTRY SUPPORTED EDUCATION — Oral Poster 53 – POSTERIOR 1Obstetrics & Gynecology, Kaiser SINGLE-INCISION SLINGS: DATA, COMPARTMENT SURGERY PROVIDES NO DIFFERENTIAL BENEFIT FOR Permanente Medical Center, Santa BARRIERS, AND THE PATIENT Clara, CA; 2Division of Research, Kaiser EXPERIENCE — ROOM 552 DEFECATORY SYMPTOMS BEFORE OR AFTER CONCOMITANT MESH Permanente Medical Center, Oakland, 3 Supported by Coloplast AUGMENTED APICAL SUSPENSION CA; FPMRS, Kaiser Permanente Medical Center, Santa Clara, CA 1:00 p.m. – 2:45 p.m. D. Arunachalam, D. S. Hale, M. Heit. Urogynecology, Indiana University, LUNCH IN THE EXHIBIT HALL – EXHIBITION Indianapolis, IN HALL AB

38 PFD WEEK 2017 OCT 3 – 7 KEY: = Virtual Conference = This session requires a ticket Scientific Program

3:17 p.m. – 3:21 p.m. 3:37 p.m. – 3:41 p.m. 2:49 p.m. – 2:53 p.m. Oral Poster 57 – COST-EFFECTIVENESS Oral Poster 61 – REDUCTION OF Oral Poster 64 – UREAPLASMA ANALYSIS OF A PRE-OPERATIVE GENITAL HIATUS SIZE DECREASES UREALYTICUM AND PAINFUL LOWER PELVIC MRI TO IDENTIFY PATIENTS AT ANATOMIC FAILURE AFTER NATIVE URINARY TRACT SYMPTOMS HIGH RISK OF SURGICAL FAILURE TISSUE VAGINAL VAULT SUSPENSION W. Hendrickson-Cahill1, K. Y. Dyer2, A. M. Wyman1, M. Salomon Gonzalez2, M. H. Vaughan, N. Y. Siddiqui, L. K. J. Tan-Kim2. 1Reproductive Medicine, J. L. Salemi3, E. Mikhail4, M. Ahmed5, Newcomb, A. C. Weidner, A. Kawasaki, M. University of California San Diego, S. Hart1, S. Lai-Yuen2. 1Female Pelvic S. Bradley. Obstetrics and Gynecology, La Jolla, CA; 2Urogynecology, Kaiser Medicine and Reconstructive Surgery, Duke University, Durham, NC Permanente San Diego, San Diego, CA University of South Florida, Tampa, FL; 2Department of Engineering, University of 3:41 p.m. – 3:45 p.m. 2:53 p.m. – 2:57 p.m. South Florida, Tampa, FL; 3Baylor College Oral Poster 62 – LEVATOR ANI Oral Poster 65 – EARLY AND of Medicine, Houston, TX; 4Department of SUBTENDED VOLUME IN PATIENTS CONSISTENT IMPROVEMENTS IN Obstetrics and Gynecology, University of WITH MESH AUGMENTATION AND URINARY SYMPTOMS AND QUALITY South Florida, Tampa, FL; 5University of SURGICAL FAILURE OF LIFE OUTCOMES IN FEMALE South Florida, Tampa, FL A. M. Wyman1, K. Greene1, L. Hahn1, OVERACTIVE BLADDER PATIENTS WITH E. Jackson1, S. Patton1, L. Hoyte2, URINARY INCONTINENCE TREATED 3:21 p.m. – 3:25 p.m. R. Bassaly1. 1Female Pelvic Medicine WITH ONABOTULINUMTOXINA IN Oral Poster 58 – IMPACT OF MORBID and Reconstructive Surgery, University A MULTICENTER, RANDOMIZED, OBESITY ON PERIOPERATIVE of South Florida, Tampa, FL; 2The Pelvic PLACEBO-CONTROLLED, OUTCOMES IN WOMEN UNDERGOING Floor Institute, Tampa, FL PHASE 4 TRIAL RECONSTRUCTIVE PELVIC ORGAN J. Gruenenfelder1, K. McCammon2, PROLAPSE SURGERY 3:45 p.m. – 3:55 p.m. V. Lucente3, A. Orejudos4, T. A. M. F. Ackenbom1, H. Sandness Nelson2, Video 12 – RETROPUBIC ROBOTIC Aboushwareb4, D. S. Hale5. 1Orange L. E. Giugale1, E. S. Lavelle1, C. M. Carter- EXCISION OF MESH FOR THE County Urology Associates, Laguna Hills, Brooks1, J. P. Shepherd2. 1University of TREATMENT OF MIDURETHRAL SLINGS CA; 2Eastern Virginia Medical School, Pittsburgh Medical Center, Pittsburgh, AND TRANSVAGINAL PROLAPSE MESH Norfolk, VA; 3Institute for Female Pelvic PA; 2St. Francis Hospital and Medical EROSION INTO THE BLADDER. Medicine & Reconstructive Surgery, Center, Hartford, CT A. Shariati. Urogynecology, FRMIU, Allentown, PA; 4Allergan plc, Irvine, Coconut Creek, FL CA; 5Urogynecology Associates, pc, 3:29 p.m. – 3:33 p.m. Indianapolis, IN QUESTIONS FOR ORAL POSTERS 55–58 3:55 p.m. – 4:00 p.m. QUESTIONS FOR ORAL POSTERS 60–62 2:57 p.m. – 3:01 p.m. 3:33 p.m. – 3:37 p.m. Oral Poster 66 – PRIMIPAROUS Oral Poster 60 – DOES SURGICAL 2:45 p.m. – 4:00 p.m. WOMEN’S EXPERIENCE AND CORRECTION OF A WIDE PRE- SCIENTIFIC CONCURRENT SESSION 8: UNDERSTANDING SURROUNDING OPERATIVE GENITAL HIATUS OFFICE-BASED THERAPY AND PATIENT OBSTETRIC PERINEAL TRAUMA: IMPACT ANATOMIC FAILURE AFTER A QUALITATIVE STUDY COUNSELING SESSION – BALLROOM B/C ROBOTIC-ASSISTED LAPAROSCOPIC M. D. Barber, R. Farrell. Moderators: Jan Baker, MS, APRN; S. E. Steele, SACROCOLPOPEXY? Obstetrics and Gynecology, Cleveland 1 2 W. Thomas Gregory M. S. Bradley , A. L. Askew , Clinic Foundation, Cleveland, OH 1 1 1 A. Kawasaki , M. H. Vaughan , A. G. Visco . 2:45 p.m. – 2:49 p.m. 1 3:01 p.m. – 3:05 p.m. Obstetrics and Gynecology, Division of Oral Poster 63 – HOLDING IT TOGETHER: Urogynecology, Duke University Medical GROUP BEHAVIORAL INTERVENTION Oral Poster 67 – ARE WOMEN 2 Center, Durham, NC; Obstetrics and IMPROVES URINARY AND BOWEL PREPARED FOR BIRTH? A STUDY OF Gynecology, Duke University Medical SYMPTOMS IN OLDER WOMEN HOW COUNSELING, PREPARATION Center, Durham, NC AND INFORMED CONSENT AFFECT H. C. Barnes1, E. Meller1, M. Wise1, J. E. SATISFACTION AND REGRET AFTER Mahoney1, R. G. Rogers2, H. W. Brown1. DELIVERY 1The University of Wisconsin–Madison, R. C. Amare1, L. Lyon2, D. Postlethwaite2, Madison, WI; 2Dell Medical School at The O. Ramm1. 1 University of Texas at Austin, Austin, TX Kaiser Permanente, Oakland, CA; 2Division of Research, Kaiser Permanente, Oakland, CA

PFD WEEK 2017 OCT 3 – 7 39 SCIENTIFIC PROGRAM (CONTINUED)

FRIDAY, OCTOBER 6 (Continued) 7University of Washington, Seattle, WA; 3:41 p.m. – 3:45 p.m. 8University of California, Riverside, CA; Oral Poster 75 – VARIATION IN 3:05 p.m. – 3:09 p.m. 9Clinical, Medtronic, Minneapolis, MN; PESSARY COUNSELING PRIOR QUESTIONS FOR ORAL POSTERS 63–67 10Metro Urology, Woodbury, MN TO SURGERY FOR PELVIC ORGAN PROLAPSE 3:09 p.m. – 3:13 p.m. 3:25 p.m. – 3:29 p.m. A. G. Sammarco, D. M. Morgan, N. S. QUESTIONS FOR ORAL POSTERS 68–71 Oral Poster 68 – PATIENT COUNSELING Kamdar, C. W. Swenson. Obstetrics and ON STRESS URINARY INCONTINENCE 3:29 p.m. – 3:33 p.m. Gynecology, University of Michigan, AND/OR PELVIC ORGAN PROLAPSE Ann Arbor, MI CONDITIONS USING TRADITIONAL Oral Poster 72 – A PILOT STUDY DIAGRAMS VERSUS AN INTERRACTIVE EVALUATING A NON-INVASIVE 3:45 p.m. – 3:50 p.m. COMPUTER PROGRAM METHOD TO CHARACTERIZE BLADDER QUESTIONS FOR ORAL POSTERS 68–75 N. Golbari1, G. Lazarou2, B. Grigorescu2. GEOMETRY FOR OVERACTIVE BLADDER 1 2 3 1Stony Brook University Medical School, S. Glass Clark , A. S. Nagle , R. Vince , 2:45 p.m. – 4:00 p.m. 4 5 1 Stony Brook, NY; 2OB/GYN, Winthrop R. Bernardo , L. R. Carucci , A. Carroll , 3 2 1 SCIENTIFIC CONCURRENT SESSION 9: University Hospital, Mineola, NY A. Klausner , J. E. Speich . Obstetrics and Gynecology, Virginia Commonwealth POPULATION STUDIES SESSION – 3:13 p.m. – 3:17 p.m. University, Chapel Hill, NC; 2Department BALLROOM D/E Oral Poster 69 – TOILETING HABITS OF of Mechanical and Nuclear Engineering, Moderators: Juana Hutchison-Colas, MD, NURSES Virginia Commonwealth University, MBA; Danielle Antosh, MD M. Brady1, A. Tjaden1, C. Brincat1, Richmond, VA; 3Department of Urology, 2:45 p.m. – 2:49 p.m. L. Brubaker1, W. Adams2. 1Obstetrics and Department of Surgery, Virginia Oral Poster 76 – ASSOCIATION Gynecology, Loyola University Medical Commonwealth University, Richmond, VA; 4 BETWEEN CO-MORBIDITIES AND Center, Maywood, IL; 2Health Sciences Department of Biomedical Engineering, FEMALE SEXUAL DYSFUNCTION: Division, Loyola University Chicago, Virginia Commonwealth University, 5 FINDINGS FROM THE THIRD NATIONAL Maywood, IL Richmond, VA; Department of Radiology, Virginia Commonwealth University, SURVEY OF SEXUAL ATTITUDES AND 3:17 p.m. – 3:21 p.m. Richmond, VA LIFESTYLES (NATSAL-3) Oral Poster 70 – A COST-EFFECTIVENESS A. R. Polland, C. B. Iglesia. Georgetown ANALYSIS OF BOTOX BOTULINUM-A 3:33 p.m. – 3:37 p.m. University/MedStar Washington Hospital TOXIN AS FIRST-LINE TREATMENT FOR Oral Poster 73 – MYOFASCIAL PAIN Center, Washington OVERACTIVE BLADDER IN PATIENTS WITH SYMPTOMS OF 2:49 p.m. – 2:53 p.m. C. M. Carter-Brooks1, J. P. Shepherd2. URINARY TRACT INFECTION 1 2 1 Oral Poster 77 – MODERN PRACTICE 1Urogynecology and Reconstructive B. J. Wolff , C. J. Joyce , C. Brincat , 1 1 PATTERNS IN WOMEN TREATED FOR Surgery, Magee-Womens Hospital of E. R. Mueller , C. M. Fitzgerald . 1 NON-NEUROGENIC OVERACTIVE UPMC, PITTSBURGH, PA; 2Urogynecology, Department of Obstetrics/Gynecology BLADDER: HOW QUICKLY DO PATIENTS St. Francis Medical Center, Hartford, CT and Urology, Loyola University Chicago Stritch School of Medicine and Loyola PROGRESS TO THIRD-LINE THERAPY? 3:21 p.m. – 3:25 p.m. University Medical Center, Maywood, IL; E. M. Wolff, S. Park, K. Odem-Davis, Oral Poster 71 – THERAPEUTIC 2Health Sciences Division, Loyola A. C. Kirby. University of Washington, OUTCOMES FOR FEMALES AND MALES University Chicago Stritch School of Seattle, WA IN THE INSITE STUDY FOR OVERACTIVE Medicine, Maywood, IL 2:53 p.m. – 2:57 p.m. BLADDER J. Mangel1, J. Bennett2, C. Comiter3, 3:37 p.m. – 3:41 p.m. Oral Poster 78 – WEIGHT AND WEIGHT E. T. Bird4, S. Zylstra5, T. L. Griebling6, Oral Poster 74 – FECAL INCONTINENCE CHANGE IMPACT STRESS AND URGE S. E. Sutherland7, K. L. Noblett8, K. J. Berg9, SYMPTOMS AND IMPACT IN URINARY INCONTINENCE SYMPTOMS F. Kan9, S. Siegel10. 1MetroHealth Medical OLDER VERSUS YOUNGER WOMEN IN POSTMENOPAUSAL WOMEN 1 1 2 Center, Cleveland, OH; 2Female Pelvic SEEKING CARE N. Young-Lin , B. Chen , J. Yang , 2 3 Medicine, Grand Rapids, MI; 3Stanford I. Meyer1, C. T. Blanchard1, E. G. Gibson2, H. Hedlin , M. L. Stefanick , L. Rogo- 1 1 University, Stanford, CA; 4Scott & White N. Judge2, H. E. Richter1. 1Obstetrics Gupta . Department of Obstetrics and Hospital, Temple, TX; 5Milford Regional and Gynecology, University of Alabama Gynecology/Division of Urogynecology and Medical Center, Whitinsville, MA; at Birmingham, Birmingham, AL; Pelvic Reconstructive Surgery, Stanford 2 6University of Kansas, Kansas City, KS; 2University of Alabama at Birmingham, University, Menlo Park, CA; Department Birmingham, AL of Medicine/Quantitative Sciences Unit,

40 PFD WEEK 2017 OCT 3 – 7 KEY: = Virtual Conference = This session requires a ticket Scientific Program

Stanford University School of Medicine, 3:13 p.m. – 3:17 p.m. 3:29 p.m. – 3:33 p.m. Stanford, CA; 3Stanford Prevention Oral Poster 82 – ONLINE PHYSICIAN QUESTIONS FOR ORAL POSTERS 81–85 Research Center, Stanford University RATINGS IN FEMALE PELVIC MEDICINE School of Medicine, Stanford, CA & RECONSTRUCTIVE SURGERY: WHAT 3:33 p.m. – 3:37 p.m. DO PATIENTS REALLY WANT? Oral Poster 86 –WHAT THE INTERNET 2:57 p.m. – 3:01 p.m. K. Asanad, P. S. Parameshwar, SAYS ABOUT VAGINAL MESH: Oral Poster 79 – PROPHYLACTIC J. Houman, A. Moradzadeh, T. Daskivich, SENTIMENT ANALYSIS OF WEBSITES ANTIBIOTICS AT THE TIME OF J. T. Anger. Urology, Cedars-Sinai Medical RELATED TO GRAFT USE IN PELVIC OBSTETRIC ANAL SPHINCTER INJURY Center, Los Angeles, CA RECONSTRUCTIVE SURGERY REPAIR: ARE WE MEETING THE MARK? D. Hobson, K. V. Meriwether, C. L. L. E. Giugale1, A. Fairchild2, S. Hasley1, 3:17 p.m. – 3:21 p.m. Kinman, S. L. Francis, R. Stewart. Female P. Fairchild1. 1Obstetrics, Gynecology Oral Poster 83 – URINARY Pelvic Medicine and Reconstructive and Reproductive Sciences, Magee- INCONTINENCE REMISSION BY Surgery, University of Louisville School of Womens Hospital of UPMC, Pittsburgh, SUBTYPE AND RELATION TO Medicine, Louisville, KY PA; 2Department of Psychology, Barnwell INDICATORS OF SEVERITY 3:37 p.m. – 3:41 p.m. College, University of South Carolina, V. Minassian1, X. Yan2, A. L. Pilzek3, W. F. Columbia, SC Stewart2. 1Brigham and Womens, Boston, Oral Poster 87 – COST IMPACT OF MA; 2Sutter Health, Walnut Creek, CA; ELECTIVE CESAREAN DELIVERY ON 3:01 p.m. – 3:05 p.m. 3Geisinger, Danville, PA FUTURE PELVIC FLOOR DISORDERS Oral Poster 80 – STRESS URINARY D. Patel, J. T. Anger, K. S. Eilber. Urology, INCONTINENCE SURGERY IN 3:21 p.m. – 3:25 p.m. Cedars-Sinai, Los Angeles, CA WASHINGTON STATE BEFORE AND Oral Poster 84 – PELVIC ORGAN AFTER INTRODUCTION OF THE MESH PROLAPSE AND URINARY 3:41 p.m. – 3:45 p.m. MIDURETHRAL SLING INCONTINENCE AFTER BARIATRIC Oral Poster 88 – BLADDER AND L. E. Stewart1, M. A. Eston1, SURGERY BOWEL DYSFUNCTION IN PATIENTS R. G. Symons2, A. C. Kirby1. 1Obstetrics I. Gabriel1, A. Tavakkoli2, V. Minassian1. WITH SPINAL STENOSIS and Gynecology, University of 1Division of Urogynecology, Brigham S. Dutta, L. A. Cadish, V. Tancioco, Washington, Seattle, WA; 2Surgery and and Women’s Hospital, Boston, MA; F. Lane. Obstetrics and Gynecology, Surgical Outcomes Research Center, 2Department of Surgery and Center for University of California, Irvine, Manhattan University of Washington, Seattle, WA Weight Management and Metabolic Beach, CA Surgery, Brigham and Women’s Hospital, 3:05 p.m. – 3:09 p.m. 3:45 p.m. – 3:49 p.m. Boston, MA QUESTIONS FOR ORAL POSTERS 76–80 Video 13 – MINIMALLY INVASIVE 3:25 p.m. – 3:29 p.m. CYSTOSCOPIC SUTURE EXCISION 3:09 p.m. – 3:13 p.m. 2 1 Oral Poster 85 – PATIENT R. Pollard , A. Petrikovets , J. W. Oral Poster 81 – INCIDENCE 1 1 UNDERSTANDING: HEALTH LITERACY Henderson . Female Pelvic Medicine AND RISK FACTORS FOR THE IN WOMEN WITH PELVIC FLOOR & Reconstructive Surgery, University DEVELOPMENT OF LOWER DISORDERS Hospitals Case Medical Center, URINARY TRACT FISTULAS AFTER 2 A. Sripad2, B. Rupp1, J. Gage1, K. M. Cleveland, OH; Urogynecology & Pelvic HYSTERECTOMY DIAGNOSED IN THE Feliciano1, M. Willis-Gray1, J. Wu1. Reconstructive Surgery, MetroHealth IMMEDIATE POST-OPERATIVE PERIOD: 1Urogynecology and Reconstructive Medical Center, Cleveland, OH AN ANALYSIS OF THE NATIONAL Pelvic Surgery, UNC Hospitals, Chapel SURGERY QUALITY IMPROVEMENT 3:49 p.m. – 3:53 p.m. Hill, NC; 2OBGYN, University of North PROGRAM (NSQIP) DATABASE QUESTIONS FOR ORAL POSTERS 86–88 Carolina, Chapel Hill, NC M. E. Florian-Rodriguez1, J. j. Hamner1, D. McIntire2, C. Wai1. 1Female Pelvic Medicine and Reconstructive Surgery, UT Southwestern, Dallas, TX; 2Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas, TX

PFD WEEK 2017 OCT 3 – 7 41 SCIENTIFIC PROGRAM (CONTINUED)

FRIDAY, OCTOBER 6 (Continued) 3:46 p.m. – 3:54 p.m. 4:45 p.m. – 4:56 p.m. Video Poster 5 – ROBOTIC VESICO- Video Poster 11 – A SITE-SPECIFIC 3:15 p.m. – 5:00 p.m. VAGINAL FISTULA REPAIR UTILIZING TECHNIQUE FOR A POSTERIOR REPAIR OMENTAL INTERPOSITION VIDEO CAFÉ – ROOM 553 A. Peacher-Seaney, L. Dabney. FPMRS, B. Moore. Moderators: Peter Jeppson, MD; Tyler D. Glazier, Virginia Urology Icahn School of Medicine at Mount Sinai, Muffly, MD Women’s Health, Midlothian, VA New York, NY 3:54 p.m. – 4:01 p.m. 3:15 p.m. – 3:25 p.m. 4:56 p.m. – 5:02 p.m. Video Poster 6 – UNIQUE APPROACHES Video Poster 1 – ROBOTIC-ASSISTED Video Poster 12 – SIGMOID EPIPLOICA TO CONCURRENT PELVIC ORGAN SACROCOLPOPERINEOPEXY AND INTERPOSITION DURING ROBOTIC PRLAPSE REPAIR AT TIME OF MODIFIED ANTERIOR RECTOPEXY VESICOVAGINAL FISTULA REPAIR GYNECOLOGIC CANCER SURGERY 1 2 1 FOR TREATMENT OF PELVIC ORGAN D. J. Sanderson , A. Eddib . Obstetrics PROLAPSE, PERINEAL DESCENT AND C. P. Chung, M. T. Wakabayashi, T. H. and Gynecology, Millard Fillmore DEFECATION DYSFUNCTION Dellinger, S. J. Lee, E. S. Han. Surgery, Suburban Hospital, Williamsville, NY; City of Hope Medical Center, Duarte, CA 2Western New York Urology Associates, R. Golan, P. Culligan. Urology, New York- Cheektowaga, NY Presbyterian Weill Cornell Medicine, New 4:01 p.m. – 4:06 p.m. York, NY QUESTIONS FOR VIDEO POSTERS 1–6 5:02 p.m. – 5:07 p.m. QUESTIONS FOR VIDEO POSTERS 10–12 3:25 p.m. – 3:28 p.m. 4:06 p.m. – 4:16 p.m. Video Poster 2 – RECTUS FASCIAL Video Poster 7 – SURGICAL FINE 4:00 p.m. – 4:15 p.m. SLING AS EASY AS MID-URETHRAL PRINTS IN CENTRAL ANTERIOR SLING VAGINAL WALL REPAIR BREAK – EXHIBIT LEVEL ATRIUM J. Shaw, C. Cowles. Obstetrics A. Nieuwoudt. Ziekenhuis Zorgsaam, and Gynecology, Tenwek Hospital, Terneuzen, Netherlands 4:15 p.m. – 5:30 p.m. Bomet, Kenya SCIENTIFIC CONCURRENT SESSION 10: 4:16 p.m. – 4:23 p.m. SURGERY SESSION 3:28 p.m. – 3:33 p.m. Video Poster 8 – LE FORT PARTIAL – BALLROOM A Video Poster 3 – TRANSVAGINAL COLPOCLEISIS: A LOW-COST MODEL Moderators: Oz Harmanli, MD; Heidi Harvie, MD, MSCE, MBA URETERAL DISSECTION DURING A. Gupta, S. Kanitsch, S. Herrera, L. Kane. UTEROSACRAL LIGAMENT Ob/Gyn, Crozer Chester Medical Center, 4:15 p.m. – 4:19 p.m. SUSPENSION PROCEDURE Philadelphia, PA Oral Poster 89 – ENHANCED RECOVERY 3 1 M. Sakinci , D. Maheshwari , PROGRAM FOR OUTPATIENT 2 1 4:23 p.m. – 4:32 p.m. O. Harmanli . Department of Ob/Gyn, UROGYNECOLOGIC SURGERY University of Massachusetts Medical Video Poster 9 – IDENTIFYING E. S. Chang1, B. Sarosiek2, School-Baystate, Springfield, MA; 2Yale THE DEFECTS: DATA FROM 563 E. Trowbridge1, K. L. Hullfish1. 1Obstetrics Urogynecology and Pelvic Reconstructive CONSECUTIVE ANTERIOR WALL & Gynecology, University of Virginia, Surgery, Yale School of Medicine, New DISSECTIONS Charlottesville, VA; 2University of Virginia Haven, CT; 3Department of Ob/Gyn, A. Nieuwoudt. Ziekenhuis Zorgsaam, Health System, University of Virginia, Akdeniz University School of Medicine, Terneuzen, Netherlands Charlottesville, VA Antalya, Turkey 4:32 p.m. – 4:38 p.m. 4:19 p.m. – 4:23 p.m. 3:38 p.m. – 3:46 p.m. QUESTIONS FOR VIDEO POSTERS 7–9 Oral Poster 90 – DOES VARIATION IN Video Poster 4 – A MODIFIED 4:38 p.m. – 4:45 p.m. BONY LANDMARKS PREDICT SUCCESS TRANSVAGINAL MESH COLPOPEXY Video Poster 10 – USE OF WITH SACRAL NEUROMODULATION: FOR ANTERIOR AND APICAL PROLAPSE EXTRACELLULAR MATRIX DURING ONE SIZE FITS ALL? D. Maheshwari1, O. Harmanli2. VAGINAL WALL REPAIR AFTER WIDE K. Husk2, L. Norris2, M. Willis-Gray2, 1Department of Ob/Gyn, University EXCISION OF A MESH K. Borawski1, E. Geller2. 1Urology, of Massachusetts Medical School- W. Chong1, A. D. Garely2, J. A. Fantl1. University of North Carolina Hospitals, Baystate, Springfield, MA; 2Yale 1Obstetrics, Gynecology and Reproductive Chapel Hill, NC; 2Urogynecology, Urogynecology and Pelvic Reconstructive Sciences, Mount Sinai Medical Center/ University of North Carolina Hospitals, Surgery, Yale School of Medicine, New Icahn School of Medicine, New York, NY; Chapel Hill, NC Haven, CT 2Obstetrics and Gynecology, South Nassau Communities Hospital, Oceanside, NY

42 PFD WEEK 2017 OCT 3 – 7 KEY: = Virtual Conference = This session requires a ticket Scientific Program

4:23 p.m. – 4:27 p.m. Mount Sinai Hospital, Toronto, ON, MA; 3OBGYN, UMass Memorial Medical Oral Poster 91 – IMPACT OF Canada; 2Anesthesia, Mount Sinai Center, Worcester, MA PREEMPTIVE ANALGESIA Hospital, Toronto, ON, Canada 4:59 p.m. – 5:03 p.m. ON POSTOPERATIVE PAIN 4:43 p.m. – 4:47 p.m. AFTER CYSTOSCOPY WITH QUESTIONS FOR ORAL POSTERS 94–98 Oral Poster 95 – PRIMARY PELVIC HYDRODISTENTION FOR PAINFUL 5:03 p.m. – 5:07 p.m. BLADDER SYNDROME/INTERSTITIAL ORGAN PROLAPSE SURGERY USING DELAYED ABSORBABLE SUTURE: Oral Poster 99 – PREDICTORS OF CYSTISIS: A PILOT STUDY OPIOID ADMINISTRATION IN THE 1 2 1 ONE-YEAR OUTCOMES COMPARING J. Fitzgerald , C. M. Kunkle , C. Chen , ACUTE POST OPERATIVE PERIOD M. Abernethy1, J. L. Blomquist3, ANTERIOR WALL SUCCESS IN M. Willis-Gray, K. Husk, T. Brueseke, J. I. C. Juan1, A. Long1, T. B. Fashokun1. VAGINAL UTEROSACRAL LIGAMENT SUSPENSION VERSUS SACRAL Wu, A. A. Dieter. OBGYN, University of 1Gynecology and Obstetrics, Johns COLPOPEXY North Carolina at Chapel Hill, Chapel Hill, Hopkins, Baltimore, MD; 2Kaiser, 1 1 NC Baltimore, MD; 3Greater Baltimore D. Bastawros , M. E. Tarr , M. A. Templin2, K. Stepp1, B. Taylor1, E. M. Medical Center, Baltimore, MD 5:07 p.m. – 5:11 p.m. Myers1. 1Female Pelvic Medicine and Oral Poster 100: A NOVEL: STRUCTURED 4:27 p.m. – 4:31 p.m. Reconstructive Surgery, Carolinas Health FELLOW TRAINING PATHWAY FOR Care System, Charlotte, NC; 2Center Oral Poster 92 – DO SPINALS ROBOTIC-ASSISTED SACROCOLPOPEXY INCREASE RATES OF URINARY for Outcomes Research and Evaluation T. Catanzarite1, J. Tan-Kim2, J. N. RETENTION: A RANDOMIZED (CORE), Charlotte, NC Nguyen3, S. Jakus-Waldman3, S. A. CONTROLLED TRIAL 4:47 p.m. – 4:51 p.m. Menefee2. 1Department of Reproductive A. Alas1, H. Devakumar2, L. Martin2, Oral Poster 96 – INDWELLING VS Medicine, Division of FPMRS, University E. A. Hurtado2, G. Davila2. 1OBGYN, IMMEDIATE REMOVAL OF FOLEY of California, San Diego, San Diego, University of Texas Health Science CATHETER AFTER ROBOTIC ASSISTED CA; 2Department of OB/GYN, Division of Center, San Antonio, TX; 2Female Pelvic LAPORASCOPIC SACROCOLPOPEXY: FPMRS, Kaiser Permanente, San Diego, Medicine and Reconstructive Surgery, A RANDOMIZED PROSPECTIVE STUDY CA; 3Department of OB/GYN, Division of Cleveland Clinic Florida, Weston, FL P.Popiel, V. Vallabh-Patel, C. Salamon. FPMRS, Kaiser Permanente, Downey, CA 4:31 p.m. – 4:35 p.m. Atlantic Health, Clifton, NJ 5:11 p.m. – 5:15 p.m. Oral Poster 93 – DOES PREOPERATIVE 4:51 p.m. – 4:55 p.m. Oral Poster 101 – PERSISTENT STRESS PROLAPSE STAGE PREDICT RISK OF Oral Poster 97 – OUTCOMES OF URINARY INCONTINENCE AFTER PERIOPERATIVE COMPLICATIONS SYNTHETIC MIDURETHRAL SLING DURING VAGINAL RECONSTRUCTIVE RECURRENT RECTOVAGINAL FISTULA REPAIR PROCEDURE: A SURGICAL SOLUTION SURGERY? 1 1 2 1 1 1 D. Maheshwari , K. Jones , O. Harmanli . A. Thomson1, J. Lanzer1, D. D. Saguan- J. N. Byrnes , J. Gebhart , J. Schmitt , 2 2 3 1Urogynecology and Pelvic Surgery, Burton2, G. M. Northington1. 1Gynecology, K. Mara , A. L. Weaver , H. K. Chua , J. Occhino1. 1Female Pelvic Medicine University of Massachusetts Medical Obstetrics and Reproductive Sciences, School-Baystate, Springfield, MA; 2Yale Emory University, Atlanta, GA; 2Kaiser and Reconstructive Surgery, Mayo Clinic, 2 Urogynecology and Pelvic Reconstructive Permanente, Jonesboro, GA Rochester, MN; Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Surgery, Yale School of Medicine, New 4:35 p.m. – 4:39 p.m. MN; 3Colon and Rectal Surgery, Mayo Haven, CT QUESTIONS FOR ORAL POSTERS 89–93 Clinic, Rochester, MN 5:15 p.m. – 5:23 p.m. 4:39 p.m. – 4:43 p.m. 4:55 p.m. – 4:59 p.m. Video 14 – VESTIBULECTOMY Oral Poster 94 – DOES Oral Poster 98 – IS MESH TECHNIQUE FOR REFRACTORY GABAPENTIN REDUCE OPOID EXPOSURE AFTER LAPAROSCOPIC VULVODYNIA USE POSTOPERATIVELY? GROUP SACROCOLPOPEXY A MYTH IN T. Crouss, N. M. Shah, M. Dawson, K. E. STUDY: A RANDOMIZED CONTROL THE ERA OF THE LIGHT WEIGHT Whitmore. Obstetrics and Gynecology, TRIAL IN WOMEN UNDERGOING POLYPROPYLENE MESH? Drexel University, Philadelphia, PA RECONSTRUCTIVE PELVIC SURGERY N. Noor1, K. L. Armstrong1, M. Ortega3, A. Li1, K. Wadsworth1, N. T. Siddiqui2, V. Demtchouk2, E. Elkadry1. 1FPMRS, 5:23 p.m. – 5:27 p.m. M. Alarab1, C. D. McDermott1, N. Lemos1, Mount Auburn Hospital, Cambridge, MA; QUESTIONS FOR ORAL POSTERS 99– D. Lovatsis1. 1Obstetrics and Gynecology, 2OBGYN, Tufts Medical Center, Boston, 101

PFD WEEK 2017 OCT 3 – 7 43 SCIENTIFIC PROGRAM (CONTINUED)

FRIDAY, OCTOBER 6 (Continued) 4:23 p.m. – 4:27 p.m. P. K. Kadam-Halani1, A. K. Pahwa2, Oral Poster 104 – EDUCATIONAL N. C. Koelper3, L. A. Arya1, 4:15 p.m. – 5:30 p.m. AND ELECTRONIC REFERRAL H. S. Harvie1,U. U. Andy1. 1Division of Urogynecology, Department of Obstetrics SCIENTIFIC CONCURRENT SESSION 11: INTERVENTIONS IN IMPROVING INCONTINENCE SCREENING AMONG and Gynecology, University of HOT TOPICS IN UROGYNECOLOGY II PRIMARY CARE PHYSICIANS Pennsylvania, Philadelphia, PA; SESSION – BALLROOM B/C 2 J. S. Zigman, V. Yuan, S. Amaya, Urogynecology, Department of Moderators: Elena Tunitsky Bitten, MD; Ray T. Yazdany. Obstetrics and Gynecology, Obstetrics and Gynecology, Keck School Foster, MD Harbor UCLA Medical Center, Torrance, CA of Medicine, University of Southern 3 4:15 p.m. – 4:19 p.m. California, Los Angeles, CA; Center for 4:27 p.m. – 4:31 p.m. Research on Reproduction and Women’s Oral Poster 102 – RATE AND Oral Poster 105 – FRACTIONAL Health, Department of Obstetrics PREDICTORS OF URINARY CO2 LASER OF THE VAGINA FOR and Gynecology, Perelman School of INCONTINENCE AT 12 MONTHS GENITOURINARY SYNDROME OF Medicine, University of Pennsylvania, POSTPARTUM MENOPAUSE: IS THE OUT-OF-POCKET 1 3 Philadelphia, PA L. E. Giugale , T. P. Canavan , P. A. COST WORTH THE OUTCOME OF 4 2 1 Moalli , S. Oliphant . Obstetrics, TREATMENT 4:43 p.m. – 4:47 p.m. Gynecology and Reproductive Sciences, P. Lang, M. Karram, Female Pelvic Medicine Oral Poster 108 – CONNECTING THE Magee-Womens Hospital of UPMC, and Reconstructive Surgery, The Christ DOTS: RELATIONSHIPS BETWEEN Pittsburgh, PA; 2University of Arkansas Hospital, Cincinnati, OH REVIEW OF SYSTEMS RESPONSES AND for Medical Sciences, Little Rock, AR; CHRONIC UROGYNECOLOGIC PAIN 3Division of Ultrasound, Magee-Womens 4:31 p.m. – 4:35 p.m. A. M. Hesson, A. G. Sammarco, Hospital of UPMC, Pittsburgh, PA; Oral Poster 106 – RATES OF OBSTETRIC M. B. Berger, H. K. Haefner. Obstetrics 4Magee-Womens Hospital of UPMC, ANAL SPHINCTER INJURIES BEFORE AND and Gynecology, Michigan Medicine, Magee-Womens Research Institute, AFTER TRAINING INVOLVING PERINEAL Ann Arbor, MI Pittsburgh, PA PROTECTION J. Yeung1, A. Stecher2, D. Mazloomdoost1, C. 4:47 p.m. – 4:51 p.m. 4:19 p.m. – 4:23 p.m. C. Crisp1, B. Smith1, S. D. Kleeman1, R. N. Oral Poster 109 – EASY TO FIND Oral Poster 103 – EARLY POST- Pauls1. 1Female Pelvic Medicine and BUT DIFFICULT TO UNDERSTAND? INJECTION URINARY TRACT INFECTION Reconstructive Surgery, TriHealth Good ANALYZING THE READABILITY OF (UTI) PREDICTS RECURRENT UTI AFTER Samaritan Hospital, Cincinnati, OH; ONLINE UROGYNECOLOGIC PATIENT ONABOTULINUM TOXIN A 2 INFORMATION 1 1 Obstetrics & Gynecology, TriHealth Good J. A. Bickhaus , M. S. Bradley , C. L. R. Stewart1, S. L. Francis1, K. V. 1 1 2 Samaritan Hospital, Cincinnati, OH A.m. undsen , A. G. Visco , T. Truong , Meriwether1, C. L. Kinman1, D. Hobson1, Y. Li 2, N. Y. Siddiqui1. 1Obstetrics & 4:35 p.m. - 4:39 p.m. J. Gaskins2. 1Obstetrics, Gynecology, and Gynecology, Duke University, Durham, QUESTIONS FOR ORAL POSTERS 102-106 Women’s Health, University of Louisville NC; 2Biostatistics and Bioinformatics, School of Medicine, Louisville, KY; Duke University, Durham, NC 4:39 p.m. – 4:43 p.m. 2University of Louisville School of Public Oral Poster 107 – COMPARISON OF Health and Information Sciences, ANORECTAL MANOMETRY TESTING IN Louisville, KY LEFT LATERAL AND DORSAL LITHOTOMY POSITIONS 4:51 p.m. – 4:55 p.m. Oral Poster 110 – OPIOID REQUIREMENTS AFTER VAGINAL HYSTERECTOMY WITH MINIMALLY INVASIVE SACROCOLPOPEXY N. M. Shah1, J. P. Shepherd2, L. Andriani1, C. Ingraham1, C. B. Iglesia3. 1Georgetown University School of Medicine, Washington; 2University of Pittsburgh Medical Center, Pittsburgh, PA; 3OB/GYN, MedStar Washington Hospital Center, Washington,

44 PFD WEEK 2017 OCT 3 – 7 KEY: = Virtual Conference = This session requires a ticket Scientific Program

4:55 p.m. – 4:59 p.m. Y. Li 2, N. Y. Siddiqui1. 1Obstetrics & 4:23 p.m. – 4:27 p.m. Oral Poster 111 – URINARY SYMPTOMS Gynecology, Duke University, Durham, Oral Poster 117 – CAN WOMEN AND THEIR EFFECT ON QUALITY OF NC; 2Biostatistics and Bioinformatics, WITH LEVATOR ANI TEAR ON MR IMAGES LIFE IN WOMEN LIVING WITH HIV: Duke University, Durham, NC EFFECTIVELY INCREASE URETHRAL A CROSS-SECTIONAL STUDY CLOSURE PRESSURE DURING A 5:15 p.m. – 5:22 p.m. M. Larouche2, S. Blitz4, J. Raboud4, VOLITIONAL PELVIC FLOOR MUSCLE N. Lipsky3, G. W. Cundiff1, D. M. Money3, Video 15 – LOGOTHETOPULOS: CONTRACTION? A FOCUS ON CONTROL OF INTRAOPERATIVE HPV in HIV Study Group3. 1Obstetrics POSTPARTUM WOMEN AT HIGH RISK FOR HEMORRHAGE WITH PELVIC and Gynecology, University of British LEVATOR ANI TEAR FROM RECENT PRESSURE PACK Columbia, Vancouver, BC, Canada; VAGINAL CHILDBIRTH 1 2 2Obstetrics and Gynecology, McGill J. Gonzalez , S. A. Davidson , T. M. Y. Sheng, J. Miller. School of Nursing, 2 1 University, Montreal, QC, Canada; Muffly . University of Colorado School University of Michigan, Ann Arbor, MI 2 3Women’s Health Research Institute, of Medicine, Aurora, CO; Denver Health, 4:27 p.m. – 4:31 p.m. Vancouver, BC, Canada; 4Toronto General Denver, CO Oral Poster 118 – TRANSFORMING Research Institute, University Health 5:22 p.m. – 5:26 p.m. COMMUNITY-BASED CONTINENCE Network, Toronto, ON, Canada QUESTIONS FOR ORAL POSTERS PROMOTION: THE BOWEL MOVEMENT H. 4:59 p.m. – 5:03 p.m. 112–114 W. Brown1, M. Wise2, S. M. Myers3, J. E. QUESTIONS FOR ORAL POSTERS Mahoney1, R. G. Rogers4. 1School of 4:15 p.m. – 5:30 p.m. 102–111 Medicine and Public Health, University of SCIENTIFIC CONCURRENT Wisconsin–Madison, Madison, WI; 2School 5:03 p.m. – 5:07 p.m. SESSION 12: NOVEL TECHNOLOGIES of Pharmacy, University of Wisconsin– Oral Poster 112 – NORMAL POP-Q AND NEUROMODULATION Madison, Madison, WI; 3Community- VALUES IN THE AVERAGE GYN SESSION – BALLROOM D/E Academic Aging Research Network, POPULATION: REVISITING THE Wisconsin Institute for Healthy Aging, Moderators: Catrina Crisp, MD; Edgar POSST STUDY 4 LeClaire, MD Madison, WI; Dell Medical School, R. Patnam, A. L. Edenfield, S. Swift. University of Texas at Austin, Austin, TX Obstetrics and Gynecology, Medical 4:15 p.m. – 4:19 p.m. 4:31 p.m. – 4:35 p.m. University of South Carolina, Oral Poster 115 – PATIENT-IMPORTANT Oral Poster 119 – ELECTRICAL Charleston, SC CRITICAL CONTENT AND THE ROLE STIMULATION OF AFFERENT NERVES IN OF PEER SUPPORT FOR WOMEN 5:07 p.m. – 5:11 p.m. THE FOOT WITH TRANSCUTANEOUS UNDERGOING SURGERY FOR PELVIC Oral Poster 113 – RISK OF ACUTE ADHESIVE PAD ELECTRODES IN WOMEN FLOOR DISORDERS CARDIAC MORBIDITY FOLLOWING WITH OAB: COMPARISON OF DIFFERENT A. M. Madsen1, G. C. Dunivan2, SURGERY FOR PELVIC ORGAN STIMULATION DURATIONS C. R. G. Rogers3, A. M. Parrillo1, V. W. Sung1. PROLAPSE Chermansky1, B. Shen1, J. Okonski1, W. C. 1Urogynecology/Obstetrics and D. Sheyn2, S. T. Mahajan1, S. A. El- de Groat2, C. Tai1. 1Urology and Gynecology, Women and Infants Hospital/ Nashar1, A. Hijaz2, X. Wang1, J. Mangel3. Urogynecology, University of Pittsburgh Warren Alpert Medical School of Brown 1Obstetrics and Gynecology, University Medical Center, Pittsburgh, PA; University, Providence, RI; 2Univeristy Hospitals Cleveland Medical Center, 2 2 of New Mexico, Albuquerque, NM; Pharmacology and Chemical Biology, Cleveland, OH; Urology, University 3 University of Pittsburgh, Pittsburgh, PA Hospitals Cleveland Medical Center, University of Texas at Austin, Austin, TX Cleveland, OH; 3Ob/gyn, Metro Health 4:19 p.m. – 4:23 p.m. 4:35 p.m. – 4:39 p.m. Medical Center, Cleveland, OH Oral Poster 116 – LOWER URINARY QUESTIONS FOR ORAL POSTERS 115–119 TRACT SYMPTOMS IN A CHRONIC 5:11 p.m. – 5:15 p.m. 4:39 p.m. – 4:43 p.m. PAIN POPULATION Oral Poster 114 – DOES A RECENT Oral Poster 124 – PROSPECTIVE NON- A. G. Sammarco1, E. K. Kobernik2, URINARY TRACT INFECTION COMPARATIVE STUDY TO ASSESS THE H. K. Haefner2, N. Honey2, M. B. Berger1. (UTI) INCREASE THE RISK OF EFFECTIVENESS OF A PIXEL CO2 LASER 1 SYSTEM IN THE TREATMENT OF POST-INJECTION UTI AFTER Female Pelvic Medicine and VULVOVAGINAL ATROPHY: INTERIM ONABOTULINUM TOXIN A? Reconstructive Surgery, University of Michigan, Ann Arbor, MI; 2Obstetrics and ANALYSIS J. A. Bickhaus1, M. S. Bradley1, C. L. Gynecology, University of Michigan, J. Schachar, H. Devakumar, L. Martin, E. A. A.m. undsen1, A. G. Visco1, T. Truong2, Ann Arbor, MI Hurtado, G. Davila. Female Pelvic Medicine and Reconstructive Surgery, Cleveland Clinic Florida, Hollywood, FL

PFD WEEK 2017 OCT 3 – 7 45 SCIENTIFIC PROGRAM (CONTINUED)

FRIDAY, OCTOBER 6 (Continued) 4:59 p.m. – 5:03 p.m. 5:25 p.m. – 5:29 p.m. QUESTIONS FOR ORAL POSTERS QUESTIONS FOR ORAL POSTERS 4:43 p.m. – 4:47 p.m. 120–124 125–127 Oral Poster 121 – DENERVATION OF THE TRIGONE FOR TREATMENT OF URGENCY 5:03 p.m. – 5:07 p.m. 7:00 p.m. – 11:00 p.m. URINARY INCONTINENCE ASSOCIATED Oral Poster 125 – DEVELOPMENT AUGSOME BEACH CARNIVAL – WITH OVERACTIVE BLADDER OF A NEUROSTIMULATOR IMPLANT WATERFIRE ARTS CENTER R. Dmochowski1, S. De Wachter6, E. TECHNIQUE FOR TIBIAL NERVE Rovner4, K. Everaert2, M. Robert3, L. Tu5. STIMULATION 1 1 2 1Urologic Surgery, Vanderbilt University G. W. Stone , D. D. Gruber , J. Buller . SATURDAY, OCTOBER 7 Medical Center, Nashville, TN; 2Uro- 1Obstetrics and Gynecology, Walter Reed gynecology, Ghent University, Gent, National Military Medical Center, Arlington, 8:30 a.m. – 8:35 a.m. 3 VA; 2Uniformed Services University of Belgium; University of Calgary, Calgary, ANNOUNCEMENTS AND PREVIEW OF 4 Health Sciences, BETHESDA, MD AB, Canada; Medical University of South 2018 – EXHIBITION HALL C 5 Carolina, Charleston, SC; University of 5:07 p.m. – 5:11 p.m. Sherbrooke, Sherbrooke, QC, Canada; Oral Poster 126 –VAGINAL SACRAL 8:35 a.m. – 9:30 a.m. 6University of Antwerp, Antwerp, Belgium COLPOPEXY: A NATURAL ORIFICE GENERAL SCIENTIFIC SESSION V – 4:47 p.m. – 4:51 p.m. APPROACH TO A GOLD STANDARD EXHIBITION HALL C Oral Poster 122 – ACCURACY PROCEDURE Moderators: Emily Lukacz, MD; Vivian OF REPORTING METHODS FOR C. R. Hanes. Urogynecology of Southern Sung, MD PERIOPERATIVE COMPLICATIONS Alabama, Mobile, AL AFTER SUB-URETHRAL SLINGS 8:35 a.m. – 8:45 a.m. 5:11 p.m. – 5:15 p.m. B. J. Hill, E. Braxton, R. Adam. OB/GYN, Paper 23 – EFFECTIVENESS AND Oral Poster 127 – EVALUATION OF Vanderbilt University, Nashville, TN SAFETY OF A NEW DISPOSABLE SER120 FOR THE TREATMENT OF VAGINAL DEVICE FOR THE NON- 4:51 p.m. – 4:55 p.m. PATIENTS WITH NOCTURIA DUE SURGICAL MANAGEMENT OF PELVIC Oral Poster 123 – ANALYSIS OF TO NOCTURNAL POLYURIA WITH ORGAN PROLAPSE (POP) IN WOMEN CONCOMITANT OVERACTIVE BLADDER DIFFERENT REFERENCE LINE BY USING E. Ziv1, S. Dascalu1, J. May2, T. Erlich3. D. M. Van Drie1, H. Lepor2, V. W. Nitti2, M. DYNAMIC MAGNETIC RESONANCE 1Gynecology-Hertzelia, Hertzelia, Israel; Cheng3, L. Cheng3, S. Fein3. 1 IMAGING IN POSTERIOR VAGINAL WALL Female 2Gynecology Ramat Hasharon, Ramat PROLAPSE AND A NOVEL PARAMETER: Pelvic Medicine and Urogynecology Hasharon, Israel; 3ConTIPI Medical Ltd, EXPOSED VAGINAL LENGTH Institute of Michigan, Grand Rapids, MI; Caesarea, Israel 2 3 1 3 B. Xie , Z. Xue , L. Chen , E. M. English , 2New York University Medical Center, New D. E. Fenner3, J. A. Ashton-Miller1, J. O. York, NY; 3Serenity Pharmaceuticals, LLC, 8:45 a.m. – 8:53 a.m. DeLancey3. 1Department of Mechanical Milford, PA Video 17 – SACRAL NEUROMODULATION Engineering, University of Michigan, Ann 5:15 p.m. – 5:25 p.m. USING RETROGRADE LEAD PLACEMENT arbor, MI; 2Department of Obstetrics and Video 16 – EXCISION OF VAGINAL IN A PATIENT WITH KYPHOSCHOLIOSIS Gynecology, Peking University People’s MESH EXPOSURE IN THE BLADDER: T. G. Lee, L. Lipetskaia, P. Doyle. 3 Hospital, Beijing, China; Department of A ROBOTIC APPROACH Obstetrics and Gynecology, University of Obstetrics and Gynecology, University of D. L. OShaughnessy1, C. J. Diblasio2, P. Rochester, Rochester, NY Michigan, Ann Arbor, MI Finamore1. 1Female Pelvic Medicine and 8:53 a.m. – 9:03 a.m. Reconstructive Surgery, Northwell Health 4:55 p.m. – 4:59 p.m. Paper 24 – THE IMPACT OF A DECISION System, Huntington, NY; 2Urology, Oral Poster 120 – BACLOFEN: AID ON TREATMENT DECISION MAKING Northwell Health System, Huntington A FORGOTTEN DRUG FOR VOIDING FOR STRESS URINARY INCONTINENCE Hospital, Huntington, NY DYSFUNCTION J. J. Navas1, S. Amaya2, T. Yazdany1. L. Martin, N. Chandrasekaran, 1FPMRS, Harbor-UCLA Medical Center, H. Devakumar, J. Schachar, Torrance, CA; 2LA BioMed, Torrance, CA E. A. Hurtado, G. Davila. Gynecology, Cleveland Clinic Florida, Weston, FL

46 PFD WEEK 2017 OCT 3 – 7 KEY: = Virtual Conference = This session requires a ticket Scientific Program

9:03 a.m. – 9:13 a.m. 11:30 a.m. – 12:30 p.m. 12:00 p.m. – 12:10 p.m. Paper 25 – OVERACTIVE VOIDING Paper 30 – THE NATURAL HISTORY OF GENERAL SCIENTIFIC SESSION VI – BEHAVIOR IN SURGICALLY-INDUCED URINARY INCONTINENCE IN WOMEN: EXHIBITION HALL C MENOPAUSAL MICE EXPOSED TO A PROSPECTIVE ANALYSIS OF THE Moderators: Charles Rardin, MD LPS IS MODULATED BY DISTINCT ; NURSES’ HEALTH STUDY I & II Cassandra Carberry, MD GENE PATHWAYS K. Hagan1, E. Erekson2, A. M. Austin2, M. G. Acevedo Alvarez1, J. Y. Yeh1, 11:30 a.m. – 11:40 a.m. V. Minassian1, M. K. Townsend1, J. P. 2 2 3 2 1 L. Alvarez-Lugo , M. Lu , N. Sukumar , Paper 27 – DOES THE AUGS NOW Bynum , F. Grodstein . 1Brigham. and 4 2 W. Hill , T. C. Chai . 1Urogynecology, RISK CALCULATOR ACCURATELY Women’s Hospital, Boston, MA; 2Geisel Yale University, New Haven, CT; 2Urology, DISCRIMINATE BETWEEN WOMEN WITH School of Medicine, Hanover, NH Yale University, New Haven, CT; AND WITHOUT POSTOPERATIVE SUI? 3 12:10 p.m. – 12:20 p.m. School of Public Health, Yale University, E. M. English, P. Schmidt, G. E. Kolenic, 4 Paper 31 – AGE-DEPEDENT CHANGES New Haven, CT; Nephrology, Beth Israel D. E. Fenner, M. B. Berger. University of Deaconess, Boston, MA IN MYELOID CELL RECRUITMENT Michigan Health System, Ann Arbor, MI AND TISSUE REPAIR IN THE MURINE 9:13 a.m. – 9:23 a.m. 11:40 a.m. – 11:50 a.m. BLADDER FOLLOWING A URINARY Paper 26 – SEXUAL FUNCTION IN Paper 28 – SLEEP QUALITY AND TRACT INFECTION RELATIONSHIPS AFFECTED BY URGE DAYTIME SLEEPINESS AMONG C. Wang. OB/Gyn, Washington University URINARY INCONTINENCE WOMEN WITH URGENCY URINARY in St. Louis, Saint Louis, MO 1 2 3 J. Cunkelman , T. Dune , M. Tulke , E. R. INCONTINENCE 3 1 12:20 p.m. – 12:30 p.m. Mueller . Food and Drug Administration, W. D. Winkelman1, A. Huang1, Q. Warsi1, 2 Paper 32 – INDUSTRY FINANCIAL Silver Spring, MD; Urology, Weill Cornell K. L. Stone11, M. Schembri1, R. G. Rogers2, 3 RELATIONSHIPS TO FEMALE PELVIC Medicine, New York, NY; Departments of 3 4 5 H. E. Richter , D. L. Myers , S. Kraus , MEDICINE AND RECONSTRUCTIVE Obstetrics/Gynecology & Urology, Loyola 6 7 8 K. Johnson , R. Hess , W. T. Gregory , C. PHYISICIANS: ANALYSIS OF SUNSHINE University Medical Center, Chicago, IL 9 10 12 S. Bradley , L. A. Arya , L. L. Subak . ACT OPEN PAYMENTS 1 9:23 a.m. – 9:28 a.m. University of California, San Francisco, T. M. Muffly1, J. S. Guido3, R. Weterings1, 2 Tip and Trick 2 – SACRAL San Francisco, CA; Dell Medical School, W. Giamberardino2. 1Female Pelvic NEUROMODULATION LEAD REMOVAL: University of Texas at Austin, Austin, TX; Medicine and Reconstructive Surgery, 3 A NOVEL TECHNIQUE University of Alabama at Birmingham, Denver Health, Denver, CO; 2University of 4 E. Dougher1, R. M. Krlin2, J. Winters2. Birmingham, AL; Brown University, Colorado School of Medicine, Aurora, CO; 5 1 Providence, RI; UT Health Science Center, 3MJW Technical Services, Amherst, NY OB/GYN, LSU-HSC , 6 New Orleans, LA; 2Urology, LSU-HSC San Antonio, TX; University of Tennessee New Orleans, New Orleans, LA Health Science Center, Memphis, TN; 12:30 p.m. – 1:30 p.m. 7University of Utah, Salt Lake City, UT; 8 WHAT ARE UROGYNECOLOGISTS 9:30 a.m. – 10:30 a.m. Oregon Health & Science University, Portland, OR; 9University of Iowa, Iowa GOING TO GET PAID AND HOW? INSIGHTS ON HOW TO NAVIGATE City, IA; 10University of Pennsylvania, Moderator: Jonathan Gleason, MD PRODUCT CONTROVERSY Philadelphia, PA; 11California Pacific Presenters: Mitchell Schuster, MD; Samantha Moderator: Cheryl Iglesia, MD Medical Center Research Institute, Pulliam, MD Panelists: Julie Cantor, MD, JD; Patrick San Francisco, CA; 12Stanford University Culligan, MD; Alan Garely, MD School of Medicine, Stanford, CA 1:30 p.m. ADJOURN 10:30 a.m. – 10:45 a.m. 11:50 a.m. – 12:00 p.m. Paper 29 – PATIENT PREPAREDNESS BREAK FOR PELVIC FLOOR PHYSICAL THERAPY: STANDARD COUNSELING VS VIDEO 10:45 a.m. – 11:30 a.m. M. Brady1, C. M. Fitzgerald1, W. Adams2, MASTER SURGEON L. Brubaker1, E. R. Mueller1, C. Brincat1. PRESENTATIONS – EXHIBITION HALL C 1Obstetrics and Gynecology, Loyola Moderators: Felicia Lane, MD; Marlene University Medical Center, Maywood, IL; Corton, MD 2Health Sciences Division, Loyola Presenters: Nucelio Lemos, MD; Beri University Chicago, Maywood, IL Ridgeway, MD

PFD WEEK 2017 OCT 3 – 7 47 EXHIBIT HALL FLOOR PLAN

48 PFD WEEK 2017 OCT 3 – 7 EXHIBITOR LISTING

Company Booth Number Company Booth Number

ACell, Inc...... 104 Intuitive Surgical...... 507 Advanced Tactile Imaging, Inc...... 110 Invuity, Inc...... 705

Allergan, Inc...... 101 LABORIE...... 316 Exhibit Hall Allergan Medical Affairs...... 608 Laclede Inc...... 617 Alma Lasers...... 109 Lumenis...... 603 AMAG Pharmaceuticals ...... 711 Lutronic ...... 719 American Urogynecologic Society (AUGS)...... 317 Marina Medical Instruments, Inc...... 606 Astellas Pharma, US, Inc...... 701 Medspira, LLC...... 615 Bioteque America Inc...... 217 Medtronic...... 501 BK Ultrasound...... 611 Neomedic International...... 100 Boston Scientific...... 201 NinoMed...... 715 Caldera Medical...... 200 Norton Medical Group...... 717 CMS Market Research...... 713 Olympus...... 718 Cogentix Medical...... 515 Pacira Pharmaceuticals...... 716 Coloplast Corp...... 211 Pathnostics...... 119 CooperSurgical...... 614 Pelvalon...... 708 Cynosure, A Hologic Company...... 115 The Prometheus Group...... 215 DSE Healthcare Solutions – PRELIEF...... 218 Sagent Pharma...... 116 Elidah...... 619 Sciton...... 107 ellura (by Trophikos)...... 214 Solace Therapeutics...... 208 Emmy Medical...... 108 Syneron Candela...... 216 Ethicon US, LLC...... 314 Teleflex...... 714 Halo Medical Technologies...... 710 Theralogix...... 707 Icon Undies...... 106 Thermi, an Almirall Company...... 601 InMode ...... 118 Tissue Regenix...... 112 Innovation Compounding, Inc...... 709 Viveve, Inc...... 607 International Urogynecological Association...... 117 Wolters Kluwer...... 609

PFD WEEK 2017 OCT 3 – 7 49 SHARE COMPREHENSIVE FPMRS RESOURCES WITH YOUR PATIENTS

Visit www.VoicesforPFD.org

Our online community, Voices for PFD, is an outlet for Features of our online community: women to share their stories, get support from other • Discussion Forums women, and ask experts about disorders impacting the • Ask the Physician Experts pelvic floor, such as incontinence and prolapse. • Downloadable Resources Pelvic Floor Dialogues • Informational Articles Patients can subscribe to our eNewsletter to keep up-to- date on the latest advancements on pelvic floor disorders.

Patient Fact Sheets Patients can utilize fact sheets to better understand diagnoses and treatment options on a variety of topics.

Voices for PFD YouTube Channel Women with pelvic disorders can subscribe to the Voices for PFD YouTube Channel to hear from leading physicians about pelvic floor disorder symptoms and treatment options.

Patient educational resources are sponsored by AUGS and supported in part through educational grants from: EXHIBITOR DIRECTORY

ACELL, INC. AMAG PHARMACEUTICALS BIOTEQUE AMERICA INC. Booth 104 Booth 711 Booth 217 SHARE www.acell.com www.amagpharma.com www.bioteque.com COMPREHENSIVE FPMRS RESOURCES ACell is a leading regenerative medicine company AMAG is a biopharmaceutical company focused on Bioteque America Inc is a medical device that develops and manufactures products designed developing and delivering important therapeutics, manfacturer and distributor specializing in to facilitate the body’s ability to repair and remodel conducting clinical research in areas of unmet gynecology, urogynecology, and urology products. WITH YOUR PATIENTS tissue. Our company helps patients in a variety need and creating education and support All products manufactured for Bioteque come from of settings heal differently. ACell’s products are programs for the patients and families we serve. an FDA inspected facility. Some of our products

gradually incorporated within the patient’s body Our currently marketed products support the include: vaginal supportive , endometrial Exhibit Hall and replaced with site-appropriate tissue. health of patients in the areas of maternal and sampling devices, vaginal , hsg catheters, women’s health, anemia management and cancer cervical dilators, instruments. Allow us to earn your ADVANCED TACTILE IMAGING, INC. supportive care. Through CBR®, we also help business. ISO 13485; CE 0434 Booth 110 families to preserve newborn stem cells, which Visit www.VoicesforPFD.org www.tactile-imaging.com are used today in transplant medicine for certain BK ULTRASOUND and blood, immune, and metabolic A developer and manufacturer of innovative Booth 611 disorders, and have the potential to play a valuable www.bkultrasound.com medical devices: vaginal treatment and monitoring role in the ongoing development of regenerative system (FemTact) composed of a laser device and medicine. For additional company information, BK Ultrasound is a global leader in pelvic floor Vaginal Tactile Imager (VTI); Laparoscopic Tactile please visit www.amagpharma.com. ultrasound. Our unique multi-compartment Imager (LTI); vaginal tactile and high definition solution lets you image the anterior, middle, and EMG guided therapy device (Restore-IT), and AMERICAN UROGYNECOLOGIC posterior compartments allowing you to see the Monitor (CM) for measurement of cervix pelvic floor architecture in superb detail and elasticity and length. SOCIETY (AUGS) high-resolution 3D. The bk3000 and Flex Focus Booth 317 ultrasound systems deliver excellent image quality, ALLERGAN, INC. www.augs.org mobility and flexibility. Booth 101 The American Urogynecologic Society (AUGS), www.allergan.com founded in 1979, is the premier society dedicated BOSTON SCIENTIFIC Allergan plc (NYSE: AGN), is a bold, global to research and education in urogynecology, and Booth 201 pharmaceutical company focused on developing, the detection, prevention, and treatment of female www.bostonscientific.com/ manufacturing and commercializing branded pelvic floor disorders. As the leader in Female femalepelvicmedicine Pelvic Medicine and Reconstructive Surgery, pharmaceuticals, devices and biologic products Boston Scientific remains committed to the AUGS promotes the highest quality patient care for patients around the world. For more information, treatment of pelvic floor disorders and to you and through excellence in education, research, and visit Allergan’s website at www.Allergan.com. your patients. We are anchored in our guiding advocacy. Visit AUGS in Booth 317 for information principle to provide innovative products that are on membership, the AQUIRE Registry, and supported with clinical data and offer robust Our online community, Voices for PFD, is an outlet for ALLERGAN MEDICAL AFFAIRS patient resources. Features of our online community: women to share their stories, get support from other Booth 608 professional programs to advance the quality of • Discussion Forums women, and ask experts about disorders impacting the www.allergan.com care. We stand by the quality of our products and ASTELLAS PHARMA US, INC. our overall commitment to women’s health. • Ask the Physician Experts pelvic floor, such as incontinence and prolapse. Allergan plc (NYSE: AGN), is a bold, global Booth 701 pharmaceutical company focused on developing, www.astellas.us CALDERA MEDICAL • Downloadable Resources Pelvic Floor Dialogues manufacturing, and commercializing branded Astellas Pharma US, Inc., a U.S. affiliate of Tokyo- • Informational Articles Patients can subscribe to our eNewsletter to keep up-to- pharmaceuticals, devices, and biologic products Booth 200 date on the latest advancements on pelvic floor disorders. for patients around the world. For more based Astellas Pharma Inc., is a pharmaceutical www.calderamedical.com company dedicated to changing tomorrow by information, visit Allergan’s website at Caldera Medical is a Women’s Health medical improving the health of people around the world www.Allergan.com. device company which focuses on improving Patient Fact Sheets through innovative and reliable pharmaceutical the quality of life for women. Caldera Medical Patients can utilize fact sheets to better understand products. For more information about Astellas develops, manufactures, and markets diagnoses and treatment options on a variety of topics. ALMA LASERS Pharma US, Inc., please visit our web site at differentiated surgical implants for the treatment Booth 109 www.astellas.us. of Stress Urinary Incontinence (Desara® Voices for PFD YouTube Channel www.ooo.com Sling System) and Pelvic Organ Prolapse Women with pelvic disorders can subscribe to the Alma Lasers is a global innovator of laser, light- (Vertessa® Lite). Voices for PFD YouTube Channel to hear from leading based, radiofrequency and ultrasound solutions physicians about pelvic floor disorder symptoms and treatment options. for the aesthetic and surgical markets. We enable practitioners to offer safe and effective CMS MARKET RESEARCH procedures while allowing patients to benefit from Booth 713 state-of-the-art, clinically proven technologies and treatments.

Patient educational resources are sponsored by AUGS and supported in part through educational grants from:

PFD WEEK 2017 OCT 3 – 7 51 EXHIBITOR DIRECTORY (CONTINUED)

COGENTIX MEDICAL ELIDAH ICON UNDIES Booth 515 Booth 619 Booth 106 www.cogentixmedical.com www.elidah.com www.iconundies.com Cogentix Medical products include Urgent® PC, Elidah has a conservative non-vaginal treatment Icon Undies are beautiful, reusable, absorbent a low-risk, office-based OAB treatment that for the one in three women with stress urinary underwear for bladder leaks. Each pair can hold up provides clinically significant and durable results; incontinence. Elitone™ strengthens the pelvic floor to eight tsp. of liquid (light and moderate options EndoSheath® Systems that combine state-of-the- muscles discreetly, non-invasively, and while going available), and are antimicrobial, anti-odor, and art endoscopic technology with a sterile, disposable about normal activities with surface electrical machine washable. Every pair purchased helps microbial barrier; and Macroplastique® bulking stimulation. Elitone improves the quality of life for fund fistula surgeries through our partnership agent for adult female SUI. Cogentix was formed tens of millions of women. with the Fistula Foundation. Truly life changing through a merger of Uroplasty and Vision‑Sciences. underwear! ELLURA (BY TROPHIKOS) COLOPLAST CORP. Booth 214 INMODE Booth 211 www.myellura.com Booth 118 www.coloplast.us ellura is a medical-grade supplement proven www.inmodemd.com With a 60-year legacy of commitment and effective as an alternative to antibiotics for UTI For over two decades the leaders and scientists dedication to women’s health, Coloplast offers prevention. Only ellura contains 36 mg PAC behind InMode have been revolutionizing the innovative solutions for the treatment of SUI and (proanthocyanidins) and inhibits bacterial adhesion medical aesthetic industry with state-of-the-art POP, featuring products such as the Altis® Single to the bladder wall, stopping the UTI before it light, RF and laser solutions. The newest addition Incision Sling System, Aris® and Supris® full starts. Patients can take once daily to prevent to their legacy of industry leading technology length slings, Restorelle® Y-Contour™, Restorelle recurrent UTIs or choose our convenient ‘on- advancements is Votiva: a safe, gentle, and DirectFix™ and Axis™ and Suspend® biologic grafts. demand’ dosing. effective non-surgical solution for feminine health. COOPERSURGICAL EMMY MEDICAL INNOVATION COMPOUNDING, INC. Booth 614 Booth 108 Booth 709 www.coopersurgical.com www.cystosure.com www.innovationcompounding.com Since our founding in 1990, CooperSurgical has Emmy Medical has developed Cystosure® a unique Innovation Compounding is a compounding researched, developed, and manufactured a 4-Way urinary catheter allowing comprehensive pharmacy that supports over 1,400 prescribers, wide range of trusted brands that have advanced office evaluation to be conducted in under 17,000 patients and 39,000 prescriptions the standard of care for families. Our diversified 10 minutes. CystoSure® makes office and OR across the nation. We commit to individualized portfolio of products and services focuses on cystoscopy safe, simple, and standardized for all pharmaceutical care through being relentless women’s health, fertility, and diagnostics. Visit us clinicians. In 2017, Emmy will be launching the in our drive for personalized medicine, at booth #614 to interact with our industry leading Kohli catheter that potentially reduces bladder compassionate toward our patients and doctors, as solutions and experience why CooperSurgical is at trauma and UTI’s. well as being a wellness advocate for our patients’ the forefront of women’s healthcare. lives and state of well being. It is our passion to ETHICON US, LLC enhance our patients’ quality of life! CYNOSURE, A HOLOGIC COMPANY Booth 314 Booth 115 www.ethicon.com INTERNATIONAL www.cynosure.com Ethicon US LLC , a Johnson & Johnson company, UROGYNECOLOGICAL MonaLisa Touch is a revolutionary fractional commercializes a broad range of innovative ASSOCIATION (IUGA) CO2 laser treatment for the painful symptoms surgical products, solutions, and technologies used Booth 117 of menopause, including intimacy. It is the only to treat some of today’s most prevalent medical www.iuga.org technology for vaginal and vulvar health with over issues, such as: colorectal and thoracic conditions, The International Urogynecological Association 18 published studies and is sold exclusively to women’s health conditions, hernias, cancer, and (IUGA) has over 3,000 members who specialize experts in female pelvic health. Patients are calling obesity. in disorders of the pelvic floor. The association it life-changing. is dedicated to the global advancement of HALO MEDICAL TECHNOLOGIES urogynecological knowledge and patient care DSE HEALTHCARE SOLUTIONS – Booth 710 through education and the promotion of basic PRELIEF www.halomedtech.com and clinical research on disorders of the female Booth 218 Halo Medical Technologies offers affordable, pelvic floor. www.prelief.com high-resolution ultrasound for diagnosing fecal DSE Healthcare Solutions, LLC offers products that incontinence, visualizing mesh and investigating provide solutions for specialty health concerns. pelvic floor disorders; optimized imaging and Examples of leading specialty health brands proprietary software designed specifically for include: PRELIEF®, a dietary supplement that the urogynecologist; true video recording, and reduces up to 95 precent of the acid in foods complete post-processing capabilities, and and beverages so patients can avoid digestive & EMR-automated reports. Uniquely-configured bladder discomfort caused by acid foods. probes are interchangeable during exams, for one comprehensive report. Visit us at Booth #710.

52 PFD WEEK 2017 OCT 3 – 7 KEY: = Virtual Conference = This session requires a ticket

INTUITIVE SURGICAL LUTRONIC NINOMED Booth 507 Booth 719 Booth 715 www.intuitivesurgical.com www.lutronic.com www.nino-med.com Intuitive Surgical is the global leader in minimally Lutronic introduces BellaV for vaginal rejuvenation NinoMed, LLC is a medical device and business invasive, robotic-assisted surgery. Its da Vinci® therapy with our ACTION II Er:YAG 2940 nm Laser. analytics company passionate about inventing Surgical System – with a 3D-HD vision system and BellaV is a safe, simple solution for problems and developing innovative products and services EndoWrist® instrumentation – enables surgeons to associated with vaginal health. Come visit us at designed to provide improved patient care, safety, offer a minimally invasive approach for a range of Booth #719! efficiency, and value. Safe-T-Secure® by NinoMed complex procedures. da Vinci is used in more than is the original all-in-one integrated trendelenburg Exhibit Hall 3,500 hospitals around the world. MARINA MEDICAL patient positioning solution for robotic and INSTRUMENTS, INC. laparoscopic surgery. INVUITY, INC. Booth 606 Booth 705 MarinaMedical.com NORTON MEDICAL GROUP www.invuity.com Booth 717 Marina Medical is a global medical device www.beanortondoc.com Invuity is a medical technology company focused company and industry leader in the diagnostic and on pioneering the use of advanced photonics to surgical aspects of Women’s Health. Our mission Norton Medical Group maintains 22 years’ provide surgeons with improved direct visualization is to design, develop and deliver surgeon-focused experience operating physician practices and of surgical cavities during open minimally invasive solutions. Stop by our booth to see how our latest Norton Immediate Care Centers throughout and minimal access procedures. Our patented innovations can help you. Kentucky and Southern Indiana. Norton Medical Intelligent Photonics converts traditional thermally Group provides comprehensive management hot, concentrated light output to thermally cool MEDSPIRA, LLC and support services to its medical providers volumetric illumination. and locations. More than 900 employed medical Booth 615 providers and nearly 2,600 employees work in www.medspira.com LABORIE over 210 locations. Booth 316 Medspira partners with leading medical institutions www.laborie.com to develop and market cost-effective diagnosis OLYMPUS and treatment solutions for a variety of medical LABORIE is proud to celebrate 50 years of Booth 718 conditions. Medspira’s mcompass is a portable www.medical.olympusamerica.com innovation and commitment to improving the anorectal manometry system utilized by private lives of patients suffering from urologic and offices and hospitals alike. We are happy to be able As a global technology leader, Olympus develops gastrointestinal disorders. LABORIE’s product line to include ultrasound and our new FDA approved solutions for healthcare professionals to help includes solutions for urodynamics, anorectal biofeedback pelvic floor retraining module on improve clinical outcomes, reduce overall costs manometry, uroflowmetry, ultrasound and pelvic the same hardware platform. The mcompass is and enhance quality of life for patients. Olympus floor rehabilitation. For more information on a great solution to help in the diagnosis and now is a pioneer in developing advanced technologies LABORIE products and educational offerings please treatment of patients with fecal incontinence and for performing minimally invasive gynecologic visit www.laborie.com. chronic constipation. surgeries. We have actively led the way in promoting laparoscopic hysterectomy and laparo- LACLEDE INC. MEDTRONIC endoscopic single site (LESS) surgery, providing training to surgeons and education to patients Booth 617 Booth 501 luvenacare.com www.medtronic.com PACIRA PHARMACEUTICALS, INC. Laclede Inc. is the manufacturer of Luvena Vaginal As a global leader in medical technology, services, Health products specializing in vaginal dryness. Booth 716 and solutions, Medtronic improves the lives and www.pacira.com Luvena products containing natural enzymes are health of millions of people each year. We use our free from harmful ingredients such as parabens deep clinical, therapeutic and economic expertise Pacira Pharma Inc, manufacturers of EXPAREL hormones and chlorhexidine. The product line to address the complex challenges faced by liposomal bupivicaine for post-surgical pain includes, Luvena Vaginal moisturizer, wipe, healthcare systems today. Let’s take healthcare management. enhanced moisturizer, feminine wash and rinse. further, together. Learn more at Medtronic.com. PATHNOSTICS LUMENIS NEOMEDIC INTERNATIONAL Booth 119 Booth 603 Booth 100 www.pathnostics.com www.lumenis.com www.neomedic.com Pathnostics is a cutting-edge diagnostic laboratory, Lumenis is a global developer and distributor of Neomedic International “The Continence focusing on difficult to treat conditions, such as medical laser systems. Lumenis has achieved Company” provides you with the right product for recurrent UTIs, Prostatitis and Interstitial Cystitis. 50 years of excellence, where products are every case: first and only long term adjustable Pathnostics developed a real time molecular recognized worldwide as an industry gold sling; first and only single incision sling without PCR test to help diagnose these conditions and a standard. Products include UltraPulse and anchors; first and only knotless incontinence proprietary antibiotic resistance piece to help the AcuPulse FemTouch fractional CO2 lasers. They mesh; first and only “anchor pulley system” clinician with the treatment course. deliver high standards of quality and reliability with for sacrospinose fixation. Neomedic Int, “The premium value and service. continence Company”.

PFD WEEK 2017 OCT 3 – 7 53 EXHIBITOR DIRECTORY (CONTINUED)

PELVALON SYNERON CANDELA TISSUE REGENIX Booth 708 Booth 216 Booth 112 www.eclipsesystem.com www.syneron-candela.com www.tissueregenixUS.com The Eclipse System is an innovative, non-surgical Syneron Candela is a leading global aesthetic DermaPure®, a next-generation decellularized therapy that offers immediate results for women device company with a comprehensive product dermal allograft, signals a new direction for soft with loss of bowel control. Founded in 2010, portfolio. The Company’s technology enables tissue surgery. Its intact vascular channels signal Pelvalon’s groundbreaking technology originated physicians to provide advanced solutions for cellular activity for enabling graft take, pro- from Stanford University’s Biodesign program, a a broad range of applications including body angiogenic response promotes integration, while collaboration between the schools of medicine and contouring, removal, tattoo removal, wrinkle maintaining the thin profile and biomechanical engineering. Eclipse is now available in limited reduction, and the treatment of vascular/ properties of native tissue for optimized handling geographies across the US. pigmented lesions, acne, leg veins, and cellulite. designed with the surgeon in mind. THE PROMETHEUS GROUP TELEFLEX VIVEVE, INC. Booth 215 Booth 714 Booth 607 www.theprogrp.com www.teleflex.com www.viveve.com Advanced platforms for pelvic floor muscle Teleflex is a global provider of medical Viveve, Inc. is dedicated to developing innovative rehabilitation, urodynamics, anorectal manometry, technologies designed to improve the health and devices in women’s health and wellness. Their multi-compartmental ultrasound, and supporting quality of people’s lives. We apply purpose driven flagship product, the Viveve® System delivers consumables and accessories. innovation—a relentless pursuit of identifying cryogen-cooled Monopolar RF (CMRF) energy deep unmet clinical needs—to benefit patients and into soft tissue while protecting delicate surface SAGENT PHARMA healthcare providers. Our portfolio is diverse, tissue. The Geneveve™ by Viveve procedure is used Booth 116 with solutions in the fields of vascular and in nearly 50 countries to treat vaginal laxity and to www.SagentPharma.com interventional access, surgical, anesthesia, cardiac improve sexual function. care, urology, emergency medicine, and respiratory SCITON care. WOLTERS KLUWER Booth 609 Booth 107 THERALOGIX www.sciton.com www.lww.com Booth 707 Wolters Kluwer is a leading publisher of medical, Sciton is committed to providing best-in-class www.theralogix.com laser and light solutions for medical professionals health, and science publications including Female who want superior durability, performance and Theralogix markets evidence-based, content- Pelvis Medicine & Reconstructive Surgery. We offer value. Sciton offers high-quality medical devices certified nutritional supplements, including an extensive selection of medical books, journals ® for laser-assisted lipolysis, fractional and full- TheraCran ONE , a once-daily capsule and electronic media for health professionals coverage skin resurfacing, hair removal, vaginal independently certified to deliver 36 mg of and students. Visit booth #609 to browse our rejuvenation, phototherapy, wrinkle reduction, cranberry proanthocyanidins (PACs), providing comprehensive product line. treatment of vascular and pigmented lesions, scar round-the-clock bacterial anti-adhesion benefits in reduction, and acne. the lower urinary tract. SOLACE THERAPEUTICS THERMI, AN ALMIRALL COMPANY Booth 208 Booth 601 www.solacetx.com www.thermi.com Solace Therapeutics is an emerging women’s ThermiVa® is an application that uses controlled health company focused on a revolutionary non- radiofrequency energy to gently heat tissue with no surgical office based treatment for unexpected downtime. ThermiVa applications are non-invasive, bladder leaks, the primary symptom of female non-ablative, and require no anesthesia; they Stress Urinary Incontinence (SUI). SUI, the most can be performed in your office at your patients’ prevalent form of incontinence among women, comfort level. The ThermiVa radiofrequency affects an estimated one in three adult women. electrode, designed for use on both internal and Solace is dedicated to improving the quality of external tissues, is disposable, and contoured life for women whose daily life is disrupted by with a sleek, ergonomic design that is easy-to- their incontinence. use. ThermiVa applications are powered by the versatile ThermiRF and ThermiVa device which have proprietary algorithms that allow physicians to select and control the application temperature, providing continuous RF dosage control.

54 PFD WEEK 2017 OCT 3 – 7 SAVE THE DATE

UROGYN

UPDATE12018 Latest Techniques & Emerging Trends

February 22-24, 2018 Andaz Scottsdale Resort and Spa Scottsdale, AZ

Engage with Innovative Problem Solvers Implement New Concepts in your Practice Optimize Patient Care Expand your knowledge of the latest treatments of complex female pelvic floor disorders and the latest important research in the field. Leave the conference with valuable insights from leaders in the field on complex and challenging clinical scenarios that you can implement immediately. Register Today!

For more information, visit www.augs.org/update2018. AUGS AWARD RECIPIENTS

JACK ROBERTSON LIFETIME RAYMOND A. LEE ENDOWMENT ACHIEVEMENT AWARD Marie Fidela Rustia Paraiso, MD Linda Brubaker, MD, MS, FACOG Thursday, October 5 | 2:00 p.m. – 2:30 p.m. Thursday, October 5 | 9:15 a.m. Exhibition Hall C Exhibition Hall C The Raymond A. Lee Endowment is a named AUGS’ most prestigious award is presented lectureship created by AUGS to honor one person periodically to an individual who has had a annually who contributed to the development and surgical lifetime of outstanding achievements in the field of Female advancement of urogynecology and to further advance the Pelvic Medicine and Reconstructive Surgery and has served knowledge and teaching of gynecologic surgery through as a role model through service, basic or clinical research ongoing AUGS educational programs. and teaching. Dr. Brubaker is recognized for her unparalleled contributions to the field of FPMRS. Her research pedigree includes work establishing the Pelvic Floors Disorders Network (PFDN). She is a tireless advocate for the field of FPMRS, as well as women experiencing pelvic floor disorders. Dr. Brubaker is a past president of AUGS and is currently serving as the Editor of Female Pelvic Medicine and Reconstructive Surgery.

RESIDENT SCHOLAR AWARDS This program funds third-year residents who have demonstrated an interest in Female Pelvic Medicine and Reconstructive Surgery to attend the AUGS Annual Scientific Meeting and experience the current research initiatives going on within the field. Each scholar receives a $1,000 award to cover travel, hotel accommodations, and meeting registration.

Kelly Benabou, MD Meagan Sloan Cramer, MD Allison Price Kellogg, MD Brown University/Women and Christiana Care Health University of Texas Infants Hospital System Health Science Center at San Antonio

Kelly Bree, MD Halley Crissman, MD, MPH Michele O’Shea, MD, MPH University of California University of Michigan Northwestern University San Diego

Lindsey Burnett, PhD, MD Kelsey Dressen, MD Lauren Westbay, MD University of California UPMC Graduate Loyola University San Diego Medical Education Medical Center

56 PFD WEEK 2017 OCT 3 – 7 PFD RESEARCH AWARD RECIPIENTS

ROBIN HAFF RESEARCH AWARD PFD RESEARCH FOUNDATION DONOR OF Ann Meers, BS, RN, CCRC THE YEAR AWARD Friday, October 6 | 8:05 a.m. Kimberly Kenton, MD Exhibition Hall C Friday, October 6 | 8:05 a.m. This award is presented annually to an individual Exhibition Hall C in recognition of outstanding and sustained The PFD Research Foundation presents the Donor contribution to female pelvic floor disorders research. The Robin of the Year Award to an individual in recognition Haff Research Award recognizes the important role that clinical of commitment to the Foundation’s mission of transforming the research nurses and research coordinators play in the clinical lives of women through the support of innovative and effective research process. Without dedicated and committed research research that advances the prevention, treatment, and cure of staff, high quality research would not be possible. female pelvic floor disorders. Ms. Meers is recognized for her talents, research skills, and Dr. Kenton is a consistent and generous donor to the Foundation passion. She has been involved in research in women’s health and a strong supporter of the Foundation’s mission. Her lifetime for 20 years, her interest in pelvic floor disorders piqued when donations total is more than $20,000. Awards she realized the many unanswered questions existed in the research. She is both a leader within Brown University and externally, where she served as the Chair for the NICHD Pelvic Floor Disorders Network Research Coordinator Committee.

FOUNDATION GRANT RECIPIENTS PFD RESEARCH FOUNDATION PFD RESEARCH FOUNDATION JUNE ALLYSON MEMORIAL FACULTY RESEARCH AWARD FACULTY RESEARCH AWARD FUND RESEARCH AWARD Mary Ackenbom, MD, Allison Wyman, MD, Judy Yeh, Yale University University of Pittsburgh University of School of Medicine Medical Center South Florida Protective Host Defense Postoperative Cognitive Estimated Levator Ani Mechanisms Against Dysfunction in Older Subtended Volume Urinary Tract Infection Women Undergoing Pelvic (eLASV): A Novel Assay in Bladder Urothelium Organ Prolapse Surgery for Predicting Surgical with Estrogen Receptor ß Outcomes in Pelvic Overexpression Organ Prolapse

PFD WEEK 2017 OCT 3 – 7 57 Help Support the PFD Research Foundation – Make a Donation Today Your contribution to the PFD Research Foundation builds a stronger future for Female Pelvic Medicine and Reconstructive Surgery and honors the work and passion of those we respect. How to Donate Cash Gifts • Gifts of Stocks and Securities • Honoraria and Speaker Fees Book Royalties • Planned Giving • AmazonSmile Visit the AUGS Booth for more information and to make your donation.

Corporate Sponsors Legacy Circle Members Allergan Foundation Linda Brubaker, MD, MS LABORIE Andrew P. Cassidenti, MD Medtronic, Inc. Vincent Lucente, MD, FACOG Donor of the Year Kimberly Kenton, MD, MS The PFD Research Foundation sincerely thanks the following individuals for their generous support. *Gifts Received between September 27, 2016 – August 30, 2017

$1,000 - $4,999 Peter Bulla Roger Goldberg Kimberly Kenton Miles Murphy Peter Scott Jeffrey Clemons Douglass Hale Yuko Komesu Karen Noblett Sandra Valaitis AnnaMarie Connolly Cheryl Iglesia Vincent Lucente Peter Rosenblatt Kristene Whitmore Help Support the PFD Research Foundation – Make a Donation Today Patrick Culligan Margie Kahn Timothy McKinney Amy Rosenman Halina Zyczynski Your contribution to the PFD Research Foundation builds a stronger future for Female Pelvic Medicine and Reconstructive Surgery and honors the work and passion of those we respect. $500 - $999 Cindy Amundsen Emily Lukacz Elizabeth Mueller Nazema Siddiqui How to Donate Felicia Lane Danielle Markle Price Deborah Myers Steven Swift Cindi Lewis Shawn Menefee Osvaldo Padron Jennifer Wu Cash Gifts • Gifts of Stocks and Securities • Honoraria and Speaker Fees Book Royalties • Planned Giving • AmazonSmile $250 - $499 Visit the AUGS Booth for more information and to make your donation. Vivian Aguilar Sean Francis Una Lee Neven Matthews Lora Plaskon Heidi Brown Chiara Ghetti Juraj Letko Carlos Medina Mitchell Schuster Christopher Chermansky W. Thomas Gregory Jerry Lowder Tyler Muffly Adam Steinberg Sarah Collins Victoria Handa Karl Luber Begum Ozel Elisa Trowbridge Kathleen Connell Magdalene Karon Sangeeta Mahajan Stephanie Picket

$100 - $249 Mary Ackenbom Elisabeth Erekson Jessica Hammett Rhonda Kotarinos Sallie Oliphant Carmen Sultana Michael Bonidie Pamela Fairchild Marie-Andree Harvey Christine LaSala Amy Park Gary Sutkin Sylvia Botros-Brey Tola Fashokun Bryan Hill Jennifer Lee Brent Parnell Jasmine Tan-Kim Jessica Bracken Kimberly Ferrante Jun Ihara Quinn Lippman Samantha Pulliam Babak Vakili Catherine Bradley Peter Finamore Keisha Jones Ali Luck Lieschen Quiroz Anthony Visco Lauren Cadish Michael Flynn Amie Kawasaki Marisa Mastropietro Charles Rardin Patricia Wallace Susan Capelle Raymond Foster Kristinell Keil Brook McFadden Rebecca Rogers Renee Ward Sage Claydon Anthony Gaddi Charles Kilpatrick Jessica McKinney Jonathan Shepherd Emily Whitcomb Sandra Culbertson Elizabeth Geller Anna Kirby Kate Meriwether Stuart Shippey, III Raul Yordan-Jovet Christina Dancz Karen Gold Leise Knoepp Michelle Morrill Laura Skoczylas Michelle Zinnert Corporate Sponsors Legacy Circle Members Keisha Dyer Cara Grimes Abner Korn Mikio Nihira Scott Smilen Autumn Edenfield Robert Gutman Elizabeth Kotarinos John Occhino Andrew Sokol Allergan Foundation Linda Brubaker, MD, MS LABORIE Andrew P. Cassidenti, MD Under $100 Emily Adams-Piper Amy Collins Robert Flora Kathy Jones-Gutzmer Cara Ninivaggio Monique Vaughn Medtronic, Inc. Vincent Lucente, MD, FACOG Danita Akingba Jill Danford Elizabeth Frankman Kimberly Kenne Michael Noone May Wakamatsu Marianna Alperin Bhumy Davé Sean George Linda Kiley Cedric Olivera Shannon Wallace Tirsit Asfaw G. Willy Davila Cynthia Hall Joseph Kowalski Anita Pillai-Allen Andrew Walter Donor of the Year Jennifer Bickhaus Nicolette Deveneau Anne Hardart Christina Kwon Mark Preston Hsin Wang Katarzyna Bochenska Michael Douso Gerardo Heredia Alix Leader-Cramer Megan Schimpf Emily Weber LeBrun Kimberly Kenton, MD, MS Cynthia Brincat Bruce Drummond Melero Doug Miyazaki David Schleicher Joshua Woelk Kristen Buono Tanaka Dune Markus Huebner Bob Moreland Saya Segal Michael Woods Camille Calderwood Sonia Dutta Melissa Huggins Margaret Mueller Neha Talreja Ladin Yurteri-Kaplan Cassandra Carberry Caroline Elmer Heather Jeffcoat Erinn Myers Megan Tarr Andrew Cassidenti Chidimma Eto Peter Jeppson Hoa Nguyen Heather van Raalte AUGS LEADERSHIP (2016-2017)

BOARD OF DIRECTORS DIRECTORS AT LARGE President Rony A. Adam, MD Halina M. Zyczynski, MD Vanderbilt University University of Pittsburgh School of Medicine

Jeffrey L. Clemons, MD MultiCare Health System President Elect Charles R. Rardin, MD, FACOG, FACS Alpert Medical School of Brown University Shawn A. Menefee, MD Kaiser Permanente, San Diego

Vice President Geoffrey W. Cundiff, MD, FACOG, FACS, FRCSC Mikio A. Nihira, MD, MPH University of British Columbia, OB/GYN University of California, Riverside

Adam C. Steinberg, DO Treasurer Hartford Hospital Raymond T. Foster, Sr., MD, MS, MHSc.

University of Missouri School of Medicine

Jennifer M. Wu, MD, MPH University of North Carolina at Chapel Hill

Immediate Past President

Douglass S. Hale, MD Methodist Hospital of Indiana

PFD Research Foundation Chair

Sandra R. Valaitis, MD

University of Chicago Hospital

AUGS Chief Executive Officer Michelle Zinnert, CAE PFD Research Foundation Vice Chair American Urogynecologic Society Karen L. Noblett, MD

University of California Irvine School of Medicine

60 PFD WEEK 2017 OCT 3 – 7 PAST PRESIDENTS AUGS STAFF Douglass Hale, MD (2015–2016) Michelle Zinnert, CAE Amy Rosenman, MD (2014–2015) Chief Executive Officer Charles Nager, MD (2013–2014) Colleen Hughes Anthony G. Visco, MD (2012–2013) Chief Operating Officer Matthew D. Barber, MD, MHS (2011–2012) Nicole Cranston Deborah Myers, MD (2010–2011) Sr. Director, Education Programs Rebecca Rogers, MD (2009–2010) Tresha Russell Dee Fenner, MD (2008–2009) Sr. Director, Quality and Performance Improvement Kris Strohbehn, MD (2007–2008) Tristan Wood Ingrid Nygaard, MD (2006–2007) Manager, Membership and Community Programs Joseph Montella, MD (2005–2006) Lindsay Smith Stephen Young, MD (2004–2005) Membership Assistant Michael Aronson, MD (2003–2004) Cynthia Stubits Linda Brubaker, MD (2002–2003) Events Senior Manager Peggy Norton, MD (2001–2002) W. Conrad Sweeting, MD (2000–2001) Ame Petry Events Coordinator Nicolette Horbach, MD (1999–2000) Mickey Karram, MD (1998–1999) Cristina Adames Richard Bump, MD (1997–1998) Events Senior Associate Robert Shull, MD (1996–1997) Lauren Lawson John O. L. DeLancey, MD (1995–1996) Education Senior Manager Alfred Bent, MD (1994–1995) Amanda O’Kane John Higgins, MD (1993–1994) Marketing and Communications Manager Charles deProsse (1992–1993) Jayne Corso J. Thomas Benson (1991–1992) Marketing and Communications Coordinator David A. Richardson (1990–1991) Jeffrey Reeves Ernest I. Kohorn (1989–1990) Staff Accountant Henry A. Thiede (1988–1989) Richard O. Davis, MD (1987–1988) J. Andrew Fantl, MD (1986–1987) Gynecologic Urology Society R. Peter Beck, MD (1985–1986) Donald R. Ostergard, MD (1984–1985) Douglas J. Marchant, MD (1983–1984) W. Glenn Hurt, MD (1982–1983) Hugh M. Shingleton, MD (1981–1982) C. Paul Hodgkinson, MD (1980–1981) Jack R. Robertson, MD (1979–1980)

PFD WEEK 2017 OCT 3 – 7 61 ANCHORSURE® – DO IT SIMPLE

Safe & easy placement

The thinnest applicator, the strongest anchoring

Your less invasive sacrospinous ligament fixation system.

Visit us at Booth 100

For more info, contact us at [email protected] or visit our website www.neomedic.com COMMITTED TO REDEFINING RELIEF

Twenty years ago, Medtronic introduced you to sacral neuromodulation and transformed the way you treat incontinence.

Today, we’re even more committed to pelvic health and serving patients.

Together, we’ll continue to redefine relief.

Stop by the Medtronic Booth and partner with us to create your personalized OAB care pathway.

Indications for Use: Sacral Neuromodulation delivered by the InterStim™ system for Urinary Control is indicated for the treatment of urinary retention and the symptoms of overactive bladder, including urinary urge incontinence and significant symptoms of urgency-frequency alone or in combination, in patients who have failed or could not tolerate more conservative treatments. The following Warning applies only to Sacral Neuromodulation for Urinary Control: Warning: This therapy is not intended for patients with mechanical obstruction such as benign prostatic hypertrophy, cancer, or urethral stricture. Sacral Neuromodulation delivered by the InterStim™ system for Bowel Control is indicated for the treatment of chronic fecal incontinence in patients who have failed or are not candidates for more conservative treatments. Contraindications for Urinary Control and for Bowel Control: Diathermy. Patients who have not demonstrated an appropriate response to test stimulation or are unable to operate the neurostimulator. Warnings/Precautions/Adverse Events: For Urinary Control: Safety and effectiveness have not been established for bilateral stimulation; , unborn fetus, and delivery; pediatric use under the age of 16; or for patients with neurological disease origins. For Bowel Control: Safety and effectiveness have not been established for bilateral stimulation; pregnancy, unborn fetus, and delivery; pediatric use under the age of 18; or for patients with progressive, systemic neurological diseases. For Urinary Control and for Bowel Control: The system may be affected by or adversely affect cardiac devices, electrocautery, defibrillators, ultrasonic equipment, , MRI, theft detectors/ screening devices. Adverse events include pain at the implant sites, new pain, lead migration, infection, technical or device problems, adverse change in bowel or voiding function, and undesirable stimulation or sensations, including jolting or shock sensations. Patients should be assessed preoperatively for the risk of increased bleeding. For full prescribing information, please call Medtronic at 1-800-328-0810 and/or consult Medtronic’s website at www.medtronic.com. Product technical manual

UC201803163 EN must be reviewed prior to use for detailed disclosure. USA Rx Only. Rev 0517

UC201803163 EN - AUGS 2017 Program Ad_FY18_v4a.indd 1 8/22/17 10:16 AM ®

Single Incision Sling System

The ONLY SLING with a AUGS Womens Health | Coloplast Altis Ad AUGS Womens Health Bleed 8.75x11.25 Trim: 8.5x11

premarket IDE study

success for key

1 ZIMMER/MADICH 90% outcomes at 2 years

Patient Improvement Pad Weight Reduction 7540 Marketplace Drive, Minneapolis MN 55344

90.4% 87.9% 90% 81.1% very much better negative pad weight reduction dry* 24 hour or much better1 CST1 of at least half1 pad weight1 compared to baseline

To learn more, visit ColoplastMD.com or ask your Coloplast sales representative for additional information.

1. Kocjancic E, Erickson E, Tu L-M, Gheiler E, Van Drie E. Two-Year Outcomes for the Altis® Adjustable Single Incision Sling System for Treatment of Stress Urinary Incontinence. Neurourol Urodyn. Released electronically October 29, 2016.

*Dry defined in study as 24 hr pad weight of ≤ 4.0g Indications: The Altis Single Incision Sling Systems are indicated for the treatment of female stress urinary incontinence (SUI) resulting from urethral hypermobility and/or intrinsic sphincter deficiency (ISD). Contraindications: Altis slings should not be used in pregnant women, or in women planning future or any patient with potential for future growth. Altis slings should not be used in those who are taking anticoagulant therapy, who have an abnormal urethra, who have an intra-operative urethral injury, are immunocompromised, who have a sensitivity to polypropylene, have a pre-existing local or systemic infection, who are immunocompromised, or women that have a known or suspected pathology which would compromise implant or implant placement. Warnings and Precautions: It is the responsibility of the surgeon to advise the prospective patients or their representatives, prior to surgery, of the possible warnings and precautions associated with the use of this product and the associated surgical risks. The Altis Sling Systems should only be used by surgeons familiar with the surgical procedures and techniques involving transvaginal placement of non-absorbable meshes and who have adequate education and experience in the treatment of female SUI. Based on physician experience and education, a thorough assessment of each patient should be made to determine the suitability of a synthetic mesh procedure. The patient should be counseled that alternative non-mesh incontinence surgeries may be appropriate, and the reason for choosing a mesh procedure should be explained. Physician should obtain patient consent prior to surgery and ensure that the patient has an understanding of the postoperative risks and potential complications of transvaginal mesh surgery. Patient counseling should include a discussion that the mesh to be implanted is a permanent implant, and that some complications associated with the implanted mesh may require additional surgery; repeat surgery may not resolve these complications. Serious adverse tissue responses or infection may require removal of mesh. Adverse Effects: Potential adverse events are those associated with surgery using implantable synthetic mesh materials. As with all foreign bodies, the Altis sling is likely to exacerbate any existing infection. Local irritation at the wound site and/or a foreign body response may occur. The following complications are known to occur with synthetic mesh implantation: mesh erosion (e.g., vaginal, bladder), mesh extrusion, mesh exposure, infection, pain (acute or chronic), and bladder, bowel, urethra, vagina, vessel, and/or nerve perforation/injury. There is also the risk of complete failure of the procedure resulting in continued incontinence due to incomplete support or overactive bladder. The occurrence of these events may require partial or complete removal of the sling. Patients should be monitored regularly after the device has been implanted for immediate treatment of any adverse reaction. See the device instructions for use for detailed information regarding the implant procedure, warnings /precautions, adverse reactions, prior to using this product. For further information, call Coloplast Corp at 800.258.3476 and/or consult the company website at www.coloplast.us.com Caution: Federal law (USA) restricts this device to sale by or on the order of a physician. Coloplast Corp. 1601 West River Road North, Minneapolis, MN 55411 USA Customer Service 800.258.3476 www.coloplast.us The Coloplast logo and Titan are registered trademarks of Coloplast A/S ©2017 All rights reserved Coloplast Corp. PM-01510 10.17